TREATMENT OF MYEOPROLIFERATIVE DISEASES

FIELD OF THE INVENTION

The invention comprises methods of reducing the numbei of platelets in mammals and pi eventing or tieating pio-thronϊbotic conditions and diseases that are characterized by an excess of, or undesired activation of, platelets using inhibitors of anti-apoptotic Bcl-2 family protein members

BACKGROUND OF TFIE INVENTION Platelets are anucleated blood cells derived from megakaryocytes that are essential for proper hemostasia and thrombosis Apoptosis-like processes have also been linked to platelet biogenesis (i e thrombopoiesis) and aging (i.e senescence) The processes of apoptosis have been extensively studied in nucleated cells; however, its role in anucleated cells is less defined. Cytochrome c, caspase-9, caspase-3, and APAF-I have been reported to be expressed in platelets indicating that platelets contain the necessary apoptotic machinery to execute programmed cell death Several studies have demonstrated that the Bcl-2 family proteins (i e. Bax, Bak, BCI-XL , and Bcl-2) are also expressed in platelets The Bcl-2 family of pioteins are the key regulators of mitochondria-dependent apoptosis in nucleated cells and consists of both anti-apoptotic (BCI-XL, Bcl-2, Bcl-w, Al, McI-I) and pro-apoptotic (Bak, Bax, Bid, Bim, Bad, Bik, Bmf, Noxa, Puma) members The decision for a cell to progress through the apoptotic pathway is dependent on the interplay between these pro-survival and pro-death proteins The pro-apoptotic proteins propagate the death signal by ultimately inducing permeabilization of the mitochondrial membrane, release of cytochrome c and caspase activation. The anti-apoptotic family members exert their protective effects by directly binding to and sequestering their pro-apoptotic counterparts Inhibition of anti- apoptotic Bcl-2 protein family members is known to induce apoptosis in cells that are dependent on these proteins for survival

Although circulating platelet production is a normal physiological process, a number of diseases are caused or exacerbated by excess of, or undesired activation of, platelets

There is therefore an existing need in the therapeutic arts for methods of reducing the number of platelets in mammals and preventing or treating pro-thrombotic conditions and diseases that are characterized by an excess of, or undesired activation of, platelets

BRIEF DESCRIPTION OF THE FIGURES

FIG 1 shows the effect of oial administration of N-(4-(4-((2-(4-chlorophenyl)-4,4- dimethylcyclohex- 1 -en- 1 -yl)methyl)pipeiazin- 1 -yl)benzoyl)-4-((( 1 R)- 3-(morpholin-4-yl)~ 1 - ((phenylsulfanyl)methyl)propyl)amino)-3-({tiifluoromethyl)su lfonyl)benzenesulfoπamide on ciiculating platelets in dogs over 24 hours

FIG 2 shows the effect of oral administration of 3-((chloro(difluoro)rneιhyl)sulfonyl)- N-(4-(4-((2-(4-chloiophenyl)-4,4-dimethylcyclohex- 1 -en- 1 -yl)methyl)pipeiazin- 1 - yl)benzoyl)-4-((( 1 R)-3~(morpholin-4-yl)-l - ((pheny3sulfanyl)melhyl)propyl)amino)benzenesulfonarnide on ciiculating platelets in dogs over 48 hours

FIG 3 shows the comparative effect of intravenous administration of N-(4-(4-({4'- chloro( 1 , 1 '-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-4-((( 1 R)-3-(dimeιhylamino)- 1 - ((phenylsulfanyl)methyl)pτopyl)amino)-3-nittobenzenesulfona mide versus the vehicle in which it is administered on circulating platelets in dogs over 72 hours.

FIG 4 shows the effect of oral administration of representative compounds 3-((chloro(difluoio)methyl)sulfonyl)-N-(4-(4-((2-(4-chloroph enyl)-4,4- dimethylcyclohex-l-en-l-yl)methyI)piperazin-l-yl)benzoyl)-4- (({lR)-3'(dimethylamino)-l- ({phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide (EXAMPLE 1 ),

N-(4_(4 -((2-{4-chloropheny 1) -5 , 5 -dimefhy 3 - 1 -cyclohex- 1 -en- 1 -y l)methyl)pipei azin- 1 - yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)m ethyl)propyl)amino)-3- ((tiifluoromethyl)sulfonyl)benzenesulfonamide (EXAMPLE 2),

N-(4-(4-((2-(4~chlorophenyl)-4 ,4-d i methy lcycl ohex- 1 -en- 1 -yl)methy 1 )piper azin- 1 - y l)benzoyl) -4 -((( 1 R)-3 -(dimethyl amino) - 1 -((phenylsulfanyl)methyl)pi opy 1) am ino)-3 - ((trifiuoiomethyl)sulfonyl)benzenesulfonamide (EXAMPLE 3),

N~(4-(4-((2-(4-chlorophenyl)cyclohex-l -en-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- ((( 1 R)-3-(2-oxa-5-azabicyclo[2,2 1 ]hept-5-yl)-l -((phenylsuIfanyI)methyl)pτopyl)amino)-3- ((trifluoiomethyl)sulfonyl)benzenesulfonamide (EXAMPLE 4),

3-((chloio(difluoio)tnethyl)sulfonyl)-N-(4-(4-((2-(4-chIo rophenyl)-4,4- dimelhylcyclohex-1 -en- 1 -yl)methyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-3-(morpholin-4-yι)-l - ((phenylsulfanyl)methyl)propyl)aniino)benzenesulfonamide (EXAMPLE 5), and

N-(4-(4-((2-(4-chloioplienyl)-4,4-dimethylcyclohex-l-en-l -yl)metliyl)piperazin-l- yl)benzoyl)-4-(({ 1 R)-3-(morpholin-4~yl)-l -((phenylsulfanyl)methyl)propyl)arnmo)-3- ({trifluoromethyl)sulfonyl)benzenesuϊfonarnide {EXAMPLE 6),

that inhibits the activity of anti-apoptotic Bcl-2 family protein members on circulating platelets in dogs.

FIG. S shows the effect of multiple oral daily dosing of N-(4-(4-((2-(4-chloiophenyl)- 5, 5 -dimethyl- 1 -cyclohex-l-en-1 -yl)methyl)piperazin-l~yl)benzoyl)-4-(((l R)-3-(morpholin-4- yI)-l-((phenylsulfanyl)rnethyl)piopyl)amino)-3- ((trif!uoromethyl)sulfonyl)benzenesulfonamide on the amount of circulating platelets in dogs.

SUMMARY OF THE INVENTION

We have discovered that inhibitors of Bcl-2 protein family members can induce a rapid, dose-dependent decrease in circulating platelets in multiple species

Therefore, one embodiment of this invention comprises compositions for preventing or treating diseases caused, exacerbated by or resulting from an excess of, or undesired activation of, platelets in a mammal, said compositions comprising a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member.

Another embodiment comprises methods of preventing or treating diseases caused, exacerbated by or resulting from an excess of, or υndesired activation of, platelets in a mammal comprising administering thereto a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member, wherein the compound has an inhibitory potency (IC5 ₀ ) of less than about 100 nanomolar, less than about 50 nanomolar, less than about 10 nanomolar or less than about 1 nanomolar

DETAILED DESCRIPTION OF THE INVENTION

Series of antagonists of antiapoptotic Bcl-2 family protein membeis ate disclosed in commonly-owned United States Application Ser. No 11/432,937 and United States Application Ser, No. 11/491,851, the specifications of which are hereby incorpoiated by ieference into this application It has since been recognized that these agents display a unique thrombocytopenia characterized by rapid clearance of ciicularing platelets in mouse, rat and dog

One embodiment of this invention comprises methods of preventing or treating diseases caused, exacerbated by or resulting ftora an excess of, or undesired activation of, platelets in a mammal comprising administering thereto a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member

Another embodiment comprises methods of preventing or treating diseases caused, exacerbated by or resulting ftorn an excess of oi undesired activation of platelets in a mammal comprising administering thereto a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member, wheiein the compound has an inhibitory potency (IC ₅₀ ) of less than about 100 nanomolar, less than about 50 nanomolar, less than about 10 nanomolar or less than about 1 nanomolar

Still another embodiment comprises methods of reducing the number of platelets in mammals and preventing or treating pro-thrombotic conditions and diseases that are characterized by an excess of, or undesiied activation of, platelets.

Still another embodiment comprises methods of preventing or treating essential tlπombocythemia in a mammal comprising administering thereto a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member

Still another embodiment comprises methods of preventing or treating essential thrombocythemia in a mammal comprising administering thereto a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member, wherein the compound has an inhibitory potency (IC ₅₀ ) of less than about 100

nanomolar, less than about 50 nanomolar, less than about 10 nanomolar or less than about 1 nanomolar

Still another embodiment comprises methods of reducing the number of platelets in a mammal and preventing or treating essential thrombocythemia

Still another embodiment comprises methods of preventing or treating essential thrombocythemia in a mammal comprising administering thereto N-(4-{4-((4'-chloro(l,i'- biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-{((lR)-3-(di methylamino)-l" {(phenylsulfanyl)rnethyl)propyl)amino)-3~nitrobenzenesulfona mide or

N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl- 1 -cyclohex-1 -en-1 -yl)methyl)piperazin-l - yl)benzoyl)-4-(({lR)-3-(moipholin-4-yl)-l-({phenylsulfanyl)m ethyI)propyl)amino)-3- ({tτifluoromethyl)sulfonyl)benzenesulfonamide

Still another embodiment comprises methods of preventing or treating essential thrombocythemia in a mammal comprising administering thereto the compound N-(4-(4-((4'- chIoro(l,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4-( ((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)methyI)piopyl)amino)-3-nitrobenzenesulfonam ide oi the compound N-(4-(4-((2-(4-chloiophenyl)-5,5-dimethyl-l-cyclohex-l-en-l- yl)methyl)pipeiazin- 1 -yl)benzoyl)-4-((( lR)-3-(moipholin-4-yl)-l - ((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoiomethyl)su lfonyl)benzenesulfonamide,

wherein the compound has an inhibitory potency (IC50) of less than about 100 nanomolar, less than about 50 nanomolar, less than about 10 nanomolar or less than about 1 nanomolar

Still another embodiment comprises methods of reducing the number of platelets in a mammal and preventing or treating essential thrombocythemia

Still another embodiment comprises methods of preventing or treating polycythemia vera in a mammal comprising administering thereto a compound which non-selectively or selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member

Still another embodiment comprises methods of preventing or treating polycythemia vera in a mammal comprising administering thereto a compound which non-selective] y oi selectively inhibits the activity of an anti-apoptotic Bcl-2 family protein member, wherein the compound has an inhibitory potency (IC ₅ 0) of less than about 100 nanomolar, less than about 50 nanomolar, less than about 10 nanomolar or less than about 1 nanomolar

Still anothei embodiment comprises methods of reducing the number of platelets in a mammal and preventing or treating polycythemia vera

Still another embodiment comprises methods of preventing or treating polycythemia vera in a mammal comprising administering thereto N-(4-(4-((4'-chloro(l,l'-biphenyl)-2- yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(dimethylamino) -l- ((phenylsulfanyl)methyl)propyl)amino)-3~nitrobenzenesulfonam ide 01

N-(4-{4-((2-(4-chlorophenyl)-5,5-dimethyl-l -cyclohex-l-en-1 -yl)methyl)piperazin-i - yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)m ethyl)propyl)amino)-3- ((triflυoromethyl)sulfonyl)benzenesulfonamide

Still another embodiment comprises methods of preventing or treating polycythemia vera in a mammal comprising administering thereto the compound N-(4-(4-((4'-chloto(l,r- biphenyl)-2-yl)metliyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(d imethylamino)-l- ((phenylsulfanyl)methyl)propyl)ammo)-3-nitrobenzenesulfonami de or

the compound N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-l-cyclohex-l-en-l- yl)methyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-3-(morpholin-4-yl)-l -

((pheny lsulf anyl)m ethyl)pr opyl) amino)-3-({tri fluoromethyl)sulfony l)benzenesu lfonamide ,

wherein the compound has an inhibitory potency (IC ₅₀ ) of less than about 100 nanomolar, less than about 50 nanomolar, less than about 10 nanomolar or less than about 1 nanomolar.

Still another embodiment comprises methods of reducing the number of platelets in a mammal and preventing or treating polycythemia vera

As used heiein, a "Bcl-2 protein family inhibitoi" refers to a therapeutic compound of any type, including small molecule-, antibody-, antisense-, small interfering RNA-, or microRNA-based compounds, that binds to at least one of Bcl-2, BcI-XL, and Bcl-w, or their corresponding rnRNAs including untranslated regions, and antagonizes the activity of the Bcl-2 family related nucleic acid or protein. The inventive methods are useful with any known or hereafter developed Bcl~2 family inhibitor Preferred Bcl-2 protein family inhibitors aie

N-(4-(4-((4'-ch!oro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)- 3- (dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-3-nitrobenzenesulfona rnide and

N-(4-(4-((2-(4-chloiophenyl)-5,5-dimethyI-l -cyclohex-1 -en-l-yl)m.ethyl)piperazin-l - yl)benzoyl)-4-(((lR)-3-(moφholin-4-yl)-l-((phenylsulfanyl)m etliyl)propyl)amino)-3- ((tiifluoromethyl)sulfonyl)benzenesulfonamide _}

both of which are capable of binding to Bcl-2, BcI-XL, and Bcl-w.

Diseases caused or exacerbated by an excess of, or undesired activation of, platelets include, but ate not limited to, essential thrombocytopenia, polycythemia vera, M7 acute myelogenous leukemia, restenosis, cardiovascular disease, perioperative antiplatelet therapy, device-associated thrombi and complications associated therewith, and the like.

Involvement of platelets in essential thrombocythemia is reported in Seminars in Hematology (2005), 42(4), 230-238 and also in New Eng J Med , 2005, 353: 1 , 33-45

Involvement of platelets in polycythemia vera is reported in Seminars in Thrombosis and Hemostatis (2006), 32(3), 267-275.

Involvement of platelets in restenosis is reported in Journal of Clinical Pathology (2006), 59(3), 232-239.

Involvement of platelets in cardiovascular disease is reported in International Journal of Clinical Practice (2003), 57(10), 898-905,

7 077579

Involvement of platelets in perioperative antiplatelet therapy is reported in Journal of Thrombosis Thrombolysis

Diseases or conditions that result from elevated platelet levels include bleeding, thrombosis or other thromboembolic complication, initiation or worsening of other diseases or disorders of the blood, such as "sticky platelet" syndrome

Bcl-2 family protein members mean Bcl-2 protein and proteins having a structural homology thereto such as, for example, BCI-XL and Bcl-w

Compounds which inhibit the activity of Bcl-2 family protein members may do so non-selectively or selectively, wherein non-selective inhibitors bind to two or more than two Bcl-2 family protein members and selective inhibitors bind to one Bcl-2 family protein member preferentially over the other Bcl-2 family protein members

Examples of non-selective and selective binders for the practice of this invention include, but are not limited to, compounds having formula (I)

(I), and therapeutically acceptable salts, prodrugs and salts of prodrugs thereof, wherein

A ¹ is N or C(A ² );

one or two or three or each of A , B , D and E are independently selected R , OR , SR ¹ , S(O)R ¹ , SO ₂ R ¹ , C(O)R ¹ , C(O)OR ¹ , OC(O)R ¹ , NHR ¹ , N(R^ ₂ , C(O)NHR ¹ , C(0)N(R') ₂ , NHC(O)R ¹ , NHC(O)OR ¹ , NR ¹ C(O)NHR ¹ , NR ^! C(0)N(R ^S ) ₂₎ SO ₂ NHR ¹ , SO ₂ N(R ^! ) ₂ ,

NHSO ₂ R ¹ ^HSO ₂ NHR ¹ or N(CH ₃ )SO ₂ N(CH ₃ )R ¹ , and the remainder are independently selected H, F, Cl, Br, I, CN, CF ₃ , C(O)OH, C(O)NH ₂ or C(O)OR ^{1 A} ; and

Y ¹ is H, CN, NO ₂ , C(O)OH, F, Cl, Br, I, CF ₃ , OCF ₃ , CF ₂ CF ₃ , OCF ₂ CF ₃ , R ¹⁷ , OR ¹⁷ , C(O)R ¹⁷ , C(O)OR ¹⁷ , SR ¹⁷ , NH ₂ , NHR ¹⁷ , N(R ^{! 7} ) ₂ , NHC(O)R ¹⁷ , C(O)NH ₂ , C(O)NHR ¹⁷ , C(O)N(R ¹⁷ ) ₂ , NHS(O)R ¹⁷ oi NHSO ₂ R ¹⁷ ; or

B and Y , logethei with the atoms to which they are attached, are imidazole or tiiazole; and

one or two oτ each of A , D and E are independently selected H, R , OR , SR , S(O)R ¹ , SO ₂ R ¹ , C(O)R ¹ , C(O)OR ¹ , OC(O)R ¹ , NHR ¹ , N(R ¹ ) ₂ , C(O)NHR ¹ , C(O)N(R ¹ ) _2ϊ NHC(O)R ¹ , NHC(O)OR ¹ , NHC(O)NHR ¹ , N(CH ₃ )C(O)N(CH ₃ )R ¹ , SO ₂ NHR ¹ , SO ₂ N(R ¹ ) _2> NHSO ₂ R ¹ , NHSO ₂ NHR ¹ OrN(CH ₃ )SO ₂ N(CH ₃ )R ¹ , and the remainder are independently selected H, F, Cl, Br, I, CF ₃ , C(O)OH, C(O)NH ₂ or C(O)OR ^{1 λ} ;

R ¹ is R ² , R ³ , R ⁴ or R ⁵ ;

. 1A

R is Ci-Ce-alkyl, C ₃ -C ₆ -alkenyl or C ₃ -C ₆ -alkynyI;

R is phenyl which is unfused or fused with benzene, heteroaiene or R ; R is cycloalkane oi heterocycloalkane;

R is heteioary] which is unfused or fused with benzene, heteroarene or R ; R is cycloalkane or heteiocycloalkane;

R is cycloalkyl, cycloalkenyl, heterocycloalkyl oi heteiocycloalkenyl, each of which

4A 4A is unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heteiocycloalkane or heterocycloalkene;

R is alkyl, allcenyl or alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R ⁶ , NC(R ^6A )(R ^6B ), R ⁷ , OR ⁷ ₅ SR ⁷ , S(O)R ⁷ , SO ₂ R ⁷ , NHR ⁷ , N(R ⁷ ) ₂ , C(O)R ⁷ , C(O)NH ₂ , C(O)NHR ⁷ , NHC(O)R ⁷ , NHSO ₂ R ⁷ , NHC(O)OR ⁷ ,

SO ₂ NH ₂ , SO ₂ NHR ⁷ , SO ₂ N(R ⁷ ) ₂ , NHC(O)NH ₂ , NHC(O)NHR ⁷ ,

NHC(O)CH(CH ₃ )NHC(O)CH(CH ₃ )NH ₂ , NHC(O)CH(CH ₃ )NHC(O)CH(CH ₃ )NHR' , OH ₁ (0), C(O)OH, N ₃ , CN, NH ₂ , CF ₃ , CF ₂ CF ₃ , F, Cl, Bi oi I substituents;

R is each of which is unsubstituted oi substituted with OH, (O),

N ₃ , CN, CF ₃ , CF ₂ CF ₃ , F, Cl, Br, I, NH ₂ , NH(CH ₃ ) or N(CH ₃ ) ₂ ;

R and R are independently selected alkyl oi, together with the N to which they are attached, R ;

R is aziridin-1-yl, azetidin-1-yl, pyπolidin-1-yl oi piperidin-l-yl, each having one CH ₂ moiety unreplaced or replaced with O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ oi NH;

R is R , R , R or R ;

R is phenyl which is unfused or fused with benzene, heteioarene oi R ;

R is phenyl which is unfused or fused with benzene, heteroarene oi R ; R is cycloalkane, cycloalkene, heteiocycloalkane or heterocycloalkene;

R is heteroaryl which is unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R is C ₃ -Cio-cycloalkyl, C ₄ -Cio-cycloalkenyl, C ₃ -Ci o-heterocycloalkyl or C ₄ -C]o-heterocycloalkenyl, each of which is unfused or fused with cycloalkane, cycloalkene, heterocycloalkane oi heterocycloalkene;

R is alkyl, alkenyl or alkynyl, each of which is unsubstituted oτ substituted with one oi two or three independently selected R ^{I 2} _> OR ¹² , NHR ¹² , N(R ¹² ) ₂ , C(O)NH ₂ , C(O)NHR ¹² , C(O)N(R ¹² ) ₂ , OH, (O), C(O)OH, N ₃ , CN, NH ₂ , CF ₃ , CF ₂ CF ₃ , F, Cl, Br or I substituents;

„ 12 . -, 13 „ 14 _n 15 „ 16

R is R , R , R oi R ;

R is phenyl which is unfused oi fused with benzene, heteroaiene or R ; R is cycloalkane, cycloalkene, heteiocycloalkane or heterocycloalkene;

R is heteroaiyl, each of which is unfused or Fused with benzene, heteroarene or

I ₄ A 14A

R ; R is cycloalkane, cycloalkene, heteiocycloalkane oi heteiocycloalkene;

R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene, each of which is unfused or fused with benzene, heteioarene oi R ; R is cycloalkane, cycloalkene, heterocycloalkane oi heteiocycloalkene;

, 16

R is alkyl, alkenyl or alkynyl;

_π 17 • γ-, 18 „ 19 „20 _n 21

R is R , R , R or R ;

R is phenyl which is unfused oi fused with benzene, heteroaiene or R ; R is cycloalkane, cycloalkene, heteiocycloalkane or heterocycloalkene;

R is heteioaryl which is unfused oi fused with benzene, heteioarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R is C ₃ -Cio-cycϊoalkyl or C- _f -Cio-cycloalkenyl, each having one or two CH ₂ moieties unreplaced or replaced with independently selected O, C(O) ₅ CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unieplaced 01 replaced with N, and each of wwhhiicchh iiss uunnffuusseedd oorr ffuusseedd wwiitthh bbeennzzeennee,, hheetteerrooaarreennee oor R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one 01 two or three independently selected R ²² , OR ²² , NHR ²² , N(R ²² ) ₂ , C(O)NH ₂ , C(O)NHR ²² , C(O)N(R ²² ) ₂ , OH, (O), C(O)OH, N ₃ , CN, NH ₂ , CF ₃ , CF ₂ CF ₃ , F, Cl, Br or I substituents;

„22 . „23 „24 „25

R is R . R or R ;

R is phenyl which is unfused oi fused with benzene, heteioarene oi R ; R is cycloalkane, cycloalkene, heterocycloalkane or heteiocycloalkene;

R is heteroatene which is unfused oi fused with benzene, heteioarene ot R ; R is cycloalkane, cycloalkene, heterocycloalkane or heteiocycloalkene;

R is Cj-Cc-cycloalkyl or C ₄ -CVcycϊoalkenyl, each having one or two CH ₂ moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unreplaced oi replaced with N, and each of which is

25A 25A unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

Z is R or R , each of which is substituted with R , R or R , each of which is substituted with F, Cl, Br, ϊ, CH ₂ R ³⁷ , CH(R ³ⁱ )(R ³⁷ ), C(R ³¹ )(R ^{31 A} )(R ³⁷ ), C(O)R ³⁷ , OR ³⁷ , SR ³⁷ , S(O)R ³⁷ , SO ₂ R ³⁷ , NHR ³⁷ or N(R ³² )R ³⁷ ;

R is phenyl which is unfused oi fused with benzene oi heteroaieπe;

R is heteroarene which is unfused or fused with benzene oi heteroarene;

R is phenyl which is unfused or fused with benzene, heteroaiene oi R ; R is cycloalkane, cycloalkene, heterocycloalkane oi heteiocycloalkene

R is heteioaryl or R ; R is cycloalkane, cycloalkene, heteiocycloalkane oi heterocycloalkene;

R is cycloalkyl or cycloalkenyl, heterocycloalkyl or heteiocycloalkenyl, each of

3OA 3OA which is unfused oi fused with a benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R ³¹ and R ^31A are independently F, Cl, Bi or alkyl or aie taken together and are Cj-Cs-spiroalkyl;

R ³² is R ³³ , C(O)R ³³ oi C(O)OR ³³ ;

_π 33 . „ 34 _n J5

R is R or R ;

R is phenyl which is unfυsed oi fused with aryl, heteroaiyl oi R ; R is cycloalkane, cycloalkene, heterocycloallcane or heteiocycloalkene;

R is alkyl which is unsubstituted or substituted with R ;

R is phenyl which is unfused or fused with benzene, heteioaiene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heteiocycloalkene;

R ³⁷ is R ³⁸ , R ³⁹ or R ⁴⁰ , each of which is substituted with F, Cl, Br, I, R ⁴¹ , OR ⁴¹ , NHR ⁴¹ , N(R ⁴¹ ) ₂ , NHC(O)OR ⁴¹ , SR ⁴¹ , S(O)R ⁴¹ or SO ₂ R ⁴ ';

R is phenyl which is unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R is heteroaryl which is unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R ⁴⁰ is C ₃ -Cg-cycloalkyl or C^Cg-cycloalkenyl, C ₃ -Cg-heterocycloalkyl or

40A

C ₃ -Cg-cycloalkenyl, each of which is unfused oi fused with benzene, heteroarene or R ; R cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

_n 4\ ■ „42 „43 _n 44 ^45

R is R , R , R or R ;

R is phenyl which is unfiised or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heteiocycloalkane oi heterocycloalkene;

R is heteioaiyl which is unfused or fused with benzene, heteroaiene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heteiocycloalkene;

R is C3-C6-cycloalkyl oi Q-Ce-cycloalkenyl, C3-C<;-heterocycloalkyl oi C ₄ -C ₆ ~heterocycloalkenyl, each of which is unfused or fused with benzene, heteioaiene oi

₄₄ A 44A

R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R is alkyl, alkenyl or alkynyl, each of which is unsυbstituted or substituted with one oi two independently selected R ⁴⁶ , OR ⁴⁶ , NHR ⁴⁶ , N(R ⁴⁶ J ₂ , C(O)NH ₂ , C(O)NHR ⁴⁶ , C(O)N(R ⁴⁶ ) _2l OH, (O) ₁ C(O)OH, N ₃ , CN, NH ₂ , CF ₃ , CF ₂ CF ₃ , F, Cl, Br or I substituents;

„46 ■ „47 _π 48 „49 R is R , R or R ;

R is phenyl which is unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane oi heterocycloalkene;

R is heteioaryl or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

R is Cj-Cβ-cycloalkyl or C ₄ -C ₆ ~cycloalkenyl, each having one or two CH ₂ moieties unieplaced or replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unreplaced oi replaced with N, and each of which is unfused or fused with benzene, heteroarene or R ; R is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;

wherein each foregoing cyclic moiety is independently unsubstituted, further unsubstituted, substituted oi further substituted with one oi two or three or four or five independently selected R ⁵⁰ , OR ⁵⁰ , SR ⁵⁰ , S(O)R ⁵⁰ , SO ₂ R ⁵⁰ , C(O)R ⁵⁰ , CO(O)R ⁵⁰ , OC(O)R ⁵⁰ , OC(O)OR ⁵⁰ , NH ₂ , NHR ⁵⁰ , N(R ^S0 ) ₂ , C(O)NH ₂ , C(O)NHR ⁵⁰ , C(O)N(R ⁵⁰ ) ₂ , C(O)NHOH,

C(O)NHOR ⁵⁰ , C(O)NHSO ₂ R ⁵⁰ , C(O)NR ⁵⁵ SO ₂ R ⁵⁰ , SO ₂ NH ₂ , SO ₂ NHR ⁵⁰ , SO ₂ N(R ⁵⁰ ) ₂ , CF ₃ , CF ₂ CF ₃ , C(O)H, C(O)OH, C(N)NH ₂ , C(N)NHR ⁵⁰ , C(N)N(R ⁵⁰ J ₂ , OH, (0), N ₃ , NO ₂ , CF ₃ , CF ₂ CF ₃ , OCF ₃ , OCF ₂ CF ₃ , F, Cl ₁ Br or I substituents;

_n S0 . „5! _n 52 „53 „54

R is R , R , R or R ;

R is phenyl which is unfused or fused with benzene, heteioaiene oi R ; R is cycloalkane, cycloalkene, heteiocycloalkane or heterocycloalkene;

R is heteroaryl or R ; R is cycloalkane, cycloalkene, helerocycloalkane oi heterocycloalkene;

R is C ₃ -C6-cycloalkyl, C4-C ₆ -cycloalkenyl, C3-C<;-heterocycloalkyl, or C ₄ -C ₆ -CyCl oalkenyl, each of which is unfused or fused with benzene, heteroarene or R ;

53A R is cycloalkane, cycloalkene, heterocycloalkane or heteiocycloalkene;

R is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one or two oi three independently selected R ⁵⁵ , OR ⁵⁵ , SR ⁵⁵ , S(O)R ⁵⁵ , SO ₂ R ⁵⁵ , NHR ⁵⁵ , N(R ⁵⁵ ) ₂ , C(O)R ⁵⁵ , C(O)NH ₂ , C(O)NHR ⁵⁵ , NFIC(O)R ⁵⁵ , NHSO ₂ R ⁵⁵ , NHC(O)OR ⁵⁵ , SO ₂ NH ₂ , SO ₂ NHR ⁵⁵ , SO ₂ N(R ⁵⁵ ) ₂ , NHC(O)NH ₂ , NHC(O)NHR ⁵⁵ , OH, (O), C(O)OH, (O), N ₃ , CN, NH ₂ , CF ₃ , OCF ₃ , CF ₂ CF ₃ , OCF ₂ CF ₃ , F, Cl, Br or I substituents;

R is alkyl, alkenyl, alkynyl, phenyl, heteroaiyl, C ₃ -C ₆ -cycloalkyl, C/t-C _δ -cycloalkenyl, C ₃ -C ₆ -heterocycloaIkyl, or Q-Cg-cycloalkenyl.

Preferred compounds of formula (I) are compounds having formula (I)-a

(I)-a,

2007/077579 and therapeutically acceptable salts, prodrugs and salts of prodrugs thereof, wherein

5a

R is hydrogen, alkyl, alkenyl oi alkynyl, each of which is unsubstituted oi substituted with one or two or three independently selected R ⁶ , NC(R ^6A )(R ^6B ), R ⁷ , OR ⁷ , SR ⁷ , S(O)R ⁷ , SO ₂ R ⁷ , NHR ⁷ , N(R ⁷ ) ₂ , C(O)R ⁷ , C(O)NH ₂ , C(O)NHR ⁷ , NHC(O)R ⁷ , NHSO ₂ R ⁷ , NHC(O)OR ⁷ , SO ₂ NH ₂ , SO ₂ NHR ⁷ , SO ₂ N(R ⁷ ) ₂ , NHC(O)NH ₂ , NHC(O)NHR ⁷ , OH, (O), C(O)OH, (O), N ₃ , CN, NH ₂ , CF ₃ , CF ₂ CF ₃ , F, Cl, Br or I substiluents

Repiesentative compounds for the piactice of this invention include, but aie not limited to,

N-(4-(4-((l,l'-biphenyl)-2-ylmelhyl)piperazin-l-yl)benzoy l)-4-(((lR)-3- (dimethylarnino)-l-((ρhenylsulfanyl)methyl)propyl)amino)-3- nitτobenzenesulfonamide, N- (4-(4-((4'-chloro(l ,r-biphenyl)-2-yl)melhyl)piperazin-l -yl)benzoyl)-4-(((l R)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3-ni tTObenzenesulfonamide, 4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)piopyl) amino)-N-(4-(4-((4'- methoxy( 1 ,1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-3-nitrobenzenesυlfonamide,

4-(((lR)-3-(dimethylarnino)-i-((phenylsulfanyl)methyl)pro pyl)amino)-N-(4-(4-((4'~ fiuoro(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3-n itrobenzenesulfonarnide,

4-(((lR)-3-(diπiethylamino)-l-((phenylsulfanyl)melhyl)piopy l)aniino)-N-(4-(4-((4 ^t - (methylsulfanyl)(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)be nzoyl)-3- nitrobenzene sulfonamide,

N-((4-(((lR)-3-(diraethylaτnino)-l-((phenylsulfanyl)meth yl)piopyl)amino)-3- nitτophenyl)sulfonyl)-4-(4-(4'-phenyl-l,r-biphenyl-2~ylinet hyl)pipeiazin-l-yl)benzamide,

4-({(lR)-3-(dimetliylamino)-l-((phenylsulfanyl)methyl)ρr opyl)amino)-3-nitτo-N-(4- (4-((4'-phenoxy(l , 1 '-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)benzene sulfonamide,

N-(4-(4-((l ,1 '-biphenyl)-2-ylmethyl)pipeiazin-l -yl)benzoyl)-4-((l ,1 -dimethyl-2- (phenylsulfanyl)ethyl)amino)-3-nitiobenzenesulfonamide,

N-(4-(4-((l,r"biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl )-4-(((lR)-3-(morpholin- 4-yl)-l-((phenylsulfanyl)methyl)piopyl)amino)~3-nitrobenzene sulfonamide, N-(4-(4"((l,r-biphenyl)~2-ylmethyl)piperazin-l-yl)benzoyl)-3 -nitτo-4-((2-

(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((4' -chlot o( 1 , 1 '-biphenyl) ~2-yl)methyl)pip ei azin- 1 -yl)benzoyl) - 3 -ni tr o-4-{ ( 2 - (phenylsulfanyl)ethyl)amino)benzenesulfonamide _s

N-(4-(4-((4'-chloro( 1 ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyI)-4-(((l R)-3- (morpholin-4-yl)-l-((phenylsulfanyl)methyl)piopyl)amino)-3-n itrobenzenesulfonamide,

N-(4-(4-((4'-chloro(l , l'-biphenyl)-2-yl)methyl)pipeτazin-l -yl)benzoyl)-4-((l ,1 - dimethyl-2-(plienylsulfanyl)ethyl)amino)-3-nitiobenzenesulfo namide, N-(4-(4-{(4'"chloio(l,l ^< -biphenyl)~2-yl)methy3)piperazin-l-yl)benzoyl)-4-(((lR)-4-

(dimethylamino)-l~((phenylsuIfanyl)methyl)butyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-((4'-chIoro{l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-({(lR)-5- (dimethylamino)-l-((phenylsulfanyl)methyl)pentyl)amino)-3-ni trobenzenesulfonamide,

N-(4-(4-((4'-fluoro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (morpholin-4-yl)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3-nitrobenzenesulfona mide,

N-(4-(4-((4'-chloro-4-fluoro(l,r-biphenyl)-2-yl)methyl)pi perazin-l -yl)benzoy])-4- ((( 1 R)-3-(dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-3- nitϊobenzenesulfonamide,

N-(4-(4-((4 ^l -chloro(l ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((l R)-3- (dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-3- (tiifluorometliyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l ,r-biphenyI)-2-yl)methyl)pipemzin-l-yl)benzoyl)-4-(((IR)-3- (morphoIin-4-yl)-l-((phenyIsulfanyl)methyl)propyl)amino)-3- (tτifluoromethyl)benzenesulfonamide, N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-3-nitro-4-

(((lR)-l-((phenylsulfanyl)methyl)-3-(pyrrolidin-l-yl)prop yl)amino)benzenesu3fonamide,

N-(4-(4-((4'-chIoro(l , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyI)-4-(( 1,1- dimelhyl-2-(l ,3-thiazol-2-ylsuIfanyl)ethyl)amino)-3-nitrobenzenesu1fonami de,

N-{4-(4-((4 ^< -chloro(l ,l ^t -biphenyl)-2-yl)methyl)piperazin-l-yl)benzoy])-4-(({lR)-3- (dimethylamino)- 1 -(( 1 ,3-thiazol-2-ylsulfanyl)methyl)piopyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-bipheny3)-2-yl)methyl)piperazin-l -yl)benzoy])-4-(((lR)-3- (dimethylamino)-l-((tiiien-2-ylsulfanyl)metliyl)propyl)amino )-3-nitrobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piρerazin-l -yl)benzoyl)-4-((( 1 R)-2-(2- (dimethyl amino)ethoxy)- 1 -((phenylsulfanyl)methyl)ethyl)amino)-3- nitrobenzenesulfonamide,

N-(4~(4-((4'-cliloro(l,r-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-4-(((lS)-3- (dimethylamino)-l-metliyl-l-((phenylsulfanyl)methyl)propyl)a mino)-3- nitrobenzene sulfonamide,

N-(4-(4-((4'-chloio< 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (methylamino)-l-((phenylsulfartyl)methyl)propyl)amino)-3-nit iobenzenesulfonarnide,

(3R)-3-(4-(((4-(4-((4'-chloro(l _s l ^l -biphenyl)-2-yl)methyl)pipeiazin-l - yl)benzoyl)amino)sulfonyl)-2-nitroanilino)-4-(phenylsulfanyl )butanoic acid, (3R)-.3-(4-(({4-(4-((4 ^! -chloro(l,l'-biphenyl)-2-yl)methyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-nitioanilino)-N-isopropyl-4-(ph enylsulfanyl)bulanamide _s

N-(4-(4-((4 ¹ -chloro(l,l'-biphenyl)-2-yl)methyl)ρipeiaziπ-l-yl)benzoyl) -4-(((lR)-3- (diisopropylamino)-l-((phenylsuIfanyl)niethyl)propyl)amino)- 3-nitrobenzenesulfonamide ₅

4-(((lR)-3-(azetidin-l-yl)-l-((phenylsulfanyl)methyl)prop yl)amino)-N-(4-(4-((4'- chloio(l ,l'-biphenyl)-2-yl)methyl)piperazin-l-yI)benzoyl)-3-nitioben zenesulfonarnide,

N-(4-(4-((4'-chloiO(l , 1 '-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3-nitro-4-(( 4- (phenylsulfanyl)tetrahydiO-3-furanyl)amino)benzenesulfonamid e,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yI)inethyl)-4-metliox ypiperidin-l-yl)benzoyl)-4- (((IR)-3-(diπiethylamino)-l-((pheπylsulfanyl)rnethyl)propy l)amino)-3~ nitrobenzenesulfonamide,

N-(4-(4-((4 ^t -chloro(l,l ^l -biphenyl)-2-yl)methyl)-4-methoxypipetidin-l-yl)benzoyl)-4- (((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)metl ^' iyl)piopyl)amino)-3- nitrobenzenesulfonamide

N-(4-(4-((4'-chloio(l , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3- hydroxy- 1 -((phenylsulfanyl)metliyl)propyl)amino)-3-nitrobenzenesulfon amide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)pipeiazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (isopropylamino)-l-((phenyIsulfanyl)methyl)piopyl)amino)-3-n itrobenzenesulfonamide,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)piop yl)amino)-N-(4-(4-(2-(2- naphthyl)benzyl)pipeiazin-l-yl)benzoyl)-3-nilτobenzenesulfo namide, 4-(((lR)-3-(diniethylamiπo)-l-((phenylsulfanyl)methyl)propy l)amino)-N-{4-(4-(2-(l- naphthyl)benzyl)pipeiazin-l-yl)benzoyl)-3'nitrobenzenesulfon ainide,

N~(4-(4-((3'-cyano(l,l ^t -biphenyl)-2-yl)melhyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((ρhenylsulfanyl)methyl)piopyl)aniino)-3- nitrobenzenesulfonamide,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)prOpyl) amino)-N-(4"(4-((3 ^t -- methoxy(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3- nitiobenzenesulfonamide,

K-(4-(4-((3 ¹ -chloro(l ,l'-biplienyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)- 3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3-ni trobenzenesulfonamide

N-(4-(4-{(2 ^! -chloio(l ,l'-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4-(((lR)-3 - (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3-ni tiObenzenesulfonamide,

N-{4-(4-(2-(l,3-benzodioxol-5-yl)benzyl)piperazin-l-yl)be nzoyl)~4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)metliyl)ptopyl)amino)-3-n itrobenzenesulfonamide,

4-((( 1 R)-3-(dimeihylamino)-l -((phenylsulfanyl)melhyl)propyl)ammo)-3-nitio-N-(4- (4-(2-(3-thienyl)benzyl)piperazin-l-yl)benzoyl)benzenesulfon amide, 4-((( 1 R)-3-(dimethylamino)-l -((phenylsulfanyl)rnetliyl)propyl)amino)-3-nitro-N-(4-

(4-(2-(pyridin-3-yl)benzyl)pipeiazin-l-yl)benzoyl)benzene sulfonamide,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)piop yl)amino)-3-nitro-N-(4- (4-(2-(quinolin-8-yl)benzyl)piperazin-l -yl)benzoyl)benzenesulfonaraide,

N-(4-(4-(2-(l-benzofuran-2-yl)benzyl)pipeiazin-3-yl)benzo yl)-4-(((lR)-3- (dimethylamino)- 1 ~({phenylsulfanyl)methyl)propyl)amino)-3-nitrobenzenesυlfon amide,

4-(((lR)-3-(dimelhylamino)-l-((phenylsulfanyl)methyl)pTOpyl) amino)-N-(4-(4-((2'- methyK 1 , 1 ^t -biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-3-nitiobenzenesulfonaτnide,

4-(((lR)-3-(dimethylamino)-l-((phenylsυlfanyl)methyl)pro pyl)amino)-3-nitro-N-(4- (4-(2-(quinolin-3-yl)benzyl)piperazin-l-yI)benzoyl)benzenesu lfonainide, N-(4-(4-((l-(4-chloiophenyl)-2-naphthyl)methyl)piperazin-l-y l)benzoyl)-3-nitro-4-

((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((l-(4-chlorophenyl)-2-naphthyl)methyl)piperazin- l-yl)benzoyI)-4-(((lR)-3- (dimethy]amino)-l-((phenylsulfanyl)methyl)ptopyl)amino)-3-ni tiobenzenesulfonamide,

N-(4-(4-((l-(4-chloτophenyl)-2-naphthyl)methyl)pipeiazin -l-yl)benzoyl)-4-(((lR)-3- (moipholin-4-yl)-l-((phenylsulfanyl)methyl)piopyl)amino)-ϊ- nitτobenzenesulfoπamide,

N-(4-(4-((4'-chloro(l ,r-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-3-πitro-4-((2- (pheny lsul fanyl )cycl opentyl) amino)benzene sul fonamide ,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-methoxypiperidin-l-yI) benzoyl)-3-nitro-4-({2- (phenylsulfanyl)cyclopentyl)amino)benzenesulfoπamide, N-{4-(4-((4 ^l -fiuoro(l,l'-biphenyl)-2-yl)methyI)pipeiazin-l-yl)benzoyl)-3 -nitro-4-((2-

(phenylsu]fanyl)eti.iyl)amino)benzenesulfonamide,

N-(4-(4-((3',4'-dichloro( 1 , 1 '-biphenyl)-2-yl)mcthyl)piperazin-l -y1)benzoyl)-3-nitro-4- ((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-{4-{4-((3',4'-dicliloroCl , 1 '-biphenyl)-2-yl)me ⁽ hyl)ρipeiaziτi-l-yl)benzoyl)-4-((( 1 R)- 3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3- nitiobenzenesulfonarnide,

N-(4-(4-((3' _J 4 ^t -dichloro{l ,r-biphenyl)-2-yl)methyl)pipeiazin-l-y3)benzoyl)-4-(((lR)- 3-(moipholin-4-yl)-l-((phenylsulfanyl)melhyl)propyl)amino)-3 -nitrobenzenesulfonamide,

3-nitio-4-({2-(phenylsulfanyl)ethyl)amino)-N-(4-(4-((4'-( trifluotomethyl)(l,r- biphenyl)-2-y])methyl)piperazin-l-yl)benzoyl)benzenesulfonam ide,

4-{((lR)-3-(dimethylaraino)-l-((ρhenylsulfanyl)methyl)propy l)amino)~3-nitro-N-{4- (4-((4'-(trifluoromethyl)Ci , 1 ^! -biphenyl)-2-yl)methyl)piperazin-l - yl)benzoyl)benzenesulfonamide,

4-(((l R)-3-(morpholin~4-yl)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3-nitro-N-(4- (4-{{4 ^! ~(trifluoromethyl)( 1 _: 1 '-biphenyl) -2~yl)methyl)piperazin- 1 - yl)benzoyl)benzenesulfonamide,

3-nitTo-4-((2-(phenylsulfanyl)ethyl)amino)-N-(4'(4-((4'-( ftifluoroniethoxy)(l,r- biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)benzenesuIfonam ide,

3-ni1io-4-((2-(phenylsulfanyl)etliyl)amino)-N-{4-(4-((4 ^t -(trifluoromethoxy)(l,r- biphenyl)-2"yl)methyl)piperazin-l-yl)benzoyl)benzenesulfonam ide,

4-((( 1 R)-3-(motpholin-4-yl)-l -{(phenylsulfanyl)methyl)piopyl)amino)-3-nitio-N-(4- (4-((4 ^! -{tτifluorOmethoxy)( 1 ,r-biphenyl)-2-yl)methyl)piperazin-l - y l)b enzoyl)benzenesulfonamide,

3-nitro-N-(4-(4-((4'-phenoxy(l,l'-biphenyl)-2-yl)methyl)pipe iazin-l-yl)benzoyl)-4- ((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide _!

4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)metliyl)pi opyl)amino)-3-nilτo-N-(4- (4-( (4'-phenoxy ( 1 , 1 '-biphenyl) -2 -yl)methyl)piperazin- 1 -y 1 )benzoyl)benzenesul fonamide ,

N-(4-(4-((4'-chloro( 1 ,r-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-4-(((l S)-3- (dimethylamino) - 1 -((phenyl sulfanyl)methyl)pi opyl)am ino) -3 -nitr obenzenesulf onamide , N-(4-(4-((4 ^l -chloro(l,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)ben2oyl)-4- ((l,l- dimethyl-2-(phenylsulfonyl)ethyl)amino)-3-nitrobenzenesulfon amide _I

N-(4-(4-((2' _J 4 ^l -dichloro(l _t r-biphenyl)-2-yl)πiethyl)piperazin-l-yl)benzoyl)-4-(((lR)- 3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3- nitrobenzenesulfonamide,

4-(((lR)-3~(dimethylamino)-l-((phenylsulfanyl)methyl)prop yl)amino)-3-nitτO-N-{4- (4-(2-(2-lhienyl)benzyl)piperazin-l-yl)benzoyl)benzenesulfon amide,

N-(4-(4-((4'-chloro-2'-methyI( 1 , 1 '-biphenyl) -2-y 3 )me thy l)pipeiazin-l -yl)benzoyl)-4- (((lR)-3-(dimethylamino ^' )-l-((phenylsulfanyl)methyl)propyl)amino)-3- nitrobenzene sυl fonamide,

N-(4-(4-((2' ₎ 4'-dif!uoro(l , 1 '-biphenyl)-2-yl)raethyl)piρeiazin-l -yl)benzoyl)-4-(((l R)- 3-(dimethylamino)-l-((phenylsulfanyl)rnethyl)proρyl)amino)- 3-nitrobenzenesulfonamide,

N-(4~ (4-(( 1 , 1 ' ~biphenyl)-2-ylmethyl)pipei azin- 1 -yl )benzoyl)-3-niti o -4 -((2- (phenylsulfonyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3-nitio-4-{(2- (phenylsulfonyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((l ,l '-biphenyl) -2 -y 1 methyl )piperazin- 1 -yl)benzoyl)-3 -ni ti o-4-((4- (phenylsulfanyl)tetrahydro-3-furanyl)amino)benzenesulfonamid e,

4-(((lR)-3-(dimethylamino)-l-({phenylsulfanyl)methyl)prop yl)amino)-N-(4-(4-(2-(5- methyl-2-thienyl)benzyl)pipeiazin-l-yl)benzoyl)-3-nitrobenze nesulfonamide, N-(4-(4-((4'-chloro(l ,r-biphenyl)-2-yl)melhyl)piperazin-l -yl)benzoy])-3-nitio-4-((4-

(phenyϊsulfonyl)telτahydro-3-furanyl)amino)benzeπesulfona mide ₅

N-(4-(4"({l ,r-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl)-3-nitio-4-(( 4- (phenyIsulfonyl)tetiahydro-3-fuianyl)amino)benzenesulfonamid e,

N-(4-(4-((4 ⁱ -chloio(l ,r-biphenyl)-2-yl)melhyl)piperazin-l-yl)benzoyl)-4-((l -methyl- 4-(phenylsulfanyl)pyπolidin-3-yl)amino)-3-nitiobenzenesulfo namide,

N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- (((lR)-3-(morpholin-4-yl)-l-((phenylsuIfanyl)methyl)propyl)a miπo)-3- nitxobenzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen- 1 -yl)methyl)piperazin-l -yl)benzoyl)-4~ (((lR)-3-(morpholin-4-yl)-l -((phenylsulfanyl)methyl)propyl)amino)-3- nitrobenzenesulfonamide ,

N-(4-(4-({4'-biomo(I ,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- (dimetliylaniino)-l-{(phenyIsulfanyl)methyl)propyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-( 1 - (4'-chloi o( 1 , 1 '-biphenyl)-2-yl)cyclopropyl)pipei a zin- 1 -yl)benzoyl) -4 - (((lR)-3-(diraethylamino)-l-((phenylsulfanyl)methyl)piopyl)a mino)-3- nitiobenzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyl)-l -cyclohexen- l-yl)melhyl)pipetazin-l -yl)benzoyl)-4- (((lR)-2-(dimethylamino)-l-((phenylsulfanyl)meihyl)etliyl)am ino)-3- nitrobenzenesulfonamide, N-(4-(4-((4'-chlorO(l _I l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-2-

(dimethylamino)-l-((phenylsulfanyl)methyl)ethyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-2- (diethylamino)-l-((phenylsulfanyl)methyl)ethyl)amino)-3-niti obenzenesulfonamide,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((lR)-2- (morpholin-4-yl)-l-((phenylsulfanyl)methyl)ethyl)amino)-3-ni trobenzenesulfonamide,

N-(4-(4-((2-(4~chlorophenyl)-l -cyclohexen-1 -yl)metliyl)piperazin-l -yl)benzoyl)-4- {((lR)-2-(diethylamino)-l-((phenylsulfanyl)methyl)ethyl)amin o)-3-nitiobenzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyl)- 1 -cyclohexen- 1 -yl)methyl)pipet azin- 1 -yl)benzoyl)-4- (((lR)-2"(morphoIin-4-yl)-l-((phenylsulfanyl)methyl)ethyl)am ino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4'-chloio( 1 , r-biphenyl)-2-yl)methyl)ρiρerazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (cyclopropyl(methyl)amino)-l-((phenylsulfanyl)methyI)piopyl) amino)-3- nitiobenzene sulfonamide ,

N-(4-(4-((l ,l'-biphenyl)-2-ylmethyl)-4-methoxypiperidin-l-yl)benzoyl)-4 -(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3-ni trObenzenesu1fonamide,

4-((( 1 R)-3-(dimethylamino)-l -{(phenylsulfanyl)methyl)ptopyl)amino)-N-(4-(4- methoxy-4-(2-(pyridin-3-yI)benzyl)piperidin- 1 -yl)benzoyl)-3-nitτobenzenesulfonamide,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)melhyl)prop yl)amino)~N-(4-(4- methoxy-4-(2-(pytidin-4-yl)benzyl)piperidin-l-yl)benzoyl)-3- nitrobenzenesulfonamide,

4-(((lR)-3-(dimetliylamino)-l-((phenylsulfanyl)methyl)pro pyl)amino)-N-(4-(4- methoxy-4-(2-{2-thienyl)benzyl)piperidin-l-yl)benzoyl)-3-nit iobenzenesulfonaniide, 4-(((l R)-3-(dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4- methoxy-4-(2-{ 3-thieny l)benzyl)piperidin- 1 -yl)b enzoyl) -3-nitrobenzene sul fonami de ,

4-(((lR)-3-(azetidin-l-yl)-l-((phenylsulfanyl)methyl)propyl) amino)-N-(4-(4-((4 ^! - chloro(l,l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3- nitrobenzenesulfonamide,

N-(4-(4-((4'-chloro(l ₎ r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3-nitro-4- ((( IR)-I -((phenylsulfanyl)mβthyl)-3-((2,2,2- trifluoioethyl)amino)ptopyl)amino)benzenesυlfonamide _J

N-(4-(4-((4 ^l -chloro(l,l'-biphenyl)-2-yl)methyl)pipeiazin-l»y3)benzoyl)" 4-(((lR)-3- (metliyl(2,2,2-trifluoroethyl)aτnino)-l-((phenylsulfanyl)me thyl)propyl)amino)-3- nittobenzenesulfonamide, N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)-4-τnethoxypiperidin- 1 -yl)benzoyl)-4-

((( 1 R)-3-(moφholin-4-yl)-l -((phenylsulfanyl)methyI)propyl)amino)-3- niti obenzenesul fonamide,

N-(4-(4-((4 ^t -chloro(l,r-biphenyl)-2-yl)methyl)-4~methoxypiperidin-l-yl)b enzoyl)-3- nitro-4-((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide, N-(4-(4-((4 ^t -chloro(l,l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4 -(((lR)-3-

(ethyl(2,2,2-tτifluoroethyl)amino)-l-((phenylsulfanyl)me thyl)propyl)amino)-3- nitrobenzenesulfonamide,

N-(4-(4-C(4 ¹ -chloio(l,l'-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4 -(((lR)-3- ((2-fluoroethyl)amino)-l-((phenylsulfanyl)methyl)piopyl)amin o)-3- nitrobenzene sul fonam ide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)raeihyl)ρiρeiazi n-l-yl)benzoyl)-4-(((tR)-3- ((2,2-difluoroethyl)amino)-l-((phenylsulfanyl)methyl)piopyl) amino)-3- nitrobcnzenesulfonamide,

N-(4-(4-((4 ^l -chloro(l,l ^t -biphenyl)-2-yl)rnelliyl)pipeiazin-l-yl)benzoyl)-l-((lR)-3- (dimethylamino)- 1 -({phenylsulfanyl)methyl)propyl)-l H-benzimidazole-5-sulfonamide,

N-(4-(4-((4 ⁽ -chIoio( 1 , 1 '-biphenyl>2-yl)methyl)piperazin- 1 -yl)benzoyl)- 1 -(( 1 R)-3- (dimethylamino)- 1 -((phenylsulfanyl)methyl)propyl)- 1 H- 1 ,2, 3-benzotiiazole-5-sulfbnamide,

5-(((4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin -l- yl)benzoyl)amino)sulfonyl)-2-(((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)niethyl)propyl)amino)benzamide,

N-(4~(4-{(4 ^< -(dimethylamino)(l,r-biphenyl)-2-yl)carbonyl)piperazin-l-yl) benzoyl)-4- {((lR)-3-(dimethylamino)-l-{(phenylsulfanyl)methyl)piopyl)am ino)-3- nitr obenzenesul fonami de ,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl) aniino)-N-(4-(4-((4 ^t - (methylsulfanyl)(l , 1 ⁽ -biphenyl)-2-yl)carbonyl)piperazin-l -yl)benzoyl)-3- nitrobenzenesulfonamide, 4-(((3 R)-3 -(dimethylamino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4-((4 ^l -

(methylsulfanyl)(l,r-biphenyl)-2-yI)carbonyl)pipeiazin~l- yl)benzoyl)-3- nitrobenzenesul fonamide ,

N-(4-(4-((4'-chloto(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl )benzoyl)-3-cyano-4- (((lR)-3-(diraethylamino)-l-((phenylsulfanyl)methyl)propyl)a mino)benzenesulfonamide, N-(4-(4~((4'-chloio(l,l ¹ -biphenyl)-2-yl)methy3)piρe ₁ azin-l-yl)benzoyl)-4-(((lR)-3-

(diraethylamino)-l-((phenylsulfanyl)methyl)piopyl)oxy)-3- nitiobenzenesulfonamide,

N"(4-(4-((4 ^t -chloio(l,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4- ({(lR)-3- (4,4-dimethyl-4,5-dihydro-lH-imidazol-l-yl)-l-((phenylsulfan yl)methyl)propyl)amino)~3- nitrobenzenesul fonamide, N-{4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin-l-y l)benzoyl)-4-(((lR)-3-

(5,6-dihydro-l(4H)~pyiimidin-l-yl)-l-((phenylsulfanyl)met hyl)propyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-((4'-chloro(l , l'-biphenyl)-2-yl)rnethyI)pipeiazin-l -yl)beπzoyl)-4-(((lR)-3-(2- methyl^^-dihydio-lH-irnidazol-l-y^-l-tCphenylsulfany^methylJ propy^aminoJ-S- nitiobenzenesulfonamide,

N-(4-(4-{(4 ¹ -chloro(l ,l ^t -biplienyl)-2-yl)raethyl)piperazin-l-yl)benzoyl)-4-(((lR)-.� �- (5,6-dihydio-l (4H)-pyrimidin-l -yl)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3- (tiifluoromethyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l,l ¹ -biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4-(((lR)-3- (2,4-dimetliyl-4,5-dJhydro-lH-imidazol-l-yl)-l-((phenylsulfa nyl)methyl)propyl)amino)-3- (trifluoromethyl)benzenesulfonamide, N-(4-(4-((4'-chloro( 1 ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((l R)-3-(2- methyl-4,5-dihydro-lH-imidazol-l-yl)-l-((phenylsulfanyl)meth yl)propyl)amino)-3- (tiifluoromethyl)benzenesulfonamide,

N-(4-(4-((4'-chloio(l,l'-biphenyl)-2-yl)methyl)piperazin-l-y l)benzoyl)-4-(((lR)~3- (4 ₅ 4-dimethyl-4,5-dihydro-lH-imidazol-l-yl)-l-({phenylsulfanyl) methyl)piopyl)amino)-3- (trifluoromethyl)benzenesulfonamide,

N-(4-(4-((2-(4-chloroplienyl)- 1 -cyclohexen- 1 -yl)methyl)piperazin-l -yl)benzoyl)-4- {((lR)-3-(dimethylamino)-i-((phenylsulfaτiyl)met]iyl)propyl )oxy)-3- (tτifiuoiOmethyl)benzenesulfonamide,

N-(4-(4- ((2-(4 -chloi ophenyl)cyclohept- 1 -en- 1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4- ((( lR)-3-{dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-3- (tiifluoromethy^benzenesulfonamide,

4-(({lR)-3-(bis{2-methoxyethyl)amino)-l-((phenylsulfanyl)met hyl)propyI)amino)-N- (4-(4-((4'-chIoro(l,l ^l -biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3- nitiobenzenesulfonamide, 4-(((lR)-3-(bis(2-methoxyetliyl)amino)-l-((phenylsulfanyl)me thyl)propyl)amino)-N-

(4-(4-((4'-chloro(l,l ^l -biphenyl)-2-yI)methyl)pipeiazin-l-yl)benzoyl)-3- (trifluoromethyl)benzenesulfonamide,

4-(((lR)-5-amino-l-{{phenylsulfanyl)methyl)pentyl)amino)~N-( 4-(4-((4'-chloro(l,l ^l - biphenyl)-4-yl)methyl)-l-piperazinyl)benzoyI)-3-nitiobenzene sulfonamide, N-(4-(4-((l,l'-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl)- 4-(((lR)-4-methyl-l-

((plienylsulfanyl)methyl)pentyl)arnino)-3-nitτObenzenesu lfonaniide, tert-butyl(5R)-5-(4-(((4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)piperazin-l - yl)benzoyl)amino)sulfonyl)-2-nitroanilino)-6-(phenylsulfanyl )hexylcaibamate,

4-(((lR)~5-amino-l-((phenylsulfanyl)methyl)pentyl)amino)-N-( 4-(4-((4 ^t -chloro(l,r- biphenyl)-2-yl)methyl)piperazm-l-yl)benzoyl)-3~m ^' tτobenzeriesulfonamide,

N-(4-(4-((4'-chloio( 1 , 1 '~biphenyl)-2-yI)meihyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-S- ((methylsulfonyl)amino)~l-((phenylsulfanyl)methyl)pentyl)ami no)-3- nitrobenzenesulfonamide,

4-(((lR)-5-((aminocarbonyl)amino)-l-((phenylsulfanyl)meth yl)pentyl)amino)-N-(4~ (4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin-l-yl)ben zoyl)-3- nitrobenzenesulfonamide,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)prop yl)amino)-N-(4-(4-(2- (methylsulfanyl)benzyl)piperazin-l-yl)benzoyl)-3-niiτobenze nesulfonamide,

4-(((lR)-3"(dimethylamino)-l-((phenylsulfanyl)methyl)piop yl)amino)-N-(4-(4-(2- {methylsulfonyl)benzy l)pipei azin- 1 -yl)benzoyl )- 3 -nitrobenzene sulfonam i de,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyI)methyl)prop yl)amino)-N-{4-(4-(2- ( 5 ,5 -dimethyl -2 -oxo- 1 , 3 -oxazolidin- 3 -yl)benzyl)pipei azin- 1 -yl )benzoy 1) -3 - nitrobenzenesulfonamide,

N-(4-(4 -(2 -cy clohexylbenzy1)pipei azin- 1 -yl )benzoyl)-4-((( 1 R)-3 -(di methy lamino)- 1 - ((phenylsul fanyl)methyl)pi opyl)amino)-3 -nitr obenzene sul fonam ide,

4-((( 1 R) -3 -(dimethyl amino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4-(2- (morpholin-4-yl)benzy 1 )piperazin- 1 -yl )benzoyl)- 3 -niti obenzenesulf onamide , 4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)piopyl) ainino)-N-(4-(4-(2-

(isopropylsulfanyl)benzyl)piperazin-l-yl)benzoyI)-3 -nitrobenzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)~l -cyclohexen-1 -yl)rnethyl)piperazin~l -yl)benzoyl)-4- (((lR)-3-(isopropyl{methyl)amino)-l-((phenylsulfanyl)methyl) propyl)amino)-3- nitiobenzenesulfonamide, N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen-1 -yl)methyl)piperazin- l-yl)benzoyl)-4-

(((lR)-3-(dipiopylamino)-l-((phenylsulfanyl)methyl)piopyl )ainino)-3- niti obenzenesulfonam i de ,

N-(4-(4-((4'-cWoro(l ,r-biphenyl)-2-yl)metliyl)piperazin-l-yl)benzoyI)-4-(((lR)-3 - (dipropylamino)-l-((ρhenylsulfanyl)methyl)piopyl)amino)-3-n itrobenzenesulfonamide, N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen-1 -yl)methyl)piρeiazin-l -yl)benzoyl)-4-

((( lR)-3-(diethylamino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3- nitrobenzenesuϊfonamide,

N-(4-(4-((4'-chloro(l ,r-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-4-C(( 1 R)-3- (diethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3-nit robenzenesulfonamide,

007/077579

N-(4-(4-{(l , r-biphenyl)-3-ylmethyl)pipeiazin-l -yl)beπzoyl)-3-nitro-4~((2- {phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((l ₎ l'-biphenyl)-3-y3melhyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- ( d imethylamino) - 1 -((phenylsulfany l)methyl)propyl)am ino) - 3 -nitxobenzenesul fonamide , N-(4-(4-((l ,r-biphenyl)-3-ylmelhyl)pipetazin-l-yI)benzoyl)-4-(((lR)-3-( moipholin-

4-yl)-l-({phenylsulfanyl)methyl)propyl)amino)-3-nitrobenz enesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)pipεrazin-l-yl)-3-flu otobenzoyl)-4-(((lR)-3- (dimethylaraino)- 1 -((phenylsulf anyl)methyl)pi opyl) am ino)- 3 -nitrobenzene sul fonami de ,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)piperazin'l-yl)-3-fluo robenzoyl)-3-mtro-4-((2- (phenylstilfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)pipeiazin-l-yl)-3-fluo iobenzoyl)-4-(((lR)-3- (morpholin-4-yl)- 1 -((phenylsulfany l)methyl)propyl) amino)- 3 -nitτ ob enzenesul fonami de ,

N-(4-(4-(( 1 ,r-biphenyl)-2-ylmelhyI)piperazin-l -yl)- 3 ,5-difluoiobenzoyl)-4-(((l R)-3- (dimethylamino)-l-({phenylsulfanyl)methyl)propyl)amino)-3-ni trobenzenesulfonamide N-(4-(4-((l,l'-biphenyl)-2-ylmethyl)pipeiazin-l-yl)-3,5-difl uorobenzoyl)-3-nitro-4-

((2'(phenylsulfanyl)ethyl)amino)benzenesulfonamide _J

N-(4-(4-{(l ₎ l ¹ -biphenyl)-2-ylmethy3)pipera2in-l-yl)-3,5-difluorobenzoyl)-4 -(((lR)-3- (morpholin-4-yl)-l-{(phenylsulfanyl)methyl)propyl)amino)-3-n itiobenzenesulfonamide,

3-nitro-N-(4-(4-((l -phenyl- lH-imidazol-2-yl)methyl)piperazin-l-yl)benzoyl)-4-((2- (phenylsulfanyl)ethyl)amino)benzenesulfonamide,

4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)methyl)pio pyl)amino)-3-nitro-N-(4- (4-((l-phenyl-lH-imidazol-2-yl)methyl)piperazin-l-yl)benzoyl )benzenesulfonamide,

3-nitio-N-(4-(4-((l-phenyl-lH-pyiazo3-5-yl)methyl)pipeiaz in-l-yl)benzoyl)-4-({2- (phenylsulfanyl)ethyl)amino)benzenesulfonamide, 4-(( ( 1 R)-3 -(motphol i n-4-yl)- 1 -( (pheny lsulfanyl)methyl)pi opy l)amino)-3 -nitro-N-(4 ~

(4-((l-phenyl-lH-pyiazol-5-yl)niethyl)piperazin-l-yl)benz oyl)benzenesulfonamide, 4-(((lR)-3-(niorpholin-4-yl)-l-((phenylsulfanyl)methyl)propy l)amino)-3-nitro-N-(4-(4-((l- phenyl - 1 H-pyi azol-5 -yl)methy l)piperazin- 1 -yl)benzoyl)benzenesul fonam ide

4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)methyl)propyl )aτnino)-3-nitro-N-(4- (4-((l -phenyl- lH-imidazol-5-yl)methyl)piperazin-l-yl)benzoyl)benzenesulfon amide, l-((3R)-3-(4-(((4-(4-((4 ^t -chloro(l,l'-biphenyl)-2-yl)methyl)piperazm-l- yl)benzoyl)amino)sulfonyl)~2-nilτoanilino)-4-{phenylsιilfa nyl)butyl)-3-azetidinecarboxylic acid,

US2007/077579

N-(4-(4-((4 ^t -chloro(l,l'-biphenyl)-2-yl)methyl)piperazm-l-yl)benzoyl)-4- {((lR)-3- ((2-hydroxy-2-methylpropyl)aniino)-l-((phenylsulfanyl)methyl )piopyl)amino)-3- nitrobenzenesulfonamide,

(((3R)-3K4-(((4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl) piperazin-l- yl)benzoyl)amino)sulfonyl)-2-nitroaniIino)-4~(phenylsulfanyl )butyl)(nietliyl)amino)acetic acid,

{2R)-l-((3R)-3-(4-(((4-(4-((4'-chloio(l,l ^! -biphenyl)-2-yl)methyl)piperazin4- yl)benzoyl)amino)sulfonyl)-2-nibOanilino)-4-(phenylsulfanyl) butyl)-2-pyπolidinecaτboxylic acid l-((3R)-3-(4-(((4-(4-((4 ^t -cliloro(l _J l'-biphenyl)^2-yl)melhyl)piperazin-I- y ^] )benzoyl)amino)sulfonyl)-2-nitroanilino)-4-(phenylsυlfanyl) butyl)-4-piperidinecarboxylic acid

N-(4-(4-((4'-chloio(l,r-biplienyl)-2-yl)methyl)piperazin- l-yl)benzoyϊ)-4-(((lR)-3- ((2-hydroxyethyl)(methyl)amino)-l-((phenylsulfanyl)methyl)pr opyl)amino)-3- nitrobenzenesulfonamide,

(2S)-l-((3R)-3-(4-(((4-(4-((4'-chloro(l,l ¹ -biphenyl)-2 ^> -yl)methyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-nitrOanilino)-4-(phenylsulfanyl )butyl)-2-pyπOlidinecaiboxylic acid,

N-(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-3-nitro-4- (({lR)-l-((phenylsulfanyl)methyl)-3-(3-(2H-tetrazol-5-yl)aze tidin-l' yl)propyl)amino)benzenesulfonamide,

(2S)-2-amino-N-((lS)-2-(((3R)-3-(4-(((4-(4-((4'-chloio(l, r-biρhenyl)-2- yl)methyl)pipeiazin-l-yl)benzoyl)amino)sulfonyl)-2-nilτoani lino)-4- (phenylsulfanyl)bujyl)amino)-l-methyl-2-oxoelhyl)propanamide , N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl )benzoyI)-3-nitro-4-

(((lR)-l-((phenylsulfanyl)methyl)-3-(2-(2H-tetrazol-5-yl) pyiTOlidm-l- yl)propyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloio(l , 1 '-biphenyl)-2-yl)melhyl)ρipeiazin-l -yl)benzoyl)-4-((( 1 R)-3-(4- (((methylsulfonyl)amino)caibonyl)piperidin-l-yl)-l-((phenyls ulfanyl)melhyl)piopyl)amino)- 3-nitrobenzenesulfonaraide,

N-(4-(4-((4'-chloio( 1 , 1 '-biphenyl^-ytymefliyljpiperazin-l -yl)benzoyl)-4-((( 1 R)-3- (dimethylaτnino)-l-((phenylsulfanyl)methyl)propyl)aπiino)b enzenesulfonamide ₎

7 077579

1 -((3^-3-(4-(((4-(4-((4'-ChIo-O(1 , 1 '-biphenyl)-2-yl)methyl)pipetazin-l - yl)benzoyl)aniino)sulfonyl)-2-nitroanilino)-4-(phenylsulfany l)butyl)-N"hydroxy-4- piperidinecarboxamide,

2-chloro-N-(4-(4-((4 ^l -chloio( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyϊ)-4- ((( 1 R)-3-(dirnethylamino)- 1 -{(phenylsulfanyl)methyϊ)propyl)amino)benzenesulfonamide,

2,6-dicliloio-N-(4-(4-((4 ^! ~cWoiO(l ₅ r-biphenyl)-2-yl)niethyϊ)pipeiazin-l-yl)benzoyl)- 4-(({iR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)prOpyl) amino)benzenesulfonamide,

4-(((l R)-3-((l R,5S)-8-azabicyclo[3.2.1 ]oct-8-yl)-l -

((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4-((4'-chloio ( 1 , 1 '-biphenyl)-2~ yl)methyl)piperazin-l-yl)benzoyl)-3-nitrobenzenesulfonamide,

4-(((lR)-3-(7-azabicyclo[2.2.1]hept-7-yl)-l-((phenylsuIfanyl )methyl)propyl)amino)- N-(4-{4-((4 ^> -chloio(l ,r~biphenyl)"2-yl)methyl)piperazin-l-yl)benzoyl)-3- nitrobenzenesulfonamide,

N-(4-(4-((4'-chloio(l,r-bipheny ^] )-2-yl)niethyl)piperazin-l-yl)benzoyl)-3-nitro-4-(2- (phenylsulfaτiyl)ethoxy)benzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(2- {phenylsulfanyl)ethoxy)-3-(trifluoiOmethyl)benzenesulfonamid e,

N-(4-(4-((4'-cliloro(l,r-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-3-nitro-4- (C(lR)-3-((lS,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl)-l- ((phenylsulfanyl)methyl)pτoρyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3-nitio-4- (((lR)-3-((lR,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl)-l- ((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

N-(4- (4-((2-(4-chloi ophenyl)- 1 -cycl ohexen- 1 -yl)methyl)pipei azin- 1 -yl )benzoy 1) -3- nitro-4-(((lR)-3-((lS,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl )-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen-1 -yl)methyl)pipeiazin- 1 ~yl)benzoyl)-3- nitro-4-(((lR)-3-((lR,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl )-l- ((phenylsulfanyl)methyl)propyl)aτnino)benzenesulfonamide, 4-{((lR)-3-(7-azabicyclo[2-2.1]hept-7-yl)-l-((phenylsulfanyl )nielhyl)propyl)amino)-

N-(4-{4-((2-(4-cliloiOphenyl)-I -cyclohexen-1 -yl)methyl)piperazin-l-yl)benzoyl)-3- nitrobenzenesulfonamide,

79

N-(4-(4-((2-(4-chlorophenyl)- 1 -cyclohexen- 1 -yl)methyl)piperazin- 1 -y])benzoyl)-4- (((lR)-3-((2R,5S)-2 ₁ 5-dimethylpyirolidin-l-yl)-l-((phenyIsulfanyl)methyl)propyl) amino)-3- nitrobenzenesυlfonamide,

N-(4-(4-((4'-chioro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-3-nitro-4- (((lR)-3-((lR,4R)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl)-l- ((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

N-(4-(4-((l _s r-biphenyl)-2-ylmetliyl)piperazin-l-yl)benzoyl)-4-(cyclohexy loxy)-3- nitrobenzenesulfonamide,

N-(4-(4-((l,r-bipheny ^] )-2-ylmethyl)pipeiazin-l-yl)benzoyl)-4-(cyclohexylmethoxy)- 3-nitrobenzeπesuIfonarnide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl )-4-(2-cyclohexylethoxy)- 3 -nitrobenzenesul fonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)pipeiazin-l-yl)benzoyl )~3-niiτo-4-(tetrahydro- 2H-pyran-4-ylamino)benzenesulfonamide, N-(4-(4-((l ,r-biphenyl)-2-ylmethyl)piperazin-l-yl)beπεoyl)-4-((2- cyclohexylethyl) amino) -3-ni hobenzenesul Fonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl )~4- (cyclohexyl(methyl)amino)-3-nitrobenzenesulfonamide,

N-{4-(4-((l,r-biphenyl)-2-ylmethyl)pipeiazin-l-yl)benzoyl )-4-(4,4- dimethylpipeiidin-l-yl)-3-nittobenzenesulfonarnide, teit-butyl 4-(4-(((4-(4-((l ,r-biphenyl)-2-ylmethyI)pipeiazin- 1 - yl)b enzoyl)amino)sulfonyl) -2-nitr ophenoxy ) - 1 -piperidinecarboxylate ,

N-(4-(4-(( 1 , 1 '-biphenyl)-2-ylmethyl)piperazin- 1 -yl)benzoyl)-3 -nitro-4-(pipeiidin-4- yloxy)benzenesulfonamide, N-(4-(4-((l ,r-biphenyl)-2-ylmetliyl)pipeiazin-l-yl)benzoyl)-4-((l-methy lpiperidin-4- y I)oxy)-3 -ni tiobenzenesul fonami de ,

N-(4-(4-((4 ^! -chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4- ((cyclohexylmethyl)amino)-3-nitrobenzenesulfonamide,

N-(4-(4-((4'-chloiO(l _» 1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4- ((cyclohexylmethyl)(propyl)amino)-3-nitrobenzenesulfonaτnid e,

4-(((l-benzylpiperidin-4-yl)methyI)amino)-N-(4-(4-((l,r-b iphenyl)-2- ylmethyl)piperazin-l-yl)benzoyl)-3-nitrObenzenesulfonamide,

N-(4-(4-(( 1 , 1 '-biphenyl) -2 -y 1 methyl)piperazin- 1 -yl)benzoyl)-4- ((cyclohexylmetliyl)(methyl)amino)-3-nitτobenzenesulfonamid e,

4-((l-benzy]piperidin-4~yl)amino)-N-(4-(4-((l,r-biphenyl) -2-ylmethyl)piperazin-l- yl)benzoyl)-3-nitrobenzenesulfbnarnide,

N-(4-(4-{(l,r-biphenyl)-2-ylmethyI)pipeiazin-l-yl)ben2oyl )-3-nitio-4-(tetrahydro~ 2H-sulfanylpyτan-4~ylamino)benzenesulfonamide, ethyl 4-(4-(((4-{4-((l,r-biphenyl)-2-ylmethyl)piperazin-l- yl)ben2oyl)amino)sulfonyl)-2-nitroanilino)'l-piperidinecaτb oxylate,

N-(4-(4-(( 1 , 1 '-biphenyl)-2-ylmethyl)pipeiazin- 1 -yl)benzoyl)-3-nilτo-4-((( 1 - propylpiperidin-4-yl)me1.1iyl)amino)benzenesυlfonamide,

N-(4-(4-((l,l'-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoy l)-4-{isopiOpylamino)-3- nitiobenzenesulfonamide,

N-(4-(4-({l,l'-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoy l)-3~nitro-4-{(2-(l,3- thiazol-2~ylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-({l,r-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl )-3-nitro-4-((2-((4-phenyl- l,3-thiazol-2-yl)sulfanyl)ethyl)amino)benzenesulfonamide, 4-((2-(l ,3-benzothia2ol-2-ylsulfanyl)ethyl)amino)-N-(4-(4-((l ,1 '-biphenyl)-2- ylmethyl)piperazin-l-yl)benzoyl)~3-mtrobenzenesulfonamide,

N-(4-(4-({4'-chloro{ 1 , 1 ^! -biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3-nitio-4-((2- ( 1 ,3-thiazol-2-ylsulfanyl)ethyl)amino)benzenesulfonamide,

4-((2-(l,3-benzoxazol-2-ylsulfanyl)ethyl)amino)-N-(4-(4-((4 ^t -chloiO(l,l'-biphenyl)-2- yl)methyl)piperazin- 1 -yl)benzoyl)-3-nitiobenzenesulfonamide,

4<(2-(13-benzothiazol-2-ylsulfanyl)ethyl)amino)-N-(4-( 4-((4'-chloro(l,l'-biphenyl)- 2-yl)methyl)piperazin-l-yl)benzoyl)-3-nitrobenzenesulfonamid e,

N-(4-(4-((4 ^! -chloro(l , r-biphenyl)-2-yl)metliyl)pipeiazin-l -yl)benzoyl)-3-nitro-4-((2- (pyrimidin-2-ylsulfanyl)ethyl)aπiino)benzenesulfonaτnide, 4-(((lR)-3-(moipholin-4-yl)-l-((phenylsulfanyl)metliyl)piOpy l)amino)-3-nitro-N-(4-

(4-(( 1 -phenyl- 1 H -py lazol -5 -yl)rnethyl)piperazin- 1 -yl)benzoy l)benzenesulfonami de ,

4-((( 1 -benzylpiperidin-4-yl)methyl)amino)-N-(4-(4-((4 ^> -chloro( 1 , 1 *-biphenyl)-2- yl)methyl)piperazin-l-yl)benzoyl)-3-nitrobenzenesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylrnethyl)piperazin-l-yl)benzoy l)-4-((2- biomoethyl)amino)-3-nitrobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 ¹ -biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((2-((4- methyl-l ,3-thiazol-2-yl)sulfanyl)ethyl)amino)-3-nitrobenzenesulfonam ide,

N-(4-(4-((4'-chloio(l,l'-biphenyl)-2-yl)metliyl)piperazin -l-yl)benzoyl)-4-(((4- melhoxycyclohexyl)methyl)amino)-3-nitiobenzenesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-yImetliyl)piperazin-l-yI)benzoy l)-3-nitro-4-((2-(2- lhienylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloio( 1 , 1 '-biphenyl)-2-yϊ)methyl)piperazm-I -yl)benzoyl)-4-(( 1,1- dimethyI-2-{2-thienylsulfanyl)ethyl)amino)-3-nitrobenzenesul fonamide, N-(4-(4-((4 ^< -chloio(l,l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4 -(((lR)"3-

(morpholin-4-yl)-l -(( 1 ,3-thiazol-2-ylsulfanyl)methyl)propyl)amino)-3- nitrobenzenesulfonamide,

(3R)-3'(4-(((4-(4-((4 ^t -chloro(l,l'-biphenyl)-2-yl)methyl)pipeiazin-l- yl)benzoyl)amino)sulfonyl)-2-nitτoanilino)-N,N-dimethyI-4-( pyrimidin-2- ylsulfanyl)butanamide,

N-(4-(4-((4'-chloro(l ,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4-{((lR)-3- {moipholin-4-yl)-3-oxo-l-((2-thienylsulfanyl)methyl)piopyl)a mino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4'-chIoro(l,l ^t -biphenyl)-2-yl)methyl)piperazin-l»yl)benzoyl)-4-((l,l- dimelhyl-2-(pyrimidin-2-ylsulfanyl)ethyl)amino)-3-nitrobenze nesulfonaniide _J

(3R)-3-(4-(((4-(4-({4'-chloro(l,l'"biphenyl)-2"yl)methyl) piperazin-l- yl)b enzoyl)am iπo)sul fonyl)-2 -niti oanil ino) -N,N-dimethyl-4-( 1 ,3 -thi azol-2 - ylsulfanyl)bulanamide,

N-(4-(4-((4 ¹ -chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3- (morpholin~4-yl)-l-((2'thienylsulfanyl)methyl)propyl)amino)- 3-nitiobenzenesιιlfonai-nide,

N-(4-(4-((4'-chloio(l,l'-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-4-(((lR)-3- (dimetliylamino)-l-(((4-(trifluoiomelhoxy)phenyl)sulfanyl)ni ethyl)propyl)amino)-3- nilTobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 ^l -biplienyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3-nitro-4-((2- phenoxyethyl) amino)benzenesulfonami de ,

N-(4-(4-((4'-chloio( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin--l -yl)benzoyl)-4-((( 1 R)-3- (motpholin-4-yl)-l-(((4-(trifluoromethoxy)phenyl)sulfanyl)me thyl)piOpyl)amino)-3- nitr obenzenesulfonaniide ,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-(((l R)- 1 - (((4-methoxyphenyl)sulfanyl)methyl)-3-(moipholin-4-yl)piopyl )amino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4 ^l -chloro(l,r-biρhenyl)-2-yl)methyl)ρiρeiazin-l-yl)bβiizoy l)-4-(((lR)-l- (((4-methylphenyl)sulfanyl)methyl)-3-(moipholin-4-yl)propyl) amino)-3- nitiobenzene sulfonamide,

N-(4-(4-((4'-chloro( 1 ,1' -biphenyl) -2-yl)methyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-3- (dimethylamino)-l-((2-thienylsυlfanyl)methyl)propyl)amino)- 3- (tiifluoromethyl)benzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl^-yljmefhyltøiperazin- 1 -yl)benzoyl)-4-((( IR)-I- (((4-chloiophenyl)sulfanyl)metliyl)-3-(morpholin-4-yl)propyl )amino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4 ^f -chloro( 1 ,l'-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-«( 1 R)-3- (dimethylamino)-l-(((4-fluoiOphenyl)sulfanyl)methyl)propyl)a mmo)-3- ni trobenzenesu lfonamide, N-(4-(4-((4'-chloio( 1 , 1 ^! -biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoy])-4-((( 1 R)- 1 -

(((4-fluoiophenyl)sulfanyl)methyl)-3-(moipholin-4-yl)prop yl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-( (4'-chl oro( 1 , 1 '-biphenyl )-2-y l)methy 1 )piperazin- 1 -yl) -2 -fluorobenzoyl)-4- (((lR)-3-(dimetliylamino)-l-((phenylsulfanyl)metliyl)propyl) amino)-3- nitiobεnzenesulfonamide,

N-(4-( 1 -((4'-chloio( 1 , 1 '-biphenyl)-2-yl)methyl)- 1 ,2,3,6-tetrahydiopyridin-4- yl)benzoyl)-4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)me thyl)propyl)amino)-3- niti obenzenesul fonamide,

N-(4-( 1 -((4'-chloro( 1 ,1 '-biphenyl)-2-yl)methyl)-l ,2,3,6-tetrahydropyiidin-4- yl)benzoyl)-4-(((lR)-3-(moφholin-4-yl)-l-((phenylsulfanyl)m ethyl)piopyl)arnino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)-2-fluorobenzoyl)-4- ({(IR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)am ino)-3- (tiifluoromethyl)benzenesulfonarnide, N-((6-(4-((4 ' - chloro( 1 , 1 '-biphenyl )-2 -yl)methy l)piper azin- 1 -yl)pyri din-3 -y 1 )carbonyl) -

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)prop yl)amino)-3- nitrobenzenesulfonamide,

N-(4-(l-((4'-chloio(l ,l ^t -biphenyl)-2-yl)methyl)piperidin-4-yl)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3-ni tiobenzenesulfonamide, N-(4-( 1 -((4'-chloro( 1 , 1 '-biphenyl)-2-y l)methyl)piperidin-4-yl)benzoyl)-4-(( ( 1 R)-3 -

(mθφholin-4-yl)-l-((phenylsulfanyl)methyl)ptopyl)amino) -3-nitioben2;enesulfonamide,

N-(4-( 1 -({4'-chIoto( 1 , l'-biphenyl)-2-yl)methyl)-l _s 2,3,6-tetrahydropyiidin-4- yl)benzoyl)-4~((( 1 R)~3-(dimethylamino)- 1 -((phenylsulfanyl)methyl)piopyl)amino)-3- (tiifluoiomethyl)benzenesulfonarnide,

N-((6-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)pipetazm-l -yl)pyτidin-3-yl)caibonyl)- 4-(((lR)-3-(moipholin-4-yl)-l-((phenylsulfanyl)methyl)propyl )amino)-3- nitrobenzenesulfonamide,

N-((6-(4-((4 ^t -chloio(l ,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)pyπdin-3-yl)carbony l)- 4-((( 1 R)-3-(dimethylamino)-l -((phenyIsulfanyl)methyI)piopyl)amino)-3- (iτifluoromethyl)benzenesulfonamide,

N-(4-(4-((4 ^t -chloro(l,r-biphenyl)-2-yl)methyl)piperidin4-yl)benzoyl)-4-( ((lR)-3- (dimethylarnino)-l-((phenylsulfanyl)methyl)propyl)amino)-3'n itrobenzeπesulfonamide,

N-(4-(4-((4'-cliloro(l _> r-biphenyl)-2-yl)metliyl)pipeiidin-l-yl)benzoyl)-4-(((lR)-3- (morpholin-4-yl)- 1 -((phenylsulfanyl)methyl)propyl)aniino)-3-nitiobenzenesulfon amide,

N-((5-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)metliyl)pipeiazin-I -yl)pyiidin-2-yl)carbonyl)- 4-((( 1 R)-3-(dimelhylaτnmo)-l -((phenyϊsulfanyl)methyl)piopyl)amino)-3- nitrobenzenesulfonamide,

N-((5-(4-((4'-chloro(l,r-biplienyl)-2-yl)melhyl)pipeiazin -l-yl)pyridin-2-yl)carbonyI)- 4-(({IR)-3-(moipholin-4-yl)-l-((phenylsulfany3)methyl)piopyl )aniino)-3- nitrobenzenesulfonamide,

N-(4-(l-({2-(4-chlotophenyl)-5,5-dimethyl-l-cyclohexen-l- yl)metliyl)-l,2,3,6- tetrahydropyridin-4-yl)benzoyl)-4-(((lR)-3-(dimethylamino)-l - ((phenylsulfanyl)methyl)propyl)amino)-3~nitrobenzenesulfonam ide, N-(4-( l-((2-(4-chlorophenyl)-l -cyclohexen-1 -yl)methyl)-l ,2,3 ,6~teirahydropyiidin-4- yl)benzoyl)-4-(((lR)-3-(dimethylartiino)-l-((phenylsulfanyl) melhyl)propyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(l -((2-{4-chlorophenyl)-l -cyclohexen- 1 ~yl)methyl)- 1 ,2,3,6-tetrahydiopyridin-4- yl)benzoyl)-4-(((lR)-3-(moτpholin-4-yl)-l-((plienylsulfanyl )methyl)propyl)amino)-3- nitrobenzenesulfonamide,

N-(4-(l-((2-(4-chlorophenyl)-5 ₎ 5-dimethyl-l-cyclohexen-l-yl)melhyl)-l ,2,3,6- tettahydropytidin-4~yl)benzoyl)-4-((( 1 R)-3-(moφholin-4-yl)-l - ({phenylsulfanyl)methyl)propyl)aτnino)-3-nitrobenzenesulfon arnide,

N-(4-(4-((4'-chloro( 1 ,1 '-biphenyl)-2-yl)methyl)-l -cyclohexen-1 -yl)benzoyl)-4-((( 1 R)- 3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3- τiitrobenzenesuIfonamide,

N-(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)-l-cyclohe xen-l-yl)benzoyl)-4-(((lR)- 3-(moipholin-4-yl)-l-((phenyIsυlfanyl)methyl)propyl)amino)- 3-nitrobenzenesulfonaτnide,

N-(4-((3aR,6aS)-5-((4'-chloio(l,I ^t -biphenyl)-2-yl)methy1)hexahydiopyrrolo[3,4- c]pyirol-2(lH)-yl)benzoyl)-4-(((l R)-3-(dimethylamino)-l -

((phenylsulfanyl)methyl)propyl)amino)-3-nitfobenzenesulfo namide,

N-(4-(4-((l,l'-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoy l)-4-(methyl((methyl-4- (πifluoτomethoxy)anilino)carbonyl)amino)-3-nitrobenzenesul fonarnide,

N-(4-(4-({l ,l'-biphenyl)-2-ylmethyl)pipeiazin-l-yl)benzoyl)-4-({(2- dimethylanilino)caibonyl)(methyl)arnino)-3-nitτoben2enesulf onamide,

N-(4-(4-((l,r-biphenyl)-2-ylmetliyl)pipeiazin-l-yl)benzoy I)-4-(((4- methoxy(methy 3 )anil ino)carbony 1 )(methyl) amino)-3 -niti ob enzenesulfonamide, N-(4-(4-((l,r-biphenyl)-2-ylmethyl)piperazin-l-y])benzoyl)-4 -({(4- dinielhylanilino)carbonyl)(melhyl)amino)-3~mtiobenzenesulfon amide,

4-(((benzhydtyl(methyl)amino)carbonyI)(methyl)amino)-N-(4 -(4-(( 1 , 1 '-biphenyl)-2- ylmethy])piperazin-l-yl)benzoyl)-3-nitrobenzenesulfonamide,

N-(4-(4-(( 1 , 1 '-biphenyl)-2-ylmethyl)piperazin- 1 -yI)benzoyl)-4-(methyl((methyl((l S)- l-phenylethyl)amino)caibonyl)amino)-3-nitiobenzenesulfonamid e,

N- (4-(4-(( 1 , 1 '-biplienyl) -2 -ylmethyl)pipet a zin- 1 -y l)benzoy I) -4 -(methyl ((methy 1 ( 2- (4 - methylpiperazin-l-yl)-l-ρhenylethyl)amino)carbonyl)amino)-3 -nitιobenzenesulfonamide, N-(4-(4-((l ,1 '-biphenyl)-2-ylτnetliyl)piperazin-l -yl)benzoyl)-4-(methyl((methyl(2- (morpholin-4-yl)-l-phenylethyl)amino)caτbonyl)amino)-3-nitr obenzenesulfonamide, N-(4-(4-((l,l ^! -biphenyl)-2-ylmethyl)pipeiazin-l-yl)benzoyl)-4-((((l,2- diphenylethyl)(methyl)amino)caτbonyl)(nielhyl)aniino)-3-nit robenzenesulfonamide,

N-(4-(4-((l,r-biphenyl)~2-ylmethyl)pipeiazin-l-yl)benzoyl )-4-((((2-(dimethylammo)- 1 -phenylethyl) (methy l)ami no)carbonyl)(methyl)amino)- 3 -niti obenzenesulfonamide ,

3-amino-N-(4-(4-((4 ^l -chloro(l,l'-biphenyl)-2-yI)melhyl)piperazin-l-yl)benzoyl)-4 - ((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloio(l ,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-l -(2- (phenylsulfanyl)ethyI)-lH-l,2,3-ben2otriazole-5-sulfonamide,

N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-l-(2- (phenylsulfanyl)ethyl)-lH-benzimidazole-5-sulfonamide, N-(4-(4-((l ,l ^l -biphenyl)-2-ylmethy])-4-methoxypiperidin-l-yl)benzoyl)-4-

((cycl ohexy lmelhyl)amino)-3 -ni trobenzene sulfonam i de,

N-(4-(4-(( 1 , 1 '-biphenyl) -2 -ylmethyl) -4 -methoxypiperi d in- 1 -yl )benzoyl) -4 - (cyclohexylamino)-3-nitrobenzenesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-methoxypiperidin-l-yl) benzoyl)-4-({l ,l- dimethyl-2-(phenylsulfanyl)ethyl)amino)-3-nitiobenzenesu]fon amide _J

N-(4-(4-((l , 1 ^! -biphenyl)-2-ylmethyl)piperazin-l -yl)benzoyl)-3-nitro-4-(( 1 - ((phenylsulfany^methy^cyclopenty^aminojbenzene-sulfonamide, N-(4-(4-(( 1 ,r-biphenyl)-2-ylmetliyl)-4-melhoxypiperidin-l -yl)benzoyl)-3-nitro-4-(( 1 -

((phenylsulfanyl)methyl)cyclopentyl)amino)benzene-sulfona mide,

N-(4-(4-((4'~chloro( 1 ,1 ^r -biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-3-nitro-4-(( 1 - ((phenylsulfanyl)metliyl)cyclopentyl)amino)benzene-sulfonami de,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-3-nitro-4- {((1 S)-I -((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(4-(( 1 , l'-b iphenyl) -2-ylmelhy l)-4-melhoxypipei i din- 1 -y l)benzoy 1 )-3 -niti o-4 - ( (( 1 S) - 1 -((phenylsu lfany l)methyl)propyl)am ino)benzene sul fonamide ,

N-(4-(4-((4 ^l -chloio(l ,l'-biphenyl)-2-yl)methyl)pipeiazin-l-y3)benzoyl)-4-({(lR)-3 - (moτphoHn-4-yl)-l-((phenylsulfanyl)methyl)propyl)amino)-3-n itτobenzenesulfoπamide, N-(4-(4-((4'-chloio(l ,r-biρhenyl)-2-yl)methyl)piρeiazin-l-yl)benzoyl)-4-((( 1 S)-3- niethyl-l-((phenylsulfanyl)niethyl)butyl)amino)-3-nitiobenze nesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-methoxypipetidin-l- yl)benzoyl)-4-(((lS)-3- methyl-l-((phenylsulfanyl)methyl)butyl)amino)-3-nitiobenzene sulfonamide,

N-(4-(4-((4'-chloio( 1 , r-biphenyl)-2-yl)melhyl)piperazin- 1 -yl)benzoyl)-3-nitro-4-(( 1 - ((phenylsulfanyl)methyl)cyclopropyl)amino)bcnzerie-sulfonami de,

N-(4-(4-((4 ^t ~chloto(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3- nitro-4-((l - ((phenylsulfanyl)methyl)cyclohexyl)amino)benzene-sulfonamide ,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((lR)-l- methyl-2-(phenylsulfanyl)ethyl)amino)-3-nitrobenzenesulfonam ide, N-(4-(4-((l,r-biphenyl)-2-ylmethyl)piperazin-l-yl)benzoyl)-4 -(((l S)-l-methyl-2-

(phenylsulfanyl)ethyl)amino)-3-nitrobenzenesulfonamide,

N-(4-(4-((l,l'-biphenyl)-2-ylmelhyl)ρiρeiaziπ-l-yl)ben zoyl)-3-nit-θ-4-(((lR,2S)-2- (phenylsulfanyl)cyclohexyl)amino)benzenesulfonarnide,

N-(4-(4-{(4'-chloio(l ,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((l R)-3- (dimethylamino)-l-((phenylsulfanyI)methyl)propyl)amino)-3- (tτifluoromethyl)benzenesulfonamide,

4-(((lR)-5-amino-l-{(phenylsulfanyl)methyl)pentyl)aτnino)-N -(4-(4-((4 ^l -chloio(l ₎ l ^l - biphenyl)~2-yl)niethyl)pipeiazin-l-yl)benzoyl)-3-nitrobenzen esulfonamide,

N-(4-(4-(( 1 , 1 '-bipheny])-2-ylmethyl)pipeiazin- 1 -yl)benzoyl)~3-nitio-4-((( 1 S)-2- (phenylsulfanyl)-l-(pyridii)-.ϊ-ylmethyl)ethyl)amino)benzen esulfonarnide,

N-(4~(4-((l,r-biphenyl)-2--ylmethyl)-4-methoxypiperidin-l -yl)benzoyl)-3-nitro-4-- ((( 1 S)-2-(phenylsulfanyl)-l -(pyiidin-3-ylmethyl)ethyl)arnino)benzenesιi3fonamide, N-(4-(4-((l ,r-biphenyl)-2-ylmethyl)piperazin-l -yl)benzoyl)-3-nitro-4-(((l S,2R)-2-

(p3ienylsulfanyl)cyclohexyl)amino)benzenesulfonamide,

N-(4-(4-(( 1 ,r-biphenyl)-2-ylniethyl)piperazin-l-yl)benzoyl)-4-(( l-(((2-methyl-3- fltiyl)sulfanyl)melhyl)cyclopentyI)amino)-3-nitrobenzenesulf onamide,

N-(4-{4~((4'-cMoro(l,r-biphenyl)-2-yl)methyl)pipeiazin-l- yl)benzoyl)-4-({l-(((2- methyl-3-furyl)sulfanyl)methyl)cyclopentyl)amino)-3-nitioben zenesulfonamide,

N-(4-(4 -((4'-cliloi o( 1 , 1' -biphenyl) -2-y l)methyl)piperazin- 1 -yl )benzoyl) -3 -niti o -4- ((( 1 S)-2-(phenylsulfanyl)- 1 -(pyridin-3-ylmethyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-3-pyridin-3-yl)methyl)pipeia zin-l-yl)benzoyl)-4-{((lR)- (dimethylamino)-l-({phenylsulfanyl)methyl)propyl)amino)-3-ni trObenzenesijlfonamide, N-(4-(4-((2-(4-chlorophenyl)pyridin-3-yl)melhyl)piperazin-l -yl)benzoyl)-3-nitio-4-

((2-(plieπylsulfanyl)ethyl)amino)benzenesulfonarnide,

N-(4-(4-((2-(4-chloiophenyl)pyridin-3-yI)methyl)piperazin -l~yl)benzoyl)-4-(((lR)-3-- (morpholin-4-yl)-l-((phenylsulfanyl)methyl)piopyl)amino)-3-n itrobenzenesulfonamide,

3-nitro-N-(4-(4-((2-phenylpyridin-3-yl)methyl)pipeiazin-l -yl)benzoyl)-4-({2- (phenylsulfanyl)ethyl)amino)benzenesulfonamide,

4-(((lR)-3-(moφholin-4-yl)-l -({phenylsulfanyl)methyl)propyl)amino)-3-nitro-N-(4- (4-((2-phenyIpyridin-3-yl)methyl)piperazin-l-yl)benzoyl)benz enesulfonamide,

4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)prop yl)amino)-3-nitro-N-(4- (4-((2-phenylpyτidin-3-yl)methyl)pipetazin-l-yl)benzoyl)ben zenesulfonamide, 4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)pτopyl )amino)-N-(4-(4-((2-(4-

{methyl sulfanyl)phenyl )pyi idin-3 -yl)methyl )pipet azin- 1 -yl)benzoyl)-3 - ni trobenzenesul fonami de,

4-((( 1 R)-3-(diniethylarnino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4-({2~(4- methoxyphenyl)pyiidin-3-yl)methyl)pipeiazin-l-yl)benzoyl)-3- nitrobenzenesulfonamide, N-(4-(4-((2-(4-(dimethylamino)phenyl)pyiidin-3-yl)methyl)pip eiazin-l-yl)benzoyl)-

4-({(lR)-3-(diraethylamiτio)-l-((phenylsulfanyl)methyl)p ropyl)ammo)-3- nitrobenzenesulfonamide,

4~(((lR)-3-(dimethylamino)-l-{(phenylsulfanyl)methyl)piop yl)amino)-N-(4-(4-((2-(4- fluoiophenyl)pyiidin-3~yl)methyl)pipeiazin-l-yI)benzoyl)-3-n itrobenzenesulfonamide,

4-((( 1 R)-3-(dimethylamino)-l -((phenylsulfanyl)methyl)propyl)aτnino)-N-(4-(4-((2-(4- (methylsυlfonyl)phenyl)pyτidin-3-yl)methyl)piperazin-l-yl) benzoyl)-3- nitiobenzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-3-nitro-4-{(2- (pyπdin-4-ylsuϊfanyl)ethyl)amino)benzeπesulfbnamide,

4-((( 1 R)-3-{dimethylamino)- 1 -((phenylsu]fanyl)methyl)propyI)ammo)-N-(4-(4-((4'- (methylsulfonyl)( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-3- nitiobenzenesulfonamide,

N-(4-(4-((4 ^! -{methylsulfonyl)(l,r-biphenyl)-2-yl)melhyl)piperaz!n-l-yl)b enzoyl)-4- (((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)niethyI)propyl) aτnino)-3- nitr obenzenesul fonamide ,

N-(4-(4-((4 ^l -chloio(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3- (motpholin-4-yl)-l-((phenylsulfonyl)methyl)propyl)amino)-3-n ilτobenzenesulfonamide,

N -(4-(4- ( (4' -(dimethylamino)( 1 , 1 '-bipheny l)-2-y 1 )methyl)pipei azin- 1 -y l)benzoyl) -4- ({(lR)-3-{dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-3- nitrobenzenesulfonamide,

(3R)-3-(4-(((4-(4-((4 ^l -chloro(l,l ¹ -biphenyl)-2-yl)melhyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-nitτoanilino)-N,N-dimethyl-4-( phenylsulfonyl)butanamide,

N-(4-(4-((4'-chloiO(l ,r-biphenyl)-2-yl)methyl)piperazin-l -y1)benzoyl)-3-nitro-4- (((3S,4R)-(phenylsulfanyl)pyrrolidin-4-yl)amino)benzenesulfo naτnide,

N-(4-(4-((4 ^> -chloio(l,r-biphenyl)-2~yl)methyl)piperazin-l-yl)benzoyl)-3- nitro»4- (((lR)-l-((phenylsulfanyl)methyl)-3-(pyridin-4- ylsulfanyl)piopyl)amino)benzenesulfonamide,

N-(4-(4-((3-(4-chlorophenyl)pyridin-4-yl)rnetliyl)pipeiaz in~l-yl)benzoyl)-4-(((lR)-3- (dimethylamino)- 1 -({phenylsulfanyl)methyl)propyl)amino)~3-nitiobenzenesulfona mide,

N-(4-(4-((3-(4-chlorophenyl)pyridin-4-yl)methyl)piperazin -l-yl)benzoyl)-3-nitro-4- ((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyl)-l-cyclopenten-l-yl)methyl)pi perazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-((phenyIsulfanyl)metliyl)propy1)a mino)-3- nitrobenzenesulfonamide,

]Sf-(4-{4-((2-(4-chlorophenyl)-l-cyclohexen-l-yl)methyl)p iperazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)ar aino)-3- nitrobenzenesulfonamide,

N-(4-(4-((2-bromo-l-cyclopenten-l-yl)methyl)piperazin-l-y l)benzoyl)-4-(({lR)-3- (dimelhylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3-ni trobenzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)- 1 -cyclohexen-1 -yl)methyl)pipeiazin- 1 -yl)benzoyl)-4- (((lR)-3-(morphoIJn-4-yl)-l-((phenylsulfanyl)mefliyl)propyl) amino)-3- nilrobeπzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen-1 -yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)am ino)-3- (trifluoromethyl)benzenesulFonamide,

N-(4-(4-((2-bromo-l-cyclohexen-l-yl)metliyl)pipeiazin-l-y l)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3-ni trobenzenesulfonamide,

N-(4-(4-((4-(4-chIorophenyl)-5,6-dihydro-2H-pyran-3-yl)me thyl)piperazin-l- yl)benzoyl)-4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)me thyl)piopyl)amino)-3- nitrobenzenesulfonamide,

4-((( 1 R)-3-(dimethylamino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4-((2-(4- methoxyphenyl)-l-cyclohexen-l-yl)methyl)piperazin-l-yl)benzo yl)-3- nitiobenzenesulfonamide,

4-((( 1 R)-3-(dimethylamino)-l -{(phenylsulfanyl)methyl)piopyl)aτnino)-N-(4-(4-((2-(4- fluorophenyl)-l -cyclohexen-1 -yl)melhyl)pipeiazin-l -yl)benzoyl)-3- nitrobenzenesulfonamide, 4-(((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)piopyl) aniino)-3-nitio-N-(4-

(4-((2-phenyl-l-cyclohexen-l-yl)methyl)piperazin-l-yl)ben zoyl)ben2enesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-l -cycloocten-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- {((lR)-3-(dimethylamino)-l-{(phenylsulfanyl)meihyl)propyl)am ino)-3- nitrobenzenesul fonami de , 4-{((lR)-3-(dimethyIamino)-l-((phenylsulfanyl)methyl)piopyl) amino)-N-(4-(4-((2-(4-

(methylsulfanyl)phenyl)- 1 -cyclohexen- 1 -yl)methyl)piperazin- 1 -yl)benzoyl)-3- nitτobenzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyl)-l-cyclohepten-l-yl)methyl)pi petazin-l-yl)benzoyl)-4- (({lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)am ino)-3- nitrobenzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyl)-l -cyclohepten-1 -yl)methyl)piperazin-l -yl)benzoy!)-4- (((lR)-3-(morpholin-4-yl)-l-({phenylsulfanyl)methyl)piopyl)a mino)-3- nitrobenzenesulfonamide,

N-(4-(4-({2-(4-chlorophenyl)-5,5-dimethyl-l -cyclohexen-1 -yl)methyl)piperazin-l - yl)benzoyl)-4-(((lR)-3-(dimetliylamino)-l-((phenylsulfanyl)n iethyl)propyl)amino)"3- nittobenzenesulfonamide,

N-(4-(4-{(2-(4-chloiophenyl)-5,5-dimethyl-l -cyclohexen- 1 -yl)methyl)piperazin-l - yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)m ethyl)propyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyI)-4-(2-(moipholin-4-yl)eth oxy)piperidin-l- yl)benzoyl)-4-{(l ,l-dimethyl-2-(phenylsulfanyl)ethyl)amino)-3-nitiobenzenesul fonamide _J

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-(2-(moipholin-4-yl) etlioxy)pipeiidin-l- yl)benzoyl)-3-nitto-4-((2-{phenylsulfanyl)ethyl)amino)benzen esuIfonamide,

N-(4-(4-((l ,l'-biplienyl)-2-ylmethyl)-4-(2-(pyπOlidin-l-yl)ethoxy)piρ eridin-l- yl)benzoyl)-4-((l,l-dimethyl-2-{phenylsulfanyl)ethyl)amino)- 3-nilτobenzenesulfonamide,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-(2-(pyrrolidin-l-yl )etlioxy)piperidin-l- yl)benzoyl)-3-nitro-4-{(2-(phenylsulfanyl)ethyl)amino)benzen esulfonamide, N-(4-(4-((l,l'-biphenyl)-2-ylmethyl)-4"(2-(pyπolidin-l-yl)e thoxy)pipetidin-l- yl)benzoyl) -3 -nitio-4-( ( 1 -((phenylsutfanyl)methyl) cy cl openty l)am ino)benzene-sulfonami de ,

N'(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-(2-(dimethylamino)e thoxy)pipeiidin-l- yl)benzoyl)-4-((l ,l-dimethyl-2-(phenylsulfanyl)ethyl)amino)-3-nitrobenzenesul fonamide,

N-(4-(4-(( 1 , 1 '-biphenyl)-2-ylmethyI)-4-(2-{dimethylamino)ethoxy)piperidin - 1 - yl)benzoy I)- 3 -ui tro-4-((2- (phenyl sulfanyl)ethyl)amino)benzenesulf onamide ,

N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-(2-(dimetnylamino)etho xy)pipeiidin-l-

N-(4-(4-(( 1 , 1 ^< -biphenyl)-2-ylmethyl)-4-(2-(piperidin-l -yl)ethoxy)pipeiidin- 1 - yl)benzoyl)-4-« 1 , 1 -dimethyl-2-(phenylsulfanyl)ethyl)amino)-3-nitrobenzenesuϊf onamide, N-(4-(4-((I,r-biphenyl)-2-ylmethyl)-4-(2-(piperidin-l-yl)eth oxy)piperidin-l- yI)benzoyl)-3-nitio-4-((2-(phenylsulfanyl)ethyl)amino)benzen esulfonarnide,

N-(4 ~(4-(( 1 , 1 '-biphenyl)-2-ylmethyl) -4-(2 -(piperidin- 1 -yl)ethoxy)piperi din- 1 - y l)b enzoy l)-3 -ni tro-4- (( 1 -((phenyl sulfanyl)methyl)cyclopentyl) am ino)benzene-sul fonami de ,

N-(4-(4-(( 1 ,1 '-biphenyl)-2-y1methyl)piperazin-l -yl)benzoyl)-4-((( 1 S)-3-(moipholin-4- yl)-l-((phenylsulfanyl)methyl)propyl)amino)-3-nitτobenzenes ulfonamide,

N-(4-(4-((4'-(2-(dimethylamino)ethoxy)(l _j r-biphenyl)-2-yl)inethyl)pipeiazin-l- yl)benzoyl)-4-((( 1 R)-3-(dimethylamino)-l -((phenylsulfanyl)methyl)ptopyl)amino)-3- nitrobenzenesulfonamide,

N-(4-(4-({4'~(2-(dimethylamino)ethoxy)(l,r-biphenyl)-2-yl )methyl)piperazin-l- yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)m ethyl)propyl)amino)-3- nitiobenzenesulfonamide,

N-(4-{4-((4'-(2-(dimethylamino)ethoxy)(l ,l'-biphenyl)-2-yl)methyl)pipeiazm-l - yl)benzoyl)-4-((l,l-dimethyl-2-(phenylsulfanyl)ethyl)amino)- 3-nitioben2enesulfonamide,

N~(4-(4-((4''(2-(dimethylamino)ethoxy)(l ,r-biphenyl)-2-yl)melhyl)piperazin-l- yl)benzoyl)-3-nitro-4-((2-(phenylsυlfanyl)ethyl)amino)benze nesulfonamide,

4-((( 1 R)-3-(dimelhyIamino)-l -((phenylsulfanyl)methyl)ρiopyl)amino)-N-(4-(4-{(4'- (2-(moipholin-4-yl)ethoxy)(l ,1 '-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-3- nitrobenzenesulfonamide,

N-(4-(4-((4 ^ι -(2-{moφholin-4-yl)ethoxy)(l,r-biphenyl)-2-yl)melhyl)pipera zin-l- yl)benzoyl)-4-((( 1 R)-3-(moipholin-4-yl)- 1 -{(phenylsulfanyl)methyl)propyl)amino)-3- nitrobenzenesulfonamide,

4-((l,l-dimethyl-2-(phenylsulfanyl)ethyl)amino)-N-(4~(4-((4 ^l -{2-(morpholin-4- yl)ellioxy)(l,l'-bipheny1)-2-yl)metliyl)piperazin-l-yl)benzo yl)-3-nitrobenzenesulfonamide ₅

N-(4-(4-((4'-(2-(moφholin-4-yl)ethoxy)(l,r-biphenyl)-2-y l)methyl)piperazin-l- yl)benzoyl)-3-nitro-4-((2-(phenylsulfanyl)ethyl)amino)benzen esulfonamide,

N-(4-(4-((4'-chloio( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (lH-imidazoM -yl)-l-((phenylsulfany])methyl)piopyl)amino)-3-nitiobenzenes ulfonarnide, N~(4-(4-((l,l'-biphenyl)-2-ylmethyl)piperazin'l-yl)benzoyl)- 4-(((iR)-3-(lH- imidazol- 1 -yl)-l -((phenylsulfanyl)melhyl)propyl)amino)-3-nitrobenzenesulfona mide,

N-(4-(4-(( 1 , 1 ^< -biphenyl)-2-y3methyl)-4-melhoxy-pipeiidin- 1 -yl)benzoyl)-4-((( 1 R)-3- (IH-imidazol-l-yl)-l-((phenylsulfanyl)methyl)propyl)amino)-3 -nitrobenzenesulfonamide,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)melhyl)piperazm-l- yl)benzoyl)-4-(((lR)-4-(4- methylpiperazin-l-yl)-l-((phenyIsulfanyl)methyl)butyl)amino) -3-nitrobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , l'-biphenyI)-2-yl)methyl)pipeiazin- 1 -yl)beπzoyl)-4-((( 1 R)-2- ((2-(dimethylamino)ethyl)(methyl)amino)-l-((phenylsulfanyl)n iethyl)ethyl)amino)-3- nitrobenzenesulfonamide,

(4R).4.(4-(((4-(4-((4 ^< -chloro( 1 , 1 ^p -biphenyl)-2-yl)methyl)pipeiazin-l - y l)benzoyl)amino)sul fonyl)- 2-nitroanilino)-N ,N-d imethyl-5 -(phenylsul fanyl)pentanamide ,

N-(4-(4-((4 ^! -chloro( 1 , 1 '-biphenyl)-2-yl)methyl)pipeiazin- 1 -yl)benzoyl)-4-((( lR)-4- (dimethylamino)-l-({phenylsulfonyI)methyl)butyl)amino)-3-nii τobenzenesulfonamide,

2-(((3R)-3-(4-(((4-(4-((4'-chloio( 1 , 1 '-biphenyl)-2-yl)raelhy])ρiρeiazin- 1 - yl)benzoyl)amino)sulfonyl)-2-nitioanilino)-4-(phenylsulfanyl )butyl)(methyl)amino)-N,N-- dimethylacetamide,

(3R)-N-(teil-butyl)-3-(4-(((4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)piρeiazin-l - yl)benzoyl)amino)sulfonyl)-2-nitioanilino)-4-(phenylsulfanyl )butanamide,

(3R)-3-(4-(((4-(4-((4'-chloro(l _! l'-biphenyl)-2-yl)raethyl)piρerazin-l- yl)benzoyl)ainino)sulfonyl)-2-nilτoanilino)-N,N-diisopropyl -4-(phenylsulfanyϊ)butananiide,

(3R)-N-(tert-butyl)-3-(4-(((4-(4-((4'-cWoro(l,l'-biphenyl)-2 -yl)metbyl)pipetazin-l- yl)benzoyl)amino)sulfonyl)-2-nitτoanilino)-N-methyl-4-(phen ylsulfanyI)butanamide, (3R)-3-(4-(((4-(4-((4 ^l -chloio(l ,r-biphenyl)-2-yl)methyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-nitroanilino)-N-isopropyl-N-met hyl-4- (phenylsulfanyl)butanamide,

N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3-nitio-4- (({ 1 R)-3 -oxo-1 -((phenylsuf fanyl)methyl)- 3-(pipeiidin-l - y^propylJamincObenzenesulfbnamide,

N-({5R)-5-(4-(((4-{4-((4 ^t -chloro(l,r-biphenyl)-2-yl)metliyl)pipetazin-l- yl)benzoyl)amino)sulfonyl)-2-nitroaniHno)-6-(phenylsulfanyl) hexyl)-2- (dimethylamino)acetamide,

(3R)-3-(4-(((4-(4-((4'-ch1oio( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 - yl)benzoyI)amino)sulfonyl)-2-nUτoanilino)-N,N-dimetliyl-4-( phenylsulfanyI)butanamide,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)me(hyl)pipeiazin-l -yl)beiizoyl)-4-(((lR)-3- (l,l-dioxidothiomorpholin-4-yt)-3-oxo-l-((phenγlsulfanyl)me lhyl)propyl)arnino)-3- niti obenzenesulfonami de ,

(3R)-3-(4-(((4-(4-((4'-chloro(l,l ^l -biphenyl)-2-yl)methyl)pipeiazin-l- yl)benzoyl)amino)sulfonyl)-2-nitioanilino)-4-(phenylsulfanyl )butanamide,

(3R)-3-(4-(((4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl) piperazin-l- yl)benzoyl)amino)sulfonyi)-2-nitroanilino)-N~cyclopropyl~4-( phenylsulfanyl)butanamide,

(3R)-3-{4-(((4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)pipe razin-l- yl)benzoyl)amino)sulfonyl)-2-niiτoanilino)-N-cyclobutyl-4-( phenylsulfanyl)butanamide, N-(4-(4-{(4 ¹ -chloro(l,l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4 --C((lR)-3-(4- methylpipeiazin-1 -yl)- 3-oxo-l -((phenylsulfanyl)methyl)propyl)amino)-3- nitiobenzenesulfonamide,

N-(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-4-(((lR)-3- (moipholin-4-yl)-3-oxo-l-((phenyIsulfanyl)methyl)propyl)amin o)-3- nitiobenzenesulfonamide,

4-(((lR)-ϊ-{azetidin-l-yl)-3-oxo-l-((phenylsulfanyl)meth yl)propyl)amino)-N-(4-{4- ((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)pipcrazin-l -yljbenzoyli-β-nitiobenzeπesulfoπamide,

(3R)-3-(4-(({4-(4-({4 ^< -chloio{l,r-biphenyl)-2-yl)methyl)piperazin-l- yl)benzoyl)amino)sul fonyl)- 2 -nitroanil ino) -N-(2-(moipholin-4-y l)elhyl) -A- (phenylsulfanyl)butanarnide,

(3R)-3-(4-(((4-(4-((4'-chloio( 1 , 1 ^r -biphenyl)-2-yl)methyl)piperazin- 1 - y I)b enzoy 1) amino)sulfonyl)-2 -nitroanil ino) -N-methy l-4-(phenyl sulfanyl)butanamide,

4-(({lR)-3-amino-l-((phenylsulfanyl)melhyl)propyl)amino)- N-(4'(4-((4'-chloro(l,r- biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-3-nitrobenzene sulfonamide,

N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)pipeτazin-l -yl)benzoy])-4-(((l R)-3- cyano-l-((pheny1sulfanyl)methyl)propyI)ammo)-3-nitiobenzenes ulfonaniide, 4-(((lR)-3-(tert-butylarnino)4-((phenylsulfanyl)methyl)piopy l)amino)-N-(4-(4-((4 ^t - chloro(l,l'-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-3~ nitrobenzeπesulfonamide,

N-(4-(4-({4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-({( 1 R)-3 - (cyclopropylamino)- 1 -((phenylsulfanyl)metliyl)piopyl)amino)- 3-nitrobenzenesulfonamide,

N-(4-(4-((4 ^! -chlot o(l,l '-biphenyl)-2-yl)rnethyl)pipeiazin-l-yl)benzoyl)-4-(((lR)-3- (cyclobutylamino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3-nitrobenzenesulfona mide,

N-(4-(4-((4'-chloio( 1 , 1 ^t -biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-4-((( 1 R)-3- ( diethylam ino) - 1 -((phenyl sul fanyl)methyl)pi opy l)amino) -3 -nitrobenzene sul fonami de ,

N'(4-{4-((4 ^l -chloro(l,l ^l -biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyI)-4-(((lR)-3- (isopropyl(methyl)amino)-l-((phenylsulfanyl)methyl)propyl)am ino)-3- nitrobenzenesulfonamide,

4-(((lR)-3-(tert-butyl(methyI)arnino)-l-((phenylsulfany3) melhyl)piopyl)amiiio)-N-(4- (4 -((4' -chloro( 1 , 1 '-biphenyl)-2 -y l)methyl)pipeiazi n- 1 -yl )benzoyl)-3 - nitrobenzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)niethyI)piperazin- l-yl)benzoyl)-3-nitro-4- ((( IR)-I -((phenylsuIfanyl)methyl)-3-(piperidin-l -yl)piopyl)amino)benzenesulfonaτnide,

N-(4-(4-((4'-chloro(l ₅ l'-biphenyl)-2-yl)methyl)piperazin-l-yl)ben2oyl)-4-(((lR)-3- (4- hydroxypiperidin-l-yl)-l-((phenylsulfanyl)π-ethyl)propyl)am ino)-3- nitiobenzenesulfonami de ,

4-(((l R)-3-(4-acetylpipeiazin- 1 -yl)~l -{(phenyIsulfanyl)methyl)piopyl)aniino)-TS!-(4- (4-((4'-chloi o ( 1 , 1 '-biphenyl) -2 -yl)methyl)pipera zin- 1 -yl)benzoy l)-3 - nitrobenzenesulfonamide,

N-(4-(4-((4'-chloiO( 1 , 1 '-biphenyl)-2-yl)methy])piperazin- 1 -yl)benzoy])-3-nitro-4- ((( 1 R)-I -((phenylsulfanyl)methy])-3-(thiomorpholin-4-yl)propyl)arnin o)benzenesulfonamide,

N-(4-(4-((4 ^I -chlorO(l,l'-biphenyl)-2-yl)methyl)pipeiazin4-yl)benzoy!)-4" (({lR)-3- ((2-(morpholin-4-yl)ethyl)amino)-l-((phenylsulfanyl)methyl)p ropyl)amino)-3" nitrobenzenesulfonamide,

N-(4-(4 -((4'-chloro( 1,1' -biphenyl) -2-y l)methyl)pip ei azin- 1 -y l)benzoyl)-3 -nitro -4- (((1 R)-I -((phenylsulfanyl)niethyl)-3-(piperazin~l -yl)piopyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloro(l _! l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- ((3R)-3-hydϊθxypyπolidin-l -yl)- 1 -((phenylsuIfanyl)melhyl)propyl)aniino)-3- nitrobenzenesulfonamide,

4-(((lR)-3-((3R)-3-aminopyirolidin-l-yl)-l-((phenylsulfanyl) methyl)propyl)aτnino)- N-(4~(4-((4'-chloio{ 1 , 1 ^! -biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3- nitrobenzenesulfonamide,

N-(4-(4-((4 ^t -chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3-(3- hydroxyazetidin- 1 -yl)- 1 -((phe]iylsulfanyl)methyl)propyl)amino)-3-nitrobenzenesυlfo namide,

N-(4-(4-((4'-cMorO(l _i r-biphenyl)-2-yl)methyl)pipeiazin-I-yI)benzoyl)-4-(((lR)-3» (4- melhylpipeiazin-l-yl)-I-((phenylsulfanyl)methyl)prOpyl)amino )-3-nitrobenzenesulfonamide,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((lR)-3' (l,l~dioxidothiomoipholin-4-yl)-l-((phenylsulfanyl)methyl)pi opyl)amino)-3- nitrobenzenesulfonamide,

4-(((lR)-3-(l,3-ben2θdioxol-5-ylamino)-l-((phenylsulfany l)methyl)propyl)amiπo)-N- (4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-3- nitiobenzenesulfonamide,

4-((( 1 R)-3-((l ,3-benzodioxol-4-ylmetlαyl)amino)- 1 -

((phenylsulfanyl)metliyl)propyl)amino)-N-(4-(4-{(4'-chloro(l ,r-biphenyl)-2- yl)methyl)piperazin-l-yl)benzoyl)-3-nitτobenzenesulfonamide , N-(4 -(4-( (4 ¹ -cbl oi o ( 1 , 1 '-biphenyl) -2-y l)methyl)piperazin- 1 -yl)benzoyl) -3 -nitro-4-

(((lR)-l-((phenylsulfanyl)methyl)-3-((pyridin-2- ylmethy 1) amino)propy l)am ino)benzene sill fonami de ,

N-(4-(4-((4'-chloro(l ₎ r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3-nitro-4- (((lR)-l-((phenylsulfanyl)methyl)-3-((2-(pyridin-2- yl)ethyl)amino)piopyl)amino)benzenesulfonarnide,

N -(4-(4-((4'-chl or o( 1 , 1 ' -biphenyi) -2 -yl)m ethyl)piperazin- 1 -yl)benzoyl)-3 -nitτo-4- (((1 R)-I -((phenylsulfanyl)methyl)-3-((pyridin-4- ylmethyl)amino)propyl)amino)benzenesulfonamide,

N-(4-(4'((4 ^l -cMoro(l ₅ l'-biphenyl)-2-yl)melhyl)pipeiazin-l-yl)benzoyl)-4-(((lR)-3- (morpholin-4~ylamino)-l-((phenylsulfanyl)rnethyl)propyl)amin o)-3- nitiobenzene sul fonamide, N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyI)ρiperazin- 1 -yl)benzoyl)-4-((( 1 R)-3-

(methyl(pyridin-4-yl)amino)-l-((ρhenylsulfanyl)methyl)pr opyl)amino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4 ^l -chloio(l ,r-biphenyl)-2-yl)rnetliyl)piperazin-l-yl)benzoyl)-3-nitro-4 - (((lR)-l-((phenylsu3fanyl)methyl)~3-(pyiidin-3-ylamino)propy l)amino)benzenesulfonamide, N-(4-(4-((4 ^l -chloio(l,l ¹ -biρhenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-

(2,6-dimethylpiperidin-l-yl)-l-((phenylsulfanyl)methyl)pi opyl)amino)-3- nitTobenzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1'-biphenyl)-2-yl)methyl)pipeiazin- 1 -yl)benzoyl)-4-((( 1 R)-3- ((2R,6S)-2,6-dimethylpiperidin-l-yl)-l-((plienylsulfanyl)met liyl)piopyl)amino)-3- nitrobenzenesulfonamide,

N-(4-(4-( (4'-chI oro( 1 , 1 ' -biphenyi) - 2-y l)methyl)piper azin- 1 -yl)benzoyl) -3 -niti o-4- {((1 R)-I -((phenylsulfanyl)methyl)-3-(pyrrolidin-l - ylamino)ptopyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloro(l , 1 '-biphenyl)-2-yl)metliyl)pipeiazin-l -yl)benzoyl)-4-((( 1 R)-3-(4- (methoxyimino)piperidin- 1 -yl)-l ~((phenylsulfanyl)methyl)piopyl)amino)-3- nitrobenzenesulfonamide,

N -(4-(4- ((4'-chI oro( 1 , 1 ' -b iphenyl) -2-y l)rnethyl)piperazin- 1 -yl )benzoyl) -3 -iii ti o-4- (((lR)-l-((phenylsulfanyl)methyl)-3-(2H-tetrazol-5-yl)piopyl )amino)benzenesulfonamide _s N-(4-(4-((4 ^l -chloro(l _> l ^l -biρhenyi)-2-yl)meihyl)piρerazin-l-yl)benzoyl)-4-(((lR)-3- (diisoptopylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3 - (ti ifluoi omethyl)benzenesul Fonami de ,

N-(4-(4-((4'-chloro(l,l ^! -biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- (isopiopylamino)- 1 -( (phenyl sulfanyl)methyl)propyl)amino)-3- (trifluoiomethyl)benzenesulfonamide,

4-(((lR)-3-(bis(2-hydroxyethyl)amino)-l-((phenylsulfanyl) methyl)propyl)amino)-N' (4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)b enzoyl)-3- niti obenzenesul fonam i de,

N-(4-(4-((4'-chloro(l , r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-3-(((l R)-3- (dimethylamino)-l~((phenylsulfanyl)methyl)propyl)amino)-4- (tτifluoromethoxy)benzenesu]fonarnide,

N-(4-(4-((4 ¹ -chloro(l,l ^l -biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4-(((lR)-3- (isopropyl(melhyl)amino)"l-((pheny]sulfanyl)methyI)piopyl)am ino)-3- (tϊifluoiomethyl)benzenesulfonamide, N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((l R)-3-

(diethylamino)-l-((ρhenylsulfanyl)methyl)propyl)araino)- 3- (trifluoiomethyl)benzenesulfonarnide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)metliyl)pxpeia2in- l-yl)benzoyl)-4-(((lR)-3- (2,5-dirnethylpyπolidin-l-yl)-l-((phenylsulfanyl)methyl)pro pyl)amino)-3- nitrobenzenesulfonarnide,

4-(((lR)-3-amino-l-((phenylsulfanyl)methyl)propyl)amino)- N-(4-(4-((4'-chloro(l,r- biphenyl)-2-yl)m ethyl)piperazin- 1 -yl)benzoyl) -3-( tri fluoiomeihy l)benzenesul fon amide,

N-(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyI)melhyl)piopyl)amino)-2- (tτifluoromethyl)benzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)melhyl)ρiρeiazin-l -yl)benzoyl)-4-((( 1 R)-3- (dimethylamino)-l-{(phenylsulfanyl)methyl)propyl)amino)-3-fl uorobenzenesulfonamide,

N-(4-(4-((4'-chloio{l ₎ r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4-(((lR)-3- (dimelhylamino)-l-((phenylsulfany1)melhyl)propyl)amino)-2- (ti-ifluoromethoxy)benzenesulfonamide,

N-(4-(4-((4'-chloro( 3 , 1 '-biρhenyl)-2-yl)melhyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-2,5- difluorobenzenesulfonamide ₅

N-(4-(4-((4 ^t -chloro(l ₎ l'-biphenyl)-2-y3)methyl)pipeiazin~l-yl)benzoyl)-4"{((lR)-3- {dimethylamino)-l-((phenylsulfanyl)metliyl)piopyl)amino)-3-m ethylbenzenesulfonamide, N-(4-(4-({2-(4-chloiophenyl)-l-cyclohexen-l-yl)methyl)pipera zin-l-yl)benzoyl)-4-

(((lR)-3-{diisopiopylaτnino)-l-((phenylsulfanyl)methyl)p ropyl)amino)-3- nitrobenzenesulfonamide,

007/077579

N-(4-(4-((4'-chloro(l ,r-biphenyl)-2-yl)methyl)piperazin-l-yI)benzoyl)-4-(((lR)-3- ((2R,5R)-2,5-dimethylpyπolidin-l-yl)-l-((phenylsulfanyl)met hyl)propyl)amino)-3- niti obenzenesulfonamide ,

N-(4-(4-({4 ^t -chloro(l,l'~biphenyl)-2-yl)melhyl)piperazin-Uyl)benzoyl)-4- ({(lR)-3- ({2S ₅ 5S)-2,5 -dimethylpy π olidin- 1 -y I)- 1 -((phenylsul fanyϊ)methyl)pr opyl)amino)- 3 - nitrobenzenesulfonamide,

N-(4-(4-((4 ^l -chloio(l , l'-biphenyl)-2-yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3- ((2R, 5 S)-2,5 -d imethylpyπ olid in- 1 -yl)- 1 -((phenyl sulfanyl )methyl)propyl)amino)-3 - nitrobenzenesulfonamide, N-(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)melhyl)pipeiazin-l-y l)benzoyl)-4-(((lR)-3-

(dimethylamino)-l-((plienylsulfanyl)methyl)piopyl)amino)- 3-nitiO-5- (tiifluoromethyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-l-cyclohexen-l-yl)metliyl)pi perazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-({phenylsulfanyl)methyl)piopyl)ar nino)-3-niho-5- (trifluoromethyl)benzenesulfonamide,

N-{4-(4-((2-(4-chloiophenyl)-l -cyclohepten-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)am ino)-3-nitro-5- {trifluoiomethyl)benzenesulfonamide,

N'(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin- l-yl)benzoyl)-3-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)metliyl)propyl)amino)-4-n itrobenzenesulfonamide,

N-(4-(4-((4 ^t -chloio(l,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)"3- (dimethylaτnino)-l-((phenylsulfanyl)methyl)piopyl)ainino)-3 ,5-diflυorobenzenesulfonamide _s methyl 5-(((4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l - yl)benzoyl)amino)sulfonyl)-2-(((lR)-3-(dimethylamino)-l- ({phenylsulfanyl)methyl)piopyl)amino)-3-niiτobenzoale,

5-(((4-(4-((4'-chloro(l,l ^I -biphenyl)-2-yl)methyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-(((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)methyl)propyl)amino)-3~nitiobenzoic acid,

5-(((4-(4-((4'-chloro(l ,l'-biphenyl)-2-yl)methyl)piperazin-l - yl)benzoyl)amino)sulfonyl)-2-(((l R)-3-(dimetliylamino)-l - ((phenylsulfanyl)methyl)propyl)amino)-3-nitrobenzoic acid,

5-( ( (4 -(4-( ( 2-(4 -chlorophenyl) ~ 1 -cyclohexen- 1 ~yl)methyl)pip erazin- 1 - yl)benzoyl)amino)sulfonyl)-2-(((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)methyl)propyl)amϊno)-3-nitrobenzoic acid,

US2007/077579

5-(((4-(4-((2-(4-chlorophenyl)-l-cyclohexen-l-yl)metliyl) piperazin-l- yl)benzoyl)amino)sulfonyl)-2-((( lR)-3-(dimethylamino)-l - ({phenylsul fany l)methyl)propyl) amino) -3 -nitrobenzarni de ,

5-(((4-(4-((4'-chIoro( 1 , 1 '-biphenyl)-2-yl)methyl)pipeiazin- 1 - yl)benzoyl)amino)sulfonyl)-2-(((l R)-3-(dimethylaτnino)-l - ((phenylsul fany l)methy])piOpyl)amino)-3-nitroberi2arnide, methyl 5-(((4-(4-((2-(4-chlorophenyl)-l -cyclohexen-l-yl)methyl)pipeiazin-l - yl)benzoyl)amino)sulfonyl)-2-{((lR)-3-(diniethylamino)-l- ((phenylsυlfanyl)methyl)propyl)amino)-3-(trifluotomethyl)be nzoate, methyl 5-(((4-(4-((4-(4-chlorophenyl)-5 ,6-dihydro-2H-pyran-3-yl)metliyl)piperazin-l - yt)benzoyl)amino)sulfonyl)-2-(({ 1 R)-3-(dimethy1amino)- 1 - ((phenylsulfanyl)methyl)pτoρyl)amino)-3-(trifluoromethyl)b enzoate, methyl 5-{((4-(4-((4'-chloio(l,r-biphenyl)-2-yl)methyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-(((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)methyl)propyl)araino)-3-(trifluoromethyl)be nzoate,

N-(4-(4-((2-(4-chlorophenyl)-l -cyclohexen-l-yl)rneti.iyl)piperazin-l-yl)benzoyl)-4- ((( 1 R)-4-((2R,5S)-2,5-dimethylpyπolidin- 1 -yl)-l -((phenylsutfanyl)methyl)butyl)amino)-3- nitrobenzenesulfonamide,

N-(4-(4-((4-(4-chloτophenyl)-5,6-dihydro-2H-pyran-3-yl)m ethyt)piperazin-l- yl)benzoyl)-4-(((lR)-4-((2R,5S)-2,5-dimethylpyπolidin-l-yl) -l- ((phenylsulfanyl)methyl)butyl)amiτ»o)-3-nilτobenzenesulfo namide, teit-butyl 3-((4-(4-((((4-(((lR)-3-(dimelhylamiπo)-l- ((phenylsulfanyl)melhyl)propyl)amino)-3- nitiopheny^sulfonyOaniinoJcarbonyljphenylJpiperaziii-l-ylJca rbony^phenylcarbamate, N-(4-(4 -(3 -(dimethyl aπiino)benzoyl )pipei azin- 1 -y l)benzoy l)-4-(( ( 1 R)-3 -

(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3 -nitrobenzenesulfonamide,

N-(4-(4-((l,l'-biphenyl)-2-y ^] metliyl)piperazin-l-yl)benzoyi)-4-(((lR)-3- (dimethylamino)-l -methyl- 1 -((phenylsulfanyl)methyl)propyl)amino)-3- nitiobenzenesulfonamide, N-(4-(4-((l ,1 '-biphenyl)-2-ylmethyl)piperazin-l -yl)benzoyl)-4-((( 1 S)-3-

(dimethylamino)- 1 -methyl- 1 -((phenyl sul fanyl)methyl)pi opyl) amino)-3 - nitrobenzenesulfonamide,

N-(4-(4-(2-(l _s 3-dihydro-2H-isoindol-2-yl)benzyl)piperazin-l -yl)benzoyl)-4-(((l R)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3-ni trobenzenesulfonamide,

79

N-(4-(4-(2-(cyclohexylamino)benzyl)pipeiazin- 1 -yl)benzoyl)-4-((( 1 R)- 3- {dimethylamino)-l-((phenylsulfanyl)methyl)propyl)ainino)-3-n itiobenzenesulfonamide,

4 -((( 1 R)-3 -{dimethylami no)- 1 - ((phenylsul fanyl)methyl)propy l)ami no) -N-(4-(4 - (2 - (isopiopylamino)benzyl)piperazin-l-yl)benzoyl)-3-iiiiiobenze nesulfonamide, N-{4-(4-(2-(benzylamino)benzyl)piperazin-l-yl)benzoyl)-4-((( lR)-3-

(dimethylamino)-l-({phenylsulfanyl)methyl)piopyl)amino)-3 -nitτobenzenesulfonamide,

4-({{lR)-3™(dimethylamino)-l-((phenyIsυlfanyl)methyl)p iopyl)amino)-3-nitro-N-(4- (4-(2-(piperidin-l-yl)benzyl)piperazm-l-yl)benzoyl)benzenesu lfonarnide,

N-(4-(4-(( 1 ,r-biphenyl)-2-ylmethyl)piperazin-l -yl)benzoyl)-3-nitro-4-((2- (phenylsιιlfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((l ,r-biphenyl)-2-ylmethyl)piperazin-l -yl)benzoyl)-4- ((cyclohexylmethyl)amino)-3-nitiobenzenesulfonamide,

N-(4-(4-((l , 1 ^! -biphenyl)-2-ylmelhyl)-4-methoxypiperidin- 1 -yl)benzoyl)-4-(((l R)-3- (raorpholin-4-yl)-l-{(phenylsulfanyl)niethyl)piopyl)amino)-3 -nitrobenzenesulfonamide, N-(4-(4-((l,r-biphenyl)-2-ylmethyl)-4-methoxypipeiidin-l-yl) benzoyl)-3-nitro~4-((2-

(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloro(l ,l ¹ -biphenyl)-2-y])methyl)piperazin-l-yl)benzoyl)-4-(((lS)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)arnino)-3-n itrobenzenesulfonamide _!

N-(4-(4-((4'-chloro(l _! r-biρhenyl)-2-yl)methyl)piperazin-l~yl)benzoyl)-4-(((lR)-l- ((phenylsulfanyl)methyl)-3-{pyπolidin-l-yl)piopyl)amino)-3- (trifluoromethyl)benzenesulfonamide,

N-(4-(4-((4-(4-clilorophenyl)pyiidin-3-yI)methyl)pipeiazi n-l -yl)benzoyl)-4-((( 1 R)-3- (dimethylamino)'l-((phenylsulfanyl)raethyl)propyl)amino)-3-n itrobenzenesulfonamide,

N-(4-(4-((4-(4~chlorophenyl)pyridin-3-yl)methyl)pipeiazin -l-yl)benzoyl)-4-(((lR)-3- (moipholin-4-yl)-l~((phenylsulfanyl)methyl)propyl)amino)-3-n itrobenzenesulfonamide,

N.(4-(4-((4'-cWoτo(l,r-biphenyl)-2-yI)methyl)pipeiazin-l -yl)benzoyl).4-(((lR)»3- (dimethylamino)-l-((phenylsulfanyl)melhyl)propyl)amino)-2-fl uoto-3- (tiifluoromelhyl)benzenesulfonamide,

N-(6-(4-((4'-chloro ( 1 , l'-bipheny l)-2-y l)methyl)piperazin- 1 -y 1 )- 1 ,2 -benzisoxazol -3 - yl)-3-nitio-4-((2"(phenylsulfanyl)ethyl)amino)benzenesulfona mide,

N-(6-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)-l,2-benzisoxazol-3- yl)-4-(((lR)-3-{moipholin-4-yl)-l-((phenylsulfanyl)methyl)pr opyl)ainino)-3- nitiobenzenesulfonamide,

N-(6-(4,4-diniethylpiperidin-l-yl)-l,2-benzisoxazol-3-yl) -.3-nitr'o-4-((2- (phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N-(6-(4,4-dimethylpiperidin-l-yl)-l ,2-benzisoxazol-3-yl)~4-(((lR)-3-(morpholin-4- yl)-l-((phenylsulfanyl)metliyl)piopyl)amino)-3-nitrobenzenes ulfonamide _J N-(6-(4-(3,3-diphenylpiopen-2-yl)piperazin-l-yl)-l _s 2-benzisoxazol-3-yl)-4-(((lR)-3-

(morpholin-4-yI)"l-((phenylsulfanyl)methyl)propyl)amino)- 3-nitrobenzenesulfonamide,

N-(6-(4-(3,3-diphenylpropen-2-yl)piperazin-l-yl)-l ,2-benzisoxazol-3-yl)-3-nitτo-4- ((2-(phenylsulfanyl)ethyl)araino)benzenesulfonamide,

N-(6-(4-((4'-chloio{ 1 , 1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)-l ,2-benzisoxazol-3- yl)-4-{((lR)-3-(dimethylaniino)-l-((phenylsulfanyl)methyl)pi opyl)amino)"3- nitrobenzenesulfonami de ,

4-((( 1 R) -3 -(dimethyl amino)- 1 -({phenylsulfanyl)methyl)propyl)amino)-N-(6-(4,4- dimethylpiperidin-l-yl)-l,2-benzisoxazol-3-yl)-3-πitτobenz enesulfonamide,

N-(6-(4-((4'-chloio( 1 , l'-biphenyl)~2-yl)methyl)piperazin- 1 -yl)- 1 -methyl-1 H-indazol- 3-yl)-3-nitio-4-((2-(phenylsulfanyl)ethyl)amino)benzenesulfo τιamide,

N-(6-(4-((4'-chloro(l,r~biphenyl)-2-yl)methyl)piperazin-l -yl)-l-methyl-iH-indazol- 3 -yl) -4-(( 1 , 1 -dimethyl -2- (phenylsul fanyl)ethyl)amino)-3 -ni iTobenzenesul fonamide ,

N-(6-(4-((4'-chloro(l ,r-biphenyl)-2-yl)methyl)piperazin-l -yl)-l -methyl-1 H-indazol- 3-yl)-4-(({lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)p ropyl)amino)-3- nitrobenzenesυlfonamide,

N-(6-(4-({4'-chloio( 1 ,r-biphenyl)-2-yl)methyl)pipeiazin-l -yl)~l -methyl-1 H-indazol- 3 -yl)-4-{ (( 1 R) -3-(morpholin-4-yl)- 1 - ((phenyl sul fany l)methyl)propyl)amino) -3 - ni trobenzenesul fonami de ,

N-(6-(4-((4'-chloro(l , l'-biphenyl)-2-yl)methyl)piperazin-l -yl)-l H-indazol-3-yl)-3- nitro-4-((2-(phenylsulfanyl)ethyl)amino)benzenesulfonamide,

N^6-(4-((4 ^t -chloro(l,r-biphenyl)-2-y3)methyl)piperazin-l-yl)-lH-indazol -3-yl)-4- (((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)prOpyl)am ino)-3- nitϊobenzenesulfonamide, and

N-(6-(4-((4'-chloro(I ,r-biphenyl)-2-yl)methyl)piperazin-l-yl)-lH-indazol-3-yl)-4- (((lR)-3-(moipholin-4-yl)-l-((phenylsulfanyl)methyl)propyl)a mino)-3- nitTobenzene sulfonamide,

N-(4-(4-((4'-chloro(l _i r-biphenyl)-2-yl)methyl)piperazin-l"yl)benzoyl)-3- (methylsulfonyl)-4-((2-(phenylsulfanyl)ethyl)amino)benzenesu lfonamide,

N-(4-(4-((4'-chloro( 1 , l'-biphenyl)-2-yl)methyl)ρiρerazin-l -yl)benzoyl)-4-(( 1 , 1 - dimethyl-2"(phenylsulfanyl)ethyl)amino)-3-(methylsulfonyl)be nzenesulfonamide,

N-(4-(4-((4'-chloio(l , 1 '-biphenyl)-2-yl)methyl)piperazin- 1 ~yl)benzoyl)-3- (methylsulfonyl)-4-(((lR)-3-(morpholin-4-yl)-l- ((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 14>iphenyl)-2-yl)methyl)pipeiazin-l -yl)beπzoyl)-4-(((l R)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3- (ethylsulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)inethyl)ρiperazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (dim ethylamino) - 1 - ((phenylsul fanyl )methy I)propy I)arn ino) -3 - (τnetliylsulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l , 1 '-biphenyl)-2-yl)methyl)pipeiazin-I -yl)benzoyl)-4~((( 1 R)-3- (diisopiopylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3 - ((trifluoiomethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chloiophenyl)cyclohex-l-en-l-yl)τnethyl)pipe razin-l-yl)benzoyl)-4-

(((lR)-3-(diisopropylamino)-l-((phenylsulfanyl)methy])pro pyl)amino)-3- ((tiifluoiornethyl)sulfonyl)ben2enesulfonamide,

N -(4- (4-({2- (4-chl oropheny l)cyclohex- 1 -en- 1 ~yl)methyl)piperazin- 1 -yl)benzoyl) -4 - (((lR)-3-((2R,5S)-2,5-dimethylpyπolidin-l-yl)-l-((phenylsul fanyl)methyl)propyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide ₅

4-(((lR)-4-(7-azabicyclo[2.2.1]hept-7-yl)-l-{(phenylsulfa nyl)metliyl)butyl)amino)-N- (4-(4-((2-(4-chloiophenyl)cyclohex-l-en-l-yl)methyl)piperazi n-l-yl)benzoyl)-3- ((lτifluoromethyl)sulfonyl)benzenesulfonamide,

4_((( i R)-4-(7-azabicyclo[2.2.1 ]hepl-7-yl)-l -({phenylsulfanyl)methyl)bυtyl)amino)-N- (4-{4-((4-(4-chloiophenyl)-5,6-dihydro-2H-pyran-3-yl)methyl) piperazin-l-yl)benzoyl)-3- ((tiifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4-(4-chlorophenyl)-5,6-dihydro-2H-pyran-3-yl)me thyϊ)piperazin-l- yl)benzoyl)-4-(((IR)-4-((2R,5S)-2,5-dimethylpyπolidin-I-yl) -l- ((phenylsulfanyl)methyl)butyl)amino)-3-((tiifluoiomelhyl)sυ lfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pipeia zin-l-yl)benzoyl)-4-

(({lR)-4-(dii sopropy lam ino)- 1 -((phenyl sulfanyl)methyl)butyl)am ino)-3 - ((trifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4-(4-chloroplienyl)-5,6-dihydro-2H-pyian-3-yl)m ethyl)pipeiazin-l- yl)benzoyl)-4-(((lR)~4-(diisopropylamino)-l-({phenylsulfanyl )niethyl)butyl)amino)-3- ((tri fluoromethy l)sul fonyl)benzene sul fonami de ,

N-(4-(4-((2-(4-chlorophenyl)cyclohex- 1 -en-1 -yl)methyl)piperazin-l -yl)benzoyl)-4~ ((( 1 R)-4-{dimethylamino)- 1 -((pheiiylsulfanyl)methyl)bulyl)aniino)-3- ({ tri fluoromethyl) sul fonyl)benzenesulfonamide,

N-(4-(4"((4-(4-chlorophenyl)~5,6-dihydio-2H-pyian-3-yl)me thyl)piperazin-l- yl)benzoyl)-4-{((lR)-4-(dimethylamino)-l-((phenylsulfanyl)me thyI)butyl)amino)-3- ((trifiuoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chIorophenyl)cyclohex-l-en-I-yl)methyl)pipera zJn-l-yl)benzoyl)-4-

(((lR)-4-((2R,5S)-2 _J 5-dimethylpyπolidin-l-yl)-l-((phenylsulfanyl)methyl)buty])a mino)-3- ((tτifluoiomethyl)sulfonyl)benzenesulfonamide,

4-({(lR)-3-(l-azetidinyl)-l-((phenylsulfanyl)methyl)propy l)amino)-N-(4-(4-((2-(4- chlorophenyl)cyclohex-l -en- 1 -yl)methyl)piperazin-l -yl)benzoyl)-3- ((trifluoromethyl)sulfonyl)benzenesulfonarnide,

4-(((lR)-3-(l-azetidinyl)-l-((phenylsulfanyl)methyl)proρ yl)amino)-N-(4-(4-C(4-(4- chloroplienyl)-5,6-dihydro-2H-pyran-3-yl)methyl)piperazin-l- yl)benzoyl)-3- ( (tri fluoromethyl) sulfonyl)benzenesul fonam ide ,

4-(((lR)-3-((3aR,6aS)-tetiahydro-lH-furo[3,4-c]pyπol-5(3H)- yl)-l- ((phenylsulfanyl)melhyl)piopyl)amino)-N-(4-(4-((2-(4-chloiop henyl)cyclohex-l -en- 1 - yl)methyl)piperazin-l-yl)benzoyl)-3-((trifluoroτnetliyl)sul fonyl)benzenesulfonamide ₎

4-(((lR)-3-((3aR,6aS)-lebahydro-lH-fuio[3,4-c]pyrrol-5(3H )-yl)-l-

((phenylsulfanyl)methyl)propyl)amino)-N~(4-(4-((4-(4-chlo rophenyl)-5,6-dihydro-2H-pyian- 3 -yl)methyl)piperazi n- 1 -yl)benzoy I) -3 -((tr if! uorornelhyl)sul fonyl)benzenesul fonami de , N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pipera zin-l-yl)benzoyl)-4-

(((lR)-3-(8-oxa-3-azabicyclo[3 2.1]oct-3-yl)-l-((phenylsulfanyl)melhyl)piopyl)amino)-3- ( (tii fluoromethyl) sulfonyl)benzenesul fonam ide,

N-(4-(4-((4-(4-chloiophenyl)-5,6-dihydio-2H-pyran-3-yl)me thyl)piperazin-l- yl)benzoyl)-4-(((lR)-3-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-l - ((phenylsulfanyl)methyl)piopyl)amino)-3'{(trifluoiomethyl)su lfonyl)benzenesulfonainide, N-(4-(4-((2-(4- chlorophenyl)cyclohex- 1 -en- 1 -yl)methyl)pipei azin- 1 -yl)benzoyl) -4- (((lR)-4-(moipholin-4-yl)-l-((phenylsulfanyl)methyl)butyl)am ino)-3- ((tiifluoromethyl)sυlfoiiyl)benzenesulfonamide,

N-(4-(4 -((2-(4-chloropheny I)- 5 ,5 -dimethylcyclohex- 1 -en- 1 -yl)methyl)piperazin- 1 - y l)b enzoy l)-4-((( 1 R)-4-(morphol ln-4 -yl) - 1 -((phenyl su lfany l)methyl)butyl)amino)-3 - ((tτifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4-((3R _J 5S)-4-((4 ¹ -chloro(l,l'-biphenyl)-2-yl)methyl)-3,5- dimethyIpipeiazinyl)benzoyl)-4-(((lR)-3-(isopropyl(methyl)am ino)~l-

((phenylsuIFanyl)metliyl)propyI)amino)-3-((ttifluoromethyl)s ulfonyl)benzenesulfonamide _!

N-(4-((3R,5S)-4-((4 ¹ -chloro(l,r-biρhenyl)-2-yl)methyl)-3,5- dimelhylpiperazinyl)benzoyl)-3-((chloro(difluoio)methyl)sulf ony])-4-(((lR)-3-((lS _s 4S)-2- oxa-5-azabicyclo[2 2 l]hept-5-yI)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

4-((( lR)-3-(7-azabicyclo[2 2 1 ]hept-7-yl)-l -((phenylsulfanyl)methyl)piopyl)amino)- N-(4-(4-((2-(4-chlorophenyl)-l -cycloliepten-1 -yl)methyl)piperazin- 1 -yl)benzoyl)-3- ((trifluoiomethyl)sulfbny3)benzenesulfonamide,

N-(4-(4-((4-(4-chloroplienyl)-5,6-dihydro-2H-pyran-3-yl)m ethyl)piperazin-l- yl)benzoyl)-4-(((l R)-3-(2-oxa-5-azabicycio[2 2 l]hept-5-yl)-l -

((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl )sulfonyl)benzenesulfonamide,

4-((( 1 R)-3-{7-azabicyclo[2 2 1 ]hept-7-yl)- 1 -((phenylsulfanyl)methyl)propyl)amino)- N-(4-(4-{(4-(4-chloiophenyl)-5,6-dihydro-2H-pyian-3-yl)methy l)pipeiazin-l-yl)benzoyl)-3- {(trifluoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chloiophenyl)cyclohex-l -en-1 -yl)methyl)pipeiazin-l-y])benzoyl)-4-

((( 1 R)- 1 -( (phenyl su lfany l)methyl )-3 -(pytrolidi n~ 1 -yl)propyl)amino)- 3 - ((trifluoromethyl)sulfonyl)benzenesulfonamide,

4-(((lR)-3-((lS,4R)-2-azabicyclo[2 2 l]hept-2-yl)-l-

({phenylsulfanyI)methyl)propyl)amino)-N-(4-(4-((2-(4-chloiop henyl)cyclohex-l-en-l- yl)methyl)pipeiazin-l-yl)benzoyl)-3-((tτifluoromethyl)sulfo nyl)benz;enesulfonamide ₁

N-{4-(4-((4 ^t -chloro(l,l ^t -biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- hydroxy~l-((phenylsulfanyl)methyl)piopyl)amino)-3-(methylsul fonyl)benzenesulfonamide,

N-(4-(4-((4 ^! -chloio( 1 , 1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((l R)-3- (diisopiopylamino)-l~((phenylsulfanyl)methyl)piopyl)amino)-3 - (rnethylsulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3- (niethylsulfonyl)-4-(((lR)-l-((phenylsulfanyl)metliyl)-3-(py πolidin-l- yl)piopyl)amino)benzenesulfonamjde,

2007/077579

(3R)-3-(4-(((4-(4-({4 ^t -chloro(l _! r-biphenyl)-2-yl)methyl)piperazin-l- yl)benzoyl)amino)sulfonyl)-2-(methylsulfonyl)anilino)-N,N-d� �sopropyl-4- (phenylsulfanyl)butanami de

(3R>3-(4-(((4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yt)methyl)piperazin-l - yl)benzoyl)amino)sulfonyl)-2-(methylsulfonyl)anilino)-N-isop ropyl-N-methyl-4- (phenylsulfanyl)butanamide

4-(((lR)-3-(azetidin-l-yl)-3-oxo-l-((phenylsulfanyl)methyl)p rOpyl)amino)-N-(4-(4- ( (4'-chloro ( 1 , l'-biphenyl)-2-yl)methyl)pipei azin- 1 -yl)benzoyl )-3 - (methylsulfony^benzenesulfonaniide, N-(4-(4-((4 ⁽ -chlorO(l,l'-biphenyl)-2-yl)melhyl)pipeiazin-l~yl)benzoyl)-4 -(((lR)-3-

(diethylamino)~l-((phenylsulfanyl)methyl)propyl)amino)-3- (methylsulfonyl)benzenesiilfbnamide,

N-(4-(4-((4'-chloro( 1 , 1 '-biphenyl)-2-yl)methyl)piρerazin- 1 -yl)benzoyl)-4-((( 1 R)-3- (isopropyl(methyl)amino)-l-((phenylsulfanyl)metliyl)propyl)a mino)-3- (methylsulfonyl)benzenesulfbnamide,

4-(((lR)-3<azetidin-l-yl)4-((phenylsulfanyl)methyl)pro pyl)atnino)-N-(4-(4-((4'- chloio(l ,r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-3- (methylsulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-3- (methylsulfonyl)-4-(((lR)-3-oxo-l-((phenylsulfanyl)raethyl)- 3-(pyπoIidin-l- yl)propyl)amino)benzenesulfonamide,

N-(4-(4-((4'-chloio(l,l ^! -biρhenyl)-2~yl)methyl)piperazin-l-yl)benzoyl)-4-({(lR)-3- (dimethyl amino) - 1 -((phenylsul fanyl)methyl)pi opyl)amino)-3"{ ( 1 , 1 ,2,2 , 2- pentafluoioethyl)sulfonyl)benzenesulfonamide, N~{4-(4-((4 ¹ -chloro(l ₎ r-biplienyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-

(dimethylamino)-l -{(phenylsulfanyl)methyl)propyl)amino)-3-(( 1 ,1, 2,2,3 ,3,3- heptafluoropropyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l _I l'-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3-(( l,2,2,2-lettafluorO-l- (trifluoiomethyl)elhyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l _} r-biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- (4,4-dimethyl-4,5-dihydio-lH-imidazol-l-yl)-l-((phenylsulfan yl)methyl)propyl)amino)-3- ((trifl uoromethy l)sul fonyl)benzenesυl fonamide ,

N-(4-(4-((4'-chloro(l,l'-biphenyl)-2-yl)methyl)piperazin- l »yl)benzoyl)-4-(({lR)-3- (5,6-dihydio-l (4H)-pyrimidin-l -yl)-l -({plienylsυlfanyl)methyl)propyl)amino)-3- ((ttifluoiOmethyl)sulfonyl)benzenesulfonamide,

) N-(4-(4-((4'-ch1oto(1 , 1 '-biphenyl)-2-yl)me1hyl)pipeiazin-I -yl)benzoyl)-4-((( lR)-3- {2,4~dimethyI-4,5-dihydro-l H-imidazol-1 -yl)-l -((phenylsulfanyl)melhyI)propyl)amino)-3- ((ttiflu oromethyl)sul fonyl)benzenesul fonamide ,

N-(4-(4-((4'-oh1oio( 1 , 1 '-biphenylH-ylJmethylJpipeiazin- 1 -yl)benzoyl)-4-((( 1 R)-3-(2- metliyl-4,5-dihydro-lH-imidazol-l-yl)-l-{(phenylsulfanyl)mel hyl)propyl)amino)-3- ((trif!uoiomethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)melhyl)pipeiazin-l -yl)benzoyl)-4-((( 1 R)-3-

(2,5-dimethylpyirolidin-l-yl)-l-((phenylsulfanyl)raethyl) propyl)amino)-3- ((trifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)piperazin-l -yl)benzoyl)-4-(((lR)-3- (isopiopyl(methyl)ai ^" nino)-l-((phenylsulfanyl)methyl)propyl)amino)-3- ({lτifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chIorophenyl)cyclohept-l -en-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- ((( 1 R)-3-(diisopropylamino)- 1 -({phenylsulfanyl)methyl)propyl)amino)-3- ((tiifluoromethyl)sulfonyl)benzenesulfonamide,

4-(((lR)-3-(bis(2-methoxyethyl)amino)-l-((phenylsulfanyl) methyl)propyl)amino)-N- (4-(4-((2-(4-chloiophenyl)cycloheχ-l-en-l-yl)methyl)piperaz in-l-yl)benzoyl)-3- ({trifluoromethyl)sulfonyl)benzenesulfonaniide,

N-(4-(4-((2-(4-chloropheny])cyclohex- 1 -en- 1 ~yl)methyl)piperazin-l -yl)benzoyl)-4- (((lR)-3-(l,4,7-dioxazonan-7-yl)-l-((phenylsulfanyl)methyl)p iopyl)amino)-3- ({trifluoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chlorophenyl)cycϊohex-I -en-1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4-

(((lR)-3-(2~methylpyiiolidin-]-yl)-l-((phenylsulfanyl)met hyl)propyl)amino)-3- {(trifiuoromethyl)sulfonyl)benzenesulfonamide,

N~(4-(4-((2-(4-chloiophenyl)cyclohex- 1 -en-1 -yl)melhyl)pipeiazin- 1 -yl)benzoyl)-4- (((lR)-3-(4,4-difluoropiperidin-l-yl)-l-((plienylsulfanyl)me thyl)piopyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-({2-{4-chlorophenyl)cyclohex- 1 -en-1 -yl)methyl)pipeiazin- 1 -yl)benzoyl)-4- (((lR)-3-((3R,5S)-3 ₎ 5-dimethoxypiperidin-l-yl)-l-((phenylsulfanyl)metliy3)piopyl )amino)-3- {(trifluoromethyl)sulfonyl)benzenesulfonamide,

N-{4-(4 -((2-(4-chloropheny l)cyclohex- 1 -en- 1 -yl)methy l)piperazin- 1 -yl)benzoy 1) -4 - C((lR)-3-((2S)-2~(raethoxymethyl)pyπohdin-l-yl)-l-((phenyls ulfanyl)methy])ptopyl)amino)- 3-((tri;fluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4 -((2-{4-c hi or opheny l)cy cl ohex- 1 -en- 1 -yl)methyl)pipei azin- 1 -yl)benzoy 1) A- (((lR)-l-((phenylsulfanyl)methyl)-3-{l ,3-thiazolidin-3-yl)propyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex- 1 -en-1 -yl)methyl)pipetazin- 1 -yl)benzoyl)-4- ((( 1 R)- 3 -(( 3 S)-3 -τnethylmoφholin-4-yl)- 1 -((phenylsulfanyl)methyl)piopyl)amino)- 3 - ((trifluoiomelhyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chloiophenyl)cyclohex-l-en-l-yl)raethyl)pipei azin-l-yl)benzoyl)-4-

(((lR)-3~(l-hydroxy-3,7-dioxa-9-azabicyclo[3 3,l]non-9-yl)-l-

((phenylsulfanyl)methyl)piopyl)amino)'3-((trifluoiomethyl )sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chloiophenyl)cyclohex-l-en-l-yl)raetliyl)pipe iazin-l-yl)benzoyl)-4- {((lS)~3-(3,7-dioxa-9~azabicyc]o[3 3 l]non-9-yl)-l-(2-phenylethyl)propyl)amino)-3- ((trifluorometliyl)sulfonyl)benzenesulfonamide,

N- (4- (4 -((2-(4-chloropheny l)cyclohex- 1 -en- 1 -y 1 )methyl)piperazi n- 1 -yl)benzoyl) -3 - ((difluoiomelliyl)sulfonyl)-4-(((lR)-3-(morpholin-4-yl)-l- ((phenylsulfanyl)methyl)piopyl)amino)benzenesulfon amide,

N-(4-(4-((2-(4~chloi ophenyl)cy cl ohex- 1 -en- 1 -yl)methy l)pipei azin- 1 -y l)benzoyl)- 3 - ((difluoromethyl)sulfonyl)-4-(((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-clilorophenyl)cyclohex-l -en-1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4- ( (( 1 R)- 3 - (dimethylamino)- 1 -((phenyl su lfany l)methy l)propyl )oxy) -3- (elhylsulfonyl)benzenesulfonamide, 3-((chIoro(difluoio)methyl)sulfonyl)-N~(4-(4-((4-(4~chloroph enyl)-5,6-dihydrθ'2H- pyran-3-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(dimeth ylamino)-l - ((phenylsulfanyl)methyl)propyl)amino)ben2enesulfonamide,

N-(4-(4-((4-(4-chlorophenyl)-5,6-dihydro-2H-pyτan-3-yl)m ethyl)piperazin-l- yl)benzoyl)-3-((difluoromethyl)sulfonyl)-4-(((lR)-3-(dimelhy lamino)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

3-((chloro(difluoio)methyl)sulfonyI)-N-(4-(4'((4-(4--chlo rophenyl)-5,6-dihydio-2H- pyran-3-yl)methy3)piperazin-l-yl)benzoyl)-4-(((lR)-3-(raorph olin-4-yl)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonaniide,

N-(4-(4-((4-(4-chIoiophenyl)-5,6-dihydro-2H-pyran~3-yl)me thyl)piperazin-l- yl)benzoyl)-4-(({lR)-3-(dimethylamino)-l-((phenylsulfanyl)me thyl)propyl)oxy)-3- (ethylsulfbnyl)benzenesulfonamide,

N-(4-(4-((4-(4-chIoiophenyl)-5,6-dihydro-2H-pyran-3-yl)me thyI)pipeiazin-l- yl)benzoyl)-3-((difluorornethyl)sulfonyl)-4-(((lR)-3-(morpho lin-4-yl)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-chIorophenyl)-5,5-dimelhylcyclohex-l-en-l- yl)methyl)pipeiazin-l- yl)benzoyl)-4-(((lR)-3-(l,4-oxazepan-4-yl)-l-({phenylsulfany l)methyl)ptopyl)amino)-ϊ- { (tr i fluoi omethyl)sul fonyljbenzenesulfonami de , N-(4-(4-((2-(4-chloiophenyl)cyclohept-l -en- 1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4-

(((lR)-3-(l ,4-oxazepan-4-yl)-l-((phenylsulfanyl)methyl)propyl)amino)-3- ( (tii fluoi omethyl) sulfony l)benzenesulfonam i de ,

3-((cliloro(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chlo rophenyl)cyclohept-l-en-i- yl)methy])pipeiazin-l-yl)benzoyl)-4-(((lR)-3-(dimethylamino) -l- ((phenylsulfanyl)methyl)piopyl)amino)benzenesυlfonamide,

3-((chloro(difluoro)methyl)sulfonyI)-N-(4-(4-((2-(4-chlor ophenyl)cyclohept-l-en-l- yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl )-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

3-((chloro(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chloi ophenyl)-5,5- dimelhylcyclohex-l-en-l-y])methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l- ((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

3-((chloio(difluoro)metliyl)sulfonyl)-N-(4-(4-((2-(4-chlorop henyl)cyclohex-l-en-l- yl)methyl)piperazin-l-yl)benzoyl)-4-(({lR)-3-(l _s 4-oxazepan-4-yl)-l- ((plienylsulfanyl)methyl)propyl)amino)benzenesulfonamide, 3-((chloro(difluoio)methyl)sulfonyI)-N-(4-(4-((2-(4-chloroph enyl)cyclohept-l-en-l- y l)methy l)pipera zi n- 1 -y l)benzoy l)-4-{ (( 1 R)-3 -( 1 ,4 -oxazepan-4 -y I)- 1 - ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

3-((chloio(difIuoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chlor ophenyl)-5,5- dimethylcyclohex-1 -en- 1 -yl)niethyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-3-(l ,4-oxazepan-4-yl)- 1 -((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

3-((chloro(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chlor ophenyl)-4,4- dimethylcyclohex-l-en-l-yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3-(l,4-oxazepan-4-yl)- l-((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

3 -((chl or o(difluoro)methy 1) sulfony 1 )-N- (4 -(4-((2- (4-chlorophenyl) cyclohex- 1 -en- 1 - yl)m ethyl)pipera zin- 1 -yl)benzoy 1 )-4-((( 1 R)-3 -(isopi opyl(methy l)amino)- 1 - ((phenylsul fanyl)methyl)pi opyl )amino)benzenesul fonam ide,

3-((chloio(difluoro)inelhyl)sulfonyl)-N-(4-(4-((2-(4-chlo rophenyl)cyclohept-l-eπ-l- yl)methyl)piperazin-l-yl)benzoyl)-4~(((lR)-3-(isopropyl(meth yl)amino)-l- {(phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)-4 ₁ 4-dimelhylcyclohex-l-en-l-yl)methyl)piperazin-l- yl)benzoyl)-4-(((l R)-3-(l ,4~oxazepan-4-yl)-l -((phenylsulfanyl)methyl)piopyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((4-(4-chIoropheny 1) -5 , 6-dihy dro~2H-pyra n-3 -yl)methyl)pipera zin- 1 - y l)b enzoy l)-4-(( ( 1 R)-3-( dimethy lam ino) - 1 -((phenylsul f anyl)methyl)propy 1) amino) -3 - ((tτifluoromelhyl)sulfonyl)beπzenesulfonaniide,

4-{((lR)-3-(7-azabicyclo[2.2.1]hept-7-yl)-l-((phenylsulfa nyl)methyl)propyl)amino)- N-(4-(4-((2-(4-chloiophenyl)-5,5-dimethylcyclohex-l-en-l-yl) melhyl)piperazin-l- yl)benzoyl)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4~(4-((4-(4-chloiophenyl)-5,6-dihydro-2H-pyian-3-yl)me thyl)pipeiazin-l- yl)benzoyl)-4-(((lR)-3-(isopropyl(methyl)amino)-l-({phenylsu lfanyl)methyl)piOpyl)amino)- 3-((frifluoiomethyl)sulfonyl)benzenesulfonamide, lert-butyl 4-(4-chlorophenyl)-5-((4-(4-((((4-(((l R)-3-(morpholin-4-yl)-l - ((phenyIsulfanyl)methyl)propyl)amiπo)-3-

((ttiflιioiomethyl)sulfonyl)phenyl)sulfonyl)amino)carbon yl)phenyl)piperazin-l-yl)methyl)- 3 , 6 -dihydio - 1 (2H)-pyri dinecatboxylate tert-butyl 4-(4-chlorophenyl)-5-((4-(4-((((4-((( 1 R)-3-(dimetliylamino)-l - ((phenylsulfanyl)methyl)propyl)amino)-3- ((tiifluoromethyl)sulfonyl)phenyl)sulfonyl)amino)carbonyl)ph enyl)pipeiazin-l-yl)methyl)- 3,6-dihydro- 1 (2H)-pyridinecarboxylate

N-(4-(4-((4-(4-chloiophenyl)-l,2,5,6-tetrahydro-3-pyridin yl)methyl)piperazin-l- yl)benzoy l)-4 -((( 1 R)-3 -(dimethylam ino) - 1 -((phenylsul fanyl )methyl)propy l)amino) - 3- {(tiifluoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((4-(4-chlorophenyl)-l,2,5,6-tetrahydiO-3~pyridinyl) methyl)piperazin-l- yl)benzoyl)-4-((( 1 R)-3-(morpliolin-4-yl)- 1 -((phenylsulfanyl)melhyl)propyl)amino)-3- { (tri fluoromethyl)sul fony l)benzenesul fonami de ,

N-(4-(4-({l-acetyl-4-(4-chlorophenyl)-l ,2,5,6-tetrahydro-3- pytidinyl)methyl)piperazin-l-yl)benzoyl)-4-({(lR)-3-(dimethy lamino)-l- ((phenylsulfanyl)πiethyl)propyl)aminiθ)-ϊ-((triflιiorome tliyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4-(4-chlorophenyl)- 1 -methyl- 1 ,2,5,6-tetrahydro-3- pyridinyl)niethyl)piperazin-l -yl)benzoyl)-4-{((l R)-3-(dimethylamino)-l -

((phenylsulfanyl)methyl)propyl)amino)-3-((ttifluoiomethyl )sulfonyl)benzenesulfonamide,

N-(4-(4-((4-(4-chlorophenyl)-l-(cyclohexylmethyl)-l ,2,5,6-tetrahydro-3- pyτ idinyl)methyl)pipei azin- 1 -y 3)b enzoyl) -4-((( 1 R)-3 -(dim ethyl amino)- 1 - ((phenylsulfanyl)methyl)propyl)amino)-3-((tiifluoiomethyl)su lfonyl)benzenesulfonamide _J N-(4-(4-((l-acetyl-4-(4-chlorophenyl)-l,2,5,6-tetrahydro-3- pyridinyl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(morphol in-4-yl)-l- ((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)su lfonyl)benzenesulfonamide,

N-(4-(4-((4-(4-chloiophenyl)~l-methyl-l,2,5,6-tetrahydro- 3> pyridinyl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(moiphoI in-4-yl)-l- ((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)su lfonyl)benzenesulfonamide, N-(4-(4 -((2-(4-chlorophenyl) -4 ,4-dimethylcy clohex - 1 -en- 1 -yl)methyl)pipe i azi n- 1 - yl)benzoyl)-4-(((lR)-3-(diethylammo)-l-((phenylsulfanyl)meth yl)propyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-(((IR,2R)-2-{4-chloiophenyl)cyclohexyI)nielhyl)pi perazin-l-yl)benzoyl)-4- (((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)methyI)piopyl)a mino)-3- ((tiifluotomethyl)sulfonyl)benzenesulfonamide,

3-((chloro(difluoro)methy})sulfonyl)-4-{((lR)-3-(morphohn -4-yl)-l-

((phenylsulfanyl)methyl)propyl)amino)-N-(4-(4-({4-(4-(tτ ifluoiomethyl)phenyl)-5,6-dihydro- 2H-pyian-3-yl)methyl)piperazin-l-yl)benzoyl)benzenesulfonami de, 4-(({lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)methyl)piopyl )amino)-N-(4-(4-((4-

(4-(trifluoromethy])phenyl)-5,6-dihydro-2H-pyian-3-yl)met hyl)pipeiazin-l-yl)benzoyl)-3- ((tiifluotomelhyl)sulfonyl)benzenesulfonamide,

3-((chloro(difluoio)methyl)sulfonyl)-N-(4-(4-((2-(4-chloi ophenyl)-4,4- diethylcy clohex- 1 -en- 1 -yl)methyl)piperazin-l ~yl)benzoyl)-4-((( 1 R)-3-(moipholin-4-yl)-l - ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(l -((4'-chloro(l ,r-biphenyl)-2-yl)methyl)-l ,2,3,6-tettahydiopyridin-4- yl)benzoyl)-4-((( 1 R)-3-(dimethylamino)-l -((phenylsulfanyl)methyl)piopyl)amino)-3- ((tiifluoromelhyl)sulfonyl)benzenesulfonamide,

N-(4-(l-((4'-chIoio(l,r-biphenyl)-2-yl)metliyl)-l,2,3,6-t etiahydiopyridin-4- yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)~l-((phenylsulfanyl)m ethyl)propyl)amino)-3- ((trifluoromelhyl)sulfonyl)benzenesulfonamide,

N-(4-( 1 -((4'-chloio(l , 1 ^! -biphenyl)-2-yl)methyl)-l yl)benzoyl)-4-({(lR)-3-(diisopropylamino)-l-((phenylsulfanyl )methyl)propyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfbnamide,

N-(4-(l -((4'-chloro(l , l'-biphenyl)-2-yl)methyl)-l ,2,3 _s 6-tetrahydropyridin-4- yl)benzoyl)-4-(((lR)-3-(isopropyl(methyl)amino)-l-((phenylsu lfanyl)metliyl)piOpyl)amino)- 3-((tiif!uoromethyl)sulfonyl)benzenesulfonamide, N^-fl-^^-chloropheny^-l-cyclohex-l-en-l-ylJmethyl)-!^^^- tetiahydropyridin-4-yl)benzoyl)-4-(((lR)-3-(dimethylamino)-l - ((phenylsulfanyl)methyl)propyl)amino)-3-((tτifluoromethyl)s ulfonyl)benzenesulfonaτnide,

N-(4-( 1 -((2-(4-chlorophenyl)- 1 -cyclohex- 1-en-l -yl)methyl)-l ,2, 3,6- letiahydropyridin-4-yl)benzoyl)-4-(((lR)-3-(raoφholin-4-yl) -l- ((phenylsulfanyl)methyl)piopyl)amino)-3-((trifluoromethyl)s� �lfonyl)benzenesulfonamide,

N-(4-( 1 -((2-(4-chIorophenyl)-l -cyclohex- 1 -en- 1 -yl)methyl)-l ,2,3,6- letrahy dropyridin-4-yl)benzoy 1) -4-(((lR)-3-(di isopi opylamino) - 1 - {(phenylsulfanyl)methy])piopyl)amino)-3-((tiifluoromethyl)su lfonyl)benzenesulfoπamide,

N-(4-(l-({2-(4-chloiophenyl)-l -cyclohex-l-en-l-yl)methyI)-l,23,6- tettahydropyridin-4-yl)benzoyl)-4-(((lR)-3-(isopiopyl(methyl )amino)-l-

((phenylsulfany])methyl)propyl)amino)-3-((trifiuoτomethy l)sulfonyl)benzenesulfonamide,

N-(4-( 1 -((2-(4-chlorophenyl)- 1 -cyclohept- 1 -en- 1 -yl)methyl)- 1 ,2,3 ,6- telτahydiopyridin-4-yl)benzoyl)-4-((( 1 R)-3-(dimethylamino)-l -

((phenylsulfanyl)metliyl)piopyl)amino)-3-((tiifluororaeth yl)sulfonyl)benzenesulfonamide, N-(4-(l-((2-(4-chloiophenyl)-l-cyclohepl-l-en-l-yl)methyl)-l ,2,3,6- tetiahydropyridin-4-yl)benzoyl)-4-({( 1 R)-3-(moiphoIin-4-yl)-l -

((phenylsulfanyl)methyl)propyl)amino)-3-((tiifluoiomethyl )sulfonyl)benzenesulfonamide, N-(4-( 1 -((4'-chloio(l , 1 '-biphenyl)-2-yl)melhyl)ρiρeridin-4-yl)benzoyl)-4-((( 1 R)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3- ((trilluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l _s r-biphenyl)-2-yl)methyl)piperidin-l-yl)beπzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)amino)-3- ((trifluoiomethyl)su1fonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l ,1 '-biphenyl)-2-yl)methyl)-l -cyclohex-l-en-l-yl)benzoyl)-4- C((lR)-3-(diraethylamino)-l-((phenylsulfanyl)metliyl)ρiopyl )amino)'3- ((tτifluotomethyl)sulfonyl)benzenesulfonamide,

N~(4-(4-((2-(4-chloiophenyl)cyclohept- 1 -en-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- ((( 1 R)-3-(moφholin-4-yl)-l -((phenylsulfanyl)melhyl)piopyl)ammo)-3- ((hifluoroniethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex- 1 -en-1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4- {((lR)-2-(dimethylamino)-l-((phenylsulfanyl)methyl)ethyl)ami no)-3- ((trifluoromethyl)sulfonyl)benzene sulfonamide, N-(4-(4-((4'-chloio(l ,1 '-biphenyl)-2-yl)methyl)pipeiazin-l -yl)benzoyl)-4-((( I R)-2-

(dimethylaτnino)-l-((phenylsulfanyl)methyl)ethyl)amino)- 3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloro(l,r-biphenyl)-2-yl)melliyl)piperazin- l-yl)benzoyl)-4-(((lR)-2- (diethyIamino)-l-((phenyIsulfanyl)methyl)ethyl)amino)-3- ((tiifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4'-chloio(l,r-biphenyl)-2-yl)raethyl)piperazin- l-yl)benzoyl)-4-(((lR)-2- (moipholin-4-yl)-l-((phenylsulfanyl)metliyl)ethyl)amino)-3- ((trifluoiomethyl)sulfonyl)benzenesiilfonamide,

N- (4-{4-((2 -(4-chloropheny l)cy clohex- 1 - en- 1 -yl)τnethyl )piperazin- 1 -y l)benzoyl)-4- (((1 R)-2-(diethylamino)-l -((phenylsulfanyl)methyl)etliyl)amino)-3- ((trifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4 -(4-((2-(4-chl oiophenyl)cyclohex- 1 -en- 1 -yl )methyl)piper azi n- 1 -yl)benzoyl) -4- (((lR)-2-{morpholin-4-yl)-l-((phenylsulfanyl)methy])ethyl)am ino)-3- ( (tri fluor omethyl)sul fonyl)benzenesul f onami de , N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pipeia zin-l~yl)benzoyl)-4-

(((lR)-3-((2R,6S)-2,6-dimethylmoipholin-l-yl)-l-((phenyls ulfanyl)methyl)piopyl)atnino)-3- ((tτifluorornethyl)sulfonyl)benzenesulfonamide,

N-(4"(4-((2-(4-chloiophenyl)cyclohex-l -en-1 -yl)methyl)piperazin-l -yl)benzoyl)-4- (((lR)-3-(2,6-dimethylmoipholin-4-yl)-l-((phenylsulfanyl)met hyl)propyl)amino)-3- ((tiifluoromelhyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyI)cyclohept-l~en-l-yl)τnelhyl) piperazin-l-yl)benzoyl)-4- (((lR)-3-((2R,6S)-2,6-dimethylmoipholin-4-yl)-l-((phenylsulf anyl)methyl)propyl)amino)-3- ((tτifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohept-l-en-l-yl)methyl)pi perazin-l-yl)benzoyl)~4- ((( 1 R)-3 - (2 ,6-dimethy lmorphol in~4-y I)- 1 -({pheny 1 sulfanyl)methyl)propyl)ami no)-3 - ((tτifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((l-(4-chloiophenyl)pipeτidin-2-yl)meihyl)pipera zin-l-yl)benzoyl)-4-(((lR)- 3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyl)aτnino)- 3~ ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chloropheny1)cyclohex-l-en-l-yl)methyl)pip erazin-l-yl)benzoyl)-4- (((lR)-3- (cy cl opropylamino)- 1 -{ (phenylsul fanyl)methyl )propyl) amino) -3 - ((trifluoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chlorophenyl)cyclohex-l -en- 1 -yl)methyl)piperazin- 1 ~yl)benzoyl)-4-

({(lR)~3-(cyclopIopyl(cyclopropylmethyl)amino)-l-((phenyl s^lfanyI)methyl)p^opyl)amino)- 3-{(tiifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlotophenyl)cyclohex- 1 -en- 1 -yl)methyl)pipeiazin-l -yl)benzoyl)-4- ({( 1 R)-3-{cyclopropyl{methyl)amino)- 1 -((phenylsulfanyl)methyl)propyl)amnio)-3- ((trifluorornethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyI)cyclohex-I-en-l-yl)methyl)pip eiazin-l-yl)benzoyl)-4- (( ( I R)-3 - ( (cyclopentylmethy l)(cyclopropy l)am mo) - 1 - ((phenylsulfanyl)methyl)piopyl)aniino)-3-((trifluoiomethyl)s ulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex- 1 -en-1 -yl)methyl)pipeiazin-l -yl)benzoyl)-4- (((lR)-3-((cyclohexylmethyl)(cyclopropyl)amino)-l-{(phenylsu lfanyl)methyl)propyl)aniino)- 3-((lτifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pip erazin-l-yl)benzoyl)-4- (((lR)-3-(cyclopropyI(tetrahydrofuran-3-yImethyl)arnino)-l-

((phenylsulfanyl)methyl)propyl)aniino)-3-((trifluotomethy l)sulfonyl)benzenesulfonamide, 4-({(lR)-3-(benzyl(cyclopiopy])amino)-l-((phenylsulfanyl)met hyl)piopyl)amino)-N-

(4-(4-((2-{4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pipei azin-l-yl)benzoyl)-3- ((tiifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4~(4-({2- (4-chlorophenyl)cycl ohex- 1 -en- 1 -yl)metliyl)pipei azin- 1 -yl)benzoyl) -4- (((lR)-3-(cyclopropyl(isobutyl)amino)-l-((phenylsulfanyl)met hyl)propyl)amino)-3- ( ( tri fluoromethyl)sul fonyl)benzenesul fonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l~en-l-yl)methyI)pi� �eiazin-l-yl)benzoyl)-4- (((1 R)-3-(cyclopropyl(telτahydro-2H-pyran-4-yl)amino)-l - ((phenylsulfanyl)methyl)propyl)amino)-3-((tiifluoroinethyl)s uIFonyl)benzenesulfonamide,

3-((chloio(difiuoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chloi ophenyl)-4,4- diethylcy cl ohex-l-en-1 -yl)methy l)piperazin- 1 -yl)benzoyl)-4 -((( 1 R) -3 -(dimethyl amino)- 1 - ((phenylsul fanyl)m ethyl)propyl)amino)benzenesulfonamide ,

N-(4-(4-((2-(4-chlorophenyl)-4,4-diethylcyclohex-l-en-l-y l)methyl)pipeiazin-l- yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)m etliyl)piopyl)amino)-3- ({lτifluoromethyl)sulfonyl)benzenesulfonamide,

( 4-(cycloliexylmethoxy)-N-((4 ^! -fluoiO(l,r-biphenyl)-4-y3)carbonyl)-3-

(methylsulfonyl)benzenesulfonamide,

N-(4-(4-(((lR,2R)-2-(4-chlorophenyl)cyclohexyl)methyl)pip erazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-((phenylsuIfanyl)metliyl)propyl)a mino)-3~ ((tτifluoiomelhyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((( 1 S,2S)-2-(4-chlorophenyl)cyclohexyl)methyl)piperazin-l -yl)benzoyl)-4- (((lR)~3-(dimethylamino)4-((phenylsulfanyl)methyl)propyl)ami no)-3- ((ttifluoi omethyl)sul fonyl)benzenesul f onamide, N-(4-(4-((( 1 R,2S)-2-(4-chloiophenyl)cyclohexyl)methyl)pipeiazin-l -yl)benzoyl)-4-

((( 1 R)-3"(dimethylamino)-l -((phenylsulfanyl)methyl)propyl)amino)-3- ({trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-(((l S,2S)-2-(4-chlorophenyl)cycloliexyl)metliyl)pipeiazin-l-yl)b enzoyl)-4- (((lR)-3-(moφholin-4-yl)-l-((phenylsulfanyl)meihyl)propyl)a mino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-({ ( 1 R,2S) -2 -(4 -chlorophenyl)cy clohexy 1 )methyl)p ipei azin- 1 -yl)benzoyl) -4 - ({{lR)-3~(morpliolin-4-yl)-l-((phenylsulfanyl)methyl)propyI) aτnino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((4 ^I -chloro(l,r-biphenyl)-2-yl)methyl)pipeiazin-l-yl)benzoyl)-4- (((lR)-3- (dipr opy lamino)- 1 - ((phenylsulfany l)methy 1 )pi opy l)araino)- 3 - ((tτifluoromelhyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l -en-l-yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3-(dipiopyl amino)- 1 -((phenyl sul fany l)methyl)propyl)amino)-3 - ((tiifluoromethyl)sulfonyl)benzenesulfonamide, N-(4-(4~((4 ^t -chloro(l,l'-biphenyl)~2-yl)melhyl)pipeiazin-l-yl)benzoyl)-4 -(((lR)-3-

(diethyl amino)- 1 - ((phenylsul fanyl)methyl )pi opyl)amino)-3- ((trifluorOmethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l -en- 1 ~yl)methyl)pipeiazin- 1 ~yl)benzoyl)-4- ({(lR)-3'(diethylamino)-l-((phenylsulfanyl)methyl)propyl)ami no)-3- ((trifluoiomethy^sulfony^benzenesulfonamide,

N'(4-(4-((2-(4-chlorophenyl)-5,5-dimethylcycloliex- 1 -en-1 -yl)melhyl)piperazin- 1 - yl)benzoyl)-4-((( 1 R)-3-(diethylamino)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3- ((trifluoromethyl)snlfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chloiophenyl)cyclohepl-l-en-I -yl)methyl)piperazin-l-yl)benzoyl)-4- (((1 R)-3-{diethylamino)- 1 -((phenylsulfanyl)methyl)propyl)arnino)-3- ((tiifluoiomethyl)sulfonyl)benzenesulfonamide, N-(4-(4-((4'-chloio(l,r-bipheiiyl)-2-yl)methyl)piperazin-l-y l)ben2oyl)-3-

((chloro(diflυoio)methyl)sulfonyl)"4-({(lR)-3-(diethylam ino)-l- {(phenyl sulfanyl)methy l)propy l)amino)benzenesul fonami de ,

3-((chloro(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chIoi ophenyl)cyclohex-l-en-l- yl)methyl)pipeiazin-l -yl)benzoyl)-4-((( 1 R)-3-(diethylamino)-l - ((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

3-((chloro(difluoro)rneihyl)sulfonyl)-N-(4-(4-{{2-(4-chlo iophenyl)cyclohept-l -en- 1 - yI)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(diethylamino)- l- ((phenylsulfanyl)raethyl)propyl)amino)benzenesulfonamide,

((({4-chlorobutyl)((3R)-3-(4-(((4-(4-((2-(4-chlorophenyl) -l-cyclohexen-l-yl)methyl)- l-pipeiazinyl)benzoyl)amino)sulfonyl)-2-((trifluorometliyl)s ulfonyl)anilino)-4- (phenylsulfanyl)butyl)amino)caibonyl)oxy)methyl pivalate,

(phosphonooxy)methyl 4-chlorobutyl((3R)-3-(4-(((4-(4-((2-(4-chlorophenyl)-l- cyclohexen-l-yl)metliyl)-l-pipeiazinyl)benzoyl)amino)sulfony l)-2- ((trifluoromethyl)sulfonyl)anilino)-4-(phenylsulfanyl)butyl) carbamate, N-(4-(4-((2-(4-chlorophenyl)-5,5-diτnethyl-l -cyclohex-1 -en-1 -yl)methyl)piperazin-l - yl)benzoyl)-4-({( 1 R)-3-(moipholin-4-yl)-l -((phenylsulfanyl)raethyl)piopyl)amino)-3» {(tτifluoromethyl)sulfonyl)benzenesulfonamide,

3-((chloto(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-clilo iophenyl)-4,4- dimethylcyclohex-l-en-l-yl)τnethyl)piperazin-l-yl)benzoyl)- 4-(((lR)-3-(inoipholin-4-yl)-l- ((plienylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

3-((chloio(difluoro)raethyl)sulfonyl)-N-(4-(4-((2-(4-chlo rophenyl)-l-cyclohex-l-en- 1 -yl)methyl)piperazin-l -yl)benzoyI)-4-((( 1 R)-3-(moipholin-4-yl)-l - ({phenylsulfany 3)methyl)propy l)amino)benzene sul fonami de ,

N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethykyclohex-l-en'l-yl)m ethyI)piperazin-l- yl)benzoyl)-4-({(lR)-3-(isopiOpyl(methyl)amino)-l-((phenylsu lfanyl)methyl)propyl)amino)- 3-((tiifluoromethyl)sulfonyl)benzenesulfonamide ₁

N-(4-(4-((2-(4-chlorophenyl)-l -cyclohepten-1 -yl)methyl)pipeiazin- 1 -yl)benzoyl)-4- (((lR)-3-(isopropyl(methyl)amino)-l-((phenylsulfanyl)melhyl) propyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

3-((chloro(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chlor ophenyl)cycIohex-l-en-l- yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-((lS,4S)-2-oxa- 5-azabicyclo[2,2.1]hept-5-yl)- 1 -((phenyl sulfany l)roethy 1 )pi opy 1 )amino)benzenesul fonami de , N-{4-(4-((2-(4-chloiophenyl)cyclohex-l-en-l-yI)methyl)pipeia zin-l-yl)benzoyl)-4-

(((lR)-3-(moφholin-4-yl)-l-((phenylsulfanyI)τnethyl)pio pyl)amino)-3- ((trifluoiomethyl)sulfoπyl)benzenesulfonamide,

4-(((lR)-3-(7-azabicyclo[2.2.1]hept-7-yl)-l-((phenylsulfa nyl)methyl)propyl)amino)- N-(4-(4-((2-(4-chlorophenyI)cyclohex-I-en-l-yl)niethyl)piper azin-l-yl)benzoyl)-3- ((tiifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyI)pip erazin-l-yl)benzoyl)-4- (((lR)-3-(2-oxa-5-azabicyclo[2 2.1]hept-5-yl)-l-((phenylsulfanyl)methyl)propyl)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-((2-(4-clilorophenyl)-5,5-dimethylcyclohex-l -en-1 -yl)methyl)pipeiazin-l - yl)benzoyl)-4-(((lR)-3-(2-oxa-5-azabicyclo[2.2.1]hept-5-yl)- l-

({phenylsulfanyl)methyl)propyl)amino)-3-((tiifluoromethyl )sulfonyI)benzenesulfonamide,

3-((chloro(difluoro)melhyl)sulfonyI)-N-{4-(4-((2-(4-chloi ophenyl)-5,5- dimetliylcyclohex-l-en-l-yl)methyl)piperazin-l-y])benzoyl)-4 -(((lR)-3-(2-oxa-5- azabicyclo[2.2. l]hept-5-yl)-l-((phenylsulfanyl)methyl)propyl)amino)benzenes ulfonamide, N-(4-(4-((2-{4-chIorophenyl)cyclohept-l-en-l-yl)methyl)pipei azin-l-yl)benzoyI)-4-

(((lR)-3-(2-oxa-5-azabicyclo[2.2 l]hept-5-yl)-l-((phenylsulfanyl)rnethyl)propyl)arnino)-3- ((tiifluoiomethyl)sulfonyl)benzenesυlfonamide,

3 -((chl oro(difluoro)melhyl) sulfony I)-N -(4 -(4-((2-(4-chloropheny 1 )cyclohept- 1 -en- 1 - yl)niethyI)piperazin~l-yl)benzoyI)-4-(((lR)-3-(2-oxa-5-azabi cyclo[2,2.1]hept-5-yl)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N-(4-(4-((2 -(4 -chlorophenyl)-4 ,4-dimethylcycl ohex- 1 -en- 1 -yl)methyl )piperazin- 1 - yl)benzoyl)-4-({(lR)-3-(isopiopyl{methyl)amino)-l-((phenylsu lfanyl)niethyl)propyl)amino)- 3 -((ti ifluoromethyl)sul fonyl)benzenesul fonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pip eiazin-l-yl)benzoyl)-4- (((lR)-3-(l,4-oxazepan-4-yl)-l-((phenylsuIfanyl)methyl)piopy l)amino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonamide,

4-(((lR)-3-(azepan-l-yl)-l-((phenylsulfanyl)melhyl)piopyl )amino)-N-(4-(4-((2-(4- chloiophenyl)- 1 -cyclohex- 1 -en- 1 -yl)raethyl)piperazin- 1 -yl)benzoyl)-3 - ((trifluoromethyl)sulfonyl)ben2enesulfonamide,

N-(4-(4-((2'(4-chIotophenyl)cyclohept-l-en-l-yl)methyl)pi perazin-i-yl)benzoyl)-4- {((lR)-3~(dimethyIaτnino)-l-((phenylsulfanyl)niethyl)ptopyl )amino)-3- ((tτifluoromethyl)sulfonyl)benzenesulfonamide, 3-((chloro(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chloroph enyl)cyclohex-l-en-l- yl)methyl)pipeiazin- 1 -yl)benzoyl)-4-((( 1 R)-3 -(dimelhylamino)- 1 - ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

3-((chloio(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chlor ophenyl)-5,5- dimethylcyclohex-1 -en-1 -yl)methyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-3-(morpholin-4-yϊ)-l - ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide,

N -(4 -(4-((2-(4-chlorophenyl)-5 , 5 -dimethyl - 1 -cyclohex- 1 -en- 1 -yl)melhyl)piperazin- 1 - y])benzoyl)-4-((( 1 R)-3-(dimethylamino)-l -((phenylsulfanyl)methyl)piopyl)amino)-3- ((trifluoiomethyl)sulfonyl)benzenesulfonamide,

N-(4-(4-( (4-(4 -chloi ophenyl) -5 ,6-dihy di o-2 H-pyran-3 -y l)methyl )piperazin-l- yl)benzoyl)-4-(((l R)-3-(moipholin-4-yl)-l -{(phenylsulfanyl)methyl)propyl)amino)-3- ((tii fluoromethyl)sul fony l)benzenesul fonami de ,

3-((cliloro(difluoro)methyl)sυlfonyl)-N-(4-(4-((2-(4-chl orophenyl)-4,4- dimethylcyclohex- 1 -en- 1 -yl)methyl)pipei azin- 1 -yl)benzoyl)-4-((( 1 R)-3- (isopiopyl(methyl)amino)-l-((phenylsulfanyl)methyl)propyl)am ino)benzenesulfonamide, 3-((chloro(difluoio)methyl)sulfonyl)-N-(4-(4-((2-(4-chloroph enyl)-5,5- dimethylcyclohex-l-en-l-yl)methyl)piperazin~l-yl)benzoyl)-4- (((lR)-3- (isopropyl(methyl)amino)-l~((phenylsulfanyl)methyl)propyl)am ino)benzenesulfonamide, N-(4-(4-((2-(4-chloiophenyl)-4,4-dimethylcyclohex-l-en-l-yl) methyl)piperazin-l- yl)benzoyl)-4-(((lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)m ethyl)propyl)amino)-3- ((tiifluororaethyl)sulfonyl)benzenesulfonamide,

3-((chloio(difluoio)metliyl)sulfonyl)-N-(4~(4-((2-(4-chIo rophenyI)-4,4- dimethylcyclohex-1 -en-1 -yl)methyl)pipeiazin-l-yl)benzoyl)-4-(((l R)-3-(( 1 S,4S)-2-oxa-5- azabicyclo[2 2 l]hept-5-yl)-l -((phenylsulfanyl)methyl)piopyl)amino)benzenesulfonamide,

N-(4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)methyl)pip erazin-l-yl)benzoyl)-4- (((lR)-3-(dimethylamino)-l-((phenylsulfanyl)methyl)propyI)am ino)-3- ((trifluoromethyl)sulfonyl)benzenesulfonaniide,

N-{4-(4-((2-(4-chlorophenyl)cyclohex-l-en-l-yl)metliyl)pi perazin-l-yl)benzoyl)-4- {((l^-l-Cfphenylsulfany^methy^-S-tpyπolidin-l-y^propy^amino j-S- ((ttifluoromethyl)sulfonyl)benzenesulfonamide,

3-{(chloro(difluoio)methyl)s«lfonyl)-N-(4-(4-{(2-(4-chlo rophenyl)-4,4- dimethylcyclohex-l-en-l-yl)methyl)piperazin-l-yl)benzoyl)-4- (((lR)-3-(diniethylamino)-l- ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide, N-(4-(4-((2-(4-chloiophenyl)cyclohept-l-en-l-yl)methyl)pipei azin-l-yl)benzoyl)-4-

(({ IR)-I -{(phenylsulfanyl)methyl)-3-(pyrrolidin-l-yl)propyl)amino)-3 - ((trifluoromethyl)sulfonyl)benzenesulfonamide,

3-((chloio(difluoro)methyl)sulfonyl)-N-(4-(4-((2-(4-chloroph enyl)-5 _s 5- dimefhylcyclohex-1 -en-1 -yl)melhyl)piperazin-l -yl)benzoyl)-4-(((lR)-l- ((phenylsulfanyl)methyl)-3-(pyiiOlidin- 1 -yl)propyl)amino)benzenesulfonamide, 3-((chloio(difluoto)methyl)suIfonyl)-N-(4-(4-((2-(4-chloiOph enyl)-4,4- dimethylcyclohex- 1 -en- 1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)- 1 - ((phenylsulf anyl )methyl) -3-(pyrroli din- 1 -y l)pi opyl) amino)benzenesul foπami de ,

3-((chloro(difluoio)methyl)sulfonyl)-N-(4-(4-((2-(4-chlor ophenyl)cyclohept-l-en-l- yl)methyl)piperazin-l -yl)benzoyl)-4-((( 1 R)-I -((phenylsulfanyl)methyl)-3-(pyiτolidin-l - yl)piopyl)amino)benzenesulfonamide,

N-(4-(4-((2-{4-chloiophenyl)cyclohex-l-en~l-yI)methyl)pip eiazin"l-yl)benzoyl)-4- {((lR)-3-(isopropyl(methyl)amino)-l-((phenylsulfanyl)methyl) propyl)amino)-3- ((tiifluoiome):hyl)sulfonyl)benzenesulfonamide, N-(4-(4-((2-(4-chlorophenyI)-4,4-dimethylcyclohex-l -en-l-yl)metliyl)piperazin-l- yl)benzoyl)-4-({(lR)-l-((phenylsulfanyl)methyl)-3-(pyiτolid in-l-yl)propyl)aniino)-3- ((lτifluoromethyl)sulfonyl)benzenesulfonamide,

3-((chloio(difluoro)methyl)sulfonyl)-N-(4-(4-{(2-(4-chlor ophenyl)cyclohex- 1 -en-1 - yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)- 1 -((phenyIsulfanyl)methyl)-3-(pyrrolidin- 1 - yl)propyl)amino)benzenesulfonamide,

N-(4-(4-((2~(4-chloiophenyl)-4,4-dirnethylcyclohex-l-en-l -yl)methyl)piperazin-l- yl)benzoyl) -4-(({ 1 R)- 3 -{d imethylam ino)- 1 -{ (phenyl sul f anyl)methy 3)pi opy l)amino)-3 - ((trifluoiomethyl)sulfonyl)benzenesulfonaπiide,

N-(4-(4-{ (2~(4-chIoropheny 1) -4,4-di methylcyc lohex- 1 -en- 1 -yl)methyl)piper azhi- 1 - yObenzoylH-rølRJ-S-tflS^S^-oxa-S-azabicyclop Z llhept-S-yl)-!- ((phenylsulfanyl)methyl)piopyl)amino)-3-((tτifluoromethyl)s ulfonyl)benzenesulfonamide

N-(4-(4-((4'-chloio(l,l'-biphenyl)-2-yI)methyl)-l-piperaz inyl)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)piopyl)amino)-3- ((tτifluoromethyl)sulfonyl)benzenesulfonamide and

N-(4-{4-((4 ^t -chloio(l ,r-biphenyl)-2-yl)methyl)-l-piperazinyl)benzoyl)-4-{((lR)-3~ (4- moiphol inyl)- 1 -({phenylsul fanyl )methyl)pi opyl )amino)-3 - ((trifluoromethyl)sulfonyl)benzenesulfonamide, and therapeutically acceptable salts, prodrugs oi salts of prodrugs thereof

Variable moieties herein are represented by identifiers (capital letters with numerical and/oi alphabetical superscripts) and may be specifically embodied

It is meant to be understood that propei valences are maintained for all moieties and combinations thereof, that monovalent moieties having more than one atom are drawn from left to right and are attached through their left ends, and that divalent moieties are also drawn fiora left to right

It is also meant to be understood that a specific embodiment of a variable moiety herein may be the same or different as another specific embodiment having the same identifier

The term "cyclic moiety," as used herein, means benzene, aryl, cycloalkane, cycloalkyl, cycloalkene, cycloalkenyl, heteroarene, heteroaryl, heterocycloalkane, heterocycloalkyl, heteiocycloalkene, heteiocycloalkenyl, spiroalkyl, spiroalkenyl, spiroheteioalkyl and spiroheteioalkenyl

The teim "arene," as used herein, means benzene.

The term "aryl," as used herein, means phenyl

The term "cycloalkane," as used herein, means C3-cycloalkane, C ₄ -cycloalkane, C ₅ - cycloalkane, C^-cycloalkane, C ₇ ~cycloalkane, Cg-cycloalkane, Cg-cycloalkane, Cjo-cycloalkane, Cn -cycloalkane, Ci2-cycloalkane, Ci ₃ -cycloalkane and C| ₄ -cycloalkane

The term "cycloalkyl," as used herein, means C ₃ -cycIoalkyl, C ₄ -cycloalkyl,

Cs-cycloalkyl Cc-cycloalkyl, C ₇ -cycloa3kyI, Cg-cycloalkyl, Cg-cycloalkyl, Cio-cycloalkyl, C] 1 -cycloalkyl, Ci ₂ -cycloalkyl, Cπ-cycloalkyl and Ci ₄ -cycloalkyl

The term "cycloalkene," as used herein, means C ₄ -cycloalkene, Cs-cycloalkene, Ce-cycloalkene, C ₇ -cycloalkene, Cs-cycloalkene, Cg-cycloalkene, Cio-cycloalkene, Cn- cycloalkene, Ci ₂ -cycloalkene ₅ Cj ₃ -cycloalkene and Ci ₄ -cycloalkene

The term "cycloalkenyl," as used herein, means C ₃ -CyCl oalkenyl, C_j-cycloalkenyl, Cs-cycloalkenyl, C ₆ -cycloalkenyl, C ₇ -cycloalkenyl, Cβ-cycloalkenyl, Cg-cycloalkenyl, Cio-cycloalkenyl, Ci 1 -cycloalkenyl, Ci ₂ -cycloalkenyl, Cu-cycloalkenyl and C] ₄ -cycloalkenyl

The term "heteroarene," as used herein, means furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyiidazine, pyridine, pyrimidine, pyiiole, thiazole, thiophene, triazine and 1,2,3-triazole

The term "heteroaryl," as used herein, means furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1 ,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thiophenyl, tiiazinyl and 1,2,3-triazolyl

The term "neterocycloalkane," as used herein, means cycloalkane having one 01 two or thiee CH ₂ moieties replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unreplaced or replaced with N and also means cycloalkane having one or two or thiee CH ₂ moieties unieplaced or replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S ₅ S(O), SO ₂ or NH and one 01 two CH moieties replaced with N

The teim "heteiocycloalkyl," as used herein, means cycloalkyl having one oi two or three CH ₂ moieties replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ 01 NH and one 01 two CH moieties unieplaced or replaced with N and also means cycloalkyl having one 01 two or three CH ₂ moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties replaced with N

The term "heteiocycloalkene," as used herein, means cycloalkene having one or two or three CH ₂ moieties replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unieplaced 01 replaced with N and also means cycloalkene having one or two 01 three CH ₂ moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ 01 NH and one or two CH moieties replaced with N

The terra "heterocycloalkenyl," as used herein, means cycloalkenyl having one or two or three CH ₂ moieties replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unieplaced or replaced with N and also means cycloalkenyl having one or two or three CH ₂ moieties unieplaced or replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties replaced with N.

The term "spiroalkyl," as used herein, means C ₂ -spiroalkyl, C3-spiroalkyl, C ₄ -spiioalkyl, Cs-spiroalkyl, Ce-spiroalkyl, C7-spiroalkyl, Cg-sphoalkyl and Cg-spiioalkyl

The term "spiroalkenyl," as used herein, means C ₂ -spiioalkenyl, C ₃ -spiroalkenyϊ,

C ₄ -spiroalkenyl, Cs-spiroalkenyl, Cβ-spiioalkenyl, C ₇ -spiτoalkenyl, Cg-spiroalkenyl and Cij-spiroalkenyl

The term "spiroheteroalkyl," as used herein, means spiroalkyl having one or two CH ₂ moieties replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH

The term "spirohetetoalkenyl," as used heiein, means spiroalkenyl having one oi two

CH ₂ moieties replaced with independently selected O, C(O), CNOH, CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties unreplaced or replaced with N and also means spiroalkenyl having one oi two CH ₂ moieties unreplaced oτ replaced with independently selected O, C(O), CNOH ₁ CNOCH ₃ , S, S(O), SO ₂ or NH and one or two CH moieties replaced with N.

The term "alkenyl," as used herein, means C ₂ -alkenyl, C ₃ -alkenyl, C4-alkenyl, C5- alkenyl and Cg-alkenyl

The term "alkyl," as used herein, means Cj-alkyl, C2-alkyl, C ₃ -alkyl, C-i-alkyl, C5- alkyl and Cό-alkyl

The term "alkynyl," as used herein, means C ₂ -alkynyl, C3-alkynyl, C ₄ -a3kynyl, C5- alkynyl and Cό-alkynyl.

The term "C ₂ -alkenyl," as used herein, means ethenyl (vinyl).

The term "Cβ-alkenyl," as used herein, means I -propen-1 -yl, I -piopen-2-yl (isopropenyl) and l-propen-3-yl (allyl).

The term "C ₄ -alkenyl," as used herein, means 1-buteri-l -yl, l-buten-2-yl, 1 ,3-butadien-l-yl, l,3-butadien-2~yl, 2-buten-l-yl, 2-buten-2-yl, 3-buten-l-yl, 3-buten-2-yl, 2-methyl-l-propen-l-yl and 2-methyl-2-propen-l -yl.

The term "Cg-alkenyl," as used herein, means 2-methylene-3-buten-l-yl,

2-methylenebut-l-yl, 2-melhyl-l-buten-l-yl, 2-methyl-l,3-butadien-l-yl,

2 -methyl -2-buten-l -yl, 2-methyl-3-buten-l -yl, 2-τnethyl-3-buten-2-yI, 3 -methyl -1 -bitten- 1 -yl, 3-methyl-l-buten-2-yl, 3 -methyl- 1 ,3-butadien-l-yl, 3-methyl-l, 3-butadien-2-yl, 3-rnethyl-2-buten-l-yl, 3 -methyl -2-buten-2-yl, 3-melhyl-3-bulen-l-yl, 3-melhyl-3-buten-2-yl, 1-penten-l-yl, l-penten-2-yl, l-penten-3-yl, 1,3-pentadien-l-yl, l,3-penta-dien-2-yl, l ,3-pentadien-3-yl, 1,4-pentadien-l-yl, 1 ,4-pentadien-2-yl, l,4-pentadien-3-yl, 2-penlen-l-yl, 2-penten-2-yl, 2-penten-3-yl, 2,4-pentadien-l-yl, 2,4-pentadien-2-yl, 3-penten-l-yl, 3-penten-2-yl, 4-penten-l-yl and 4-penten-2-yl

The term "C ₆ -alkenyl," as used herein, means 2,2-diniethyl-3-buten-l-yl, 2,3-dirnethyl-l-buten-l-yl, 2,3-dimethyl-l,3-butadien-l-yl, 2,3-dimethyl-2-buten-l-yl, 2,3 -dimethyl- 3 -buten- 1 -yl, 2,3-dimethyl-3-buten-2-yl, 3,3-dimethyl-l-buten-l-yl, 3 ,3 -dimethyl- 1 -buten-2-yl, 2-ethenyl-l ,3-butadien-l-yl, 2-ethenyl -2-buten-l -yl, 2-ethyl-l -buten-1-yl, 2-ethyl-l ,3-butadien-I -yl, 2-ethyl-2-buten-l-yl, 2-ethyl-3-buten-l -yl, 1-hexen-l-yl, l-hexen-2-yl, l-hexen-3-yl, 1,3-hexadien-l-yl, 1 ,3-hexadien-2-yl, l,3-hexadieπ-3-yl, 1,3,5-hexatrien-l-yl, l,3,5~hexalτien-2-y1, l,3,5-hexatrien-3-yl, 1,4-hexadien-l-yl, 1 ,4-hexadien-2-yl, 1 ,4-hexadien-3-yl, 1,5-hexadien-I-yl, l,5-hexadien-2-yl, l,5-hexadien-3-yl, 2-hexen-l-yl, 2-hexen-2-yl, 2-hexen-3-yl, 2,4-hexadien-l-yl, 2,4-hexadien-2-yl, 2,4-hexadien-3-yl, 2,5-hexadien-l-yl, 2,5-hexadien-2- yl, 2,5-hexadien-3-yl, 3-hexen-l-yl, 3-hexen-2-yl, 3-hexen-3-yl, 3,5-hexadien-l-yl, 3,5-hexadien-2-yl, 3,5-hexadien-3-yl, 4-hexen-l-yl, 4-hexen~2-yl, 4-hexen-3-yl, 5-hexen-l-yl, 5-hexen-2-yl, 5-hexen-3-yl, 2-niethylene-3-methyl-3-buten-l-yl, 2-methylene-3-methylbut-l-yl, 2-methylene-3-penten-l-yl, 2-methylene-4-penten-l-yl, 2-methylenepent-l-yl, 2-methylenepent-3-yl, 3-methylene- 1-penten-l-yl, 3 -methylene- l-penten-2-yl, 3-methylenepent-l-yl, 3 -methylene- 1 ,4-pentadien-l-yl, 3-methy3ene-l ,4-pentadien-2-yl, 3-methylene-pent-2-yl, 2-methyl-l-penlen-l-yl, 2-methyl- l-penten-3-yl, 2-methyl-l ,3-pentadien-l-yl, 2-methyl-l,3-pentadien-3-yl, 2-methyl-l,4- pentadien-1-yl, 2-methyl-l ,4-pentadien-3-yl, 2-methyl-2-penten-l-yl, 2-methyl-2-penten- 3-yl, 2-methyl-2,4-pentadien-l-yl, 2-methyl-2,4-pentadien-3-yl, 2-methyl-3-penten-l-yl, 2-methyl-3-penten-2-yl, 2-methyl-3-penten-3-yl, 2-methyl-4-penten-l-yl, 2-methyl-4- penten-2-yl, 2-methyl-4-penten-3-yl, 3-methyl-l -penten- 1 -yl, 3 -methyl- 1 -penten-2-yl, 3-methyl-l ,3-ρentadien-l -yl, 3-methyl- 1 ,3-pentadien-2-yl, 3-methyl-l ,4-pentadien-l -yl, 3-methyl-l ,4-pentadien-2-yl, 3-methyl-2-penten-l-yl, 3-methyl-2-penten-2-yl, 3-methyl-2,4- pentadien-1-yl, 3 -methyl-3 -penten- 1-yl, 3-melhyl-3-penten-2-yl, 3-methyl-4-penten-l-yl,

3-methyl-4-penten-2-yl, 3-methyl-4-penten-3-yl, 4-methyl-l-penten-l-yl, 4-methyl-l- penten-2-yl, 4-rnethyl-l~penten-3-yl, 4-methyl-l,3-penladien-l-yl, 4-τnethy 3-1,3 - pentadien-2-yl, 4-methyl-l,3-pentadien-3-yl, 4-methyl-l,4-pentadien-l-yl, 4-methyl-l ,4-pentadien-2-yl, 4-melhyl-l ,4~pentadien-3-yl, 4-methylene-2-penten-3-yl, 4-methyl-2-penten-l-yl, 4-methyl-2-penten-2-yl, 4-methyI-2-penten-3-yl,

4-methyl-2,4-pentadien-l-yl, 4-methyl-2,4-pentadien-2-yl, 4-methyl-3-penlen-l-yl, 4-methyl-3-penten-2-yl, 4-methyl-3-penten-3-yl, 4-methyl-4-penten-l-yl and 4-methyl-4- penten-2-yl.

The term "Cj-allcyl," as used herein, means methyl

The term "C ₂ -alkyI," as used herein, means ethyl.

The term "Cβ-alkyl," as used herein, means prop-1-yl and prop-2-yl (isopropyl).

The term "C ₄ -alkyI," as used herein, means but-l-yl, but-2-yl, 2-methylprop-l-yl and 2-methylpiop-2~yl (tert-butyl).

The term "Cs-alkyl," as used herein, means 2,2-dimethylprop-l-yl (neo-pentyl), 2-rnethylbut-l-yl, 2-methylbut-2-yl, 3-melhylbut-l-yl, 3-methylbut-2-yl, pent-1-yl, pent-2-yl and pent-3-yl .

The term "Cβ-alkyϊ," as used herein, means 2,2-dimethylbut-l-yl, 2,3-dimethylbut-l-yl, 2,3-dimethylbut-2-yl, 3,3-dimelhylbut-l-yl, 3,3-dimethylbut-2-yl, 2-ethylbut-l-yl, hex-l-yl, hex-2-yl, hex-3-yl, 2-methylpent-l-yl, 2-methylpent-2-yl, 2-methylpent-3-yl, 3-methylpent-l-yI, 3-melhylpent-2-yl, 3-methylpent-3-yl, 4-methylpent-l-yl and 4-methylpent-2-yl.

The teπn "C ₂ ~alkynyl," as used herein, means ethynyl (aceiylenyl).

The term "Cj-alkynyl," as used herein, means 1-propyn-l-yl and 2~propyn-l-y3 (propargyl)

The term "C4-alkynyl," as used herein, means 1-bιityn-l-yl, 13-butadiyn-I-yI, 2~butyn-l-yl, 3-butyn-l-yl and 3-butyn-2-yl

The term "Cs-alkynyl," as used herein, means 2-methyl -3-butyn-l-yl,

2-methyl-3-butyn-2-yl, 3-methyl-l-butyn-l-yl, 1,3-penladiyn-l-yl, 1,4-pentadiyn-l-yl, l,4-penladiyn-3-yl, 2,4-pentadiyn-l-yl, 1-pentyn-l-yl, l-pentyn-3-yl, 2-pentyn-l-yl, 3-pentyn-l-yl, 3-pentyn-2-yl, 4-pentyn-l-yl and 4-pentyn-2-yl

The teim "Cή-alkynyl," as used herein, means 2,2-dimethyl-3-butyn-l -yl,

3,3-diniethyl-l-butyn-l-yl, 2-ethyl-3-butyn-l-yl, 2~ethynyl-3-butyn-l-yl, 1-hexyn-l-yl, l-hexyn-3-yl, 1,3-hexadiyn-l-yl, 1,3,5-hexatriyn-l-yl, 1,4-hexadiyn-l-yl, l ,4-hexadiyn-3-yl, 1,5-hexadiyn-l-yl, l,5-hexadiyn-3-yl, 2-hexyn-l-yl, 2,5-hexadiyn-l-yl, 3-hexyn-l-yl, 3-hexyn-2~yl, 3,5-hexadiyn-2-yl, 4-hexyn-l -yl, 4-hexyn-2-yl, 4-hexyn-3-yl, 5-hexyn-l-yl, 5-hexyn-2-yl, 5-hexyn-3-yl, 2-rnethyl-3-pentyn-l-yl, 2-methyl-3-pentyn-2-yl _J 2-methyl-4-pentyn-l -yl, 2-methyl-4-pentyn-2-yl, 2-methyl-4-pentyn-3-yl _! 3 -methyl- 1-pentyn-l-yl, 3-methyl-4-pentyn-l-yl, 3-τnethyl-4-pentyn-2-yl, 3-methyl- 1 ,4-pentadiyn- 1 -yl, 3 -methyl- 1 ,4-pentadiyn-3-yl, 3-methyl-4-pentyn-l-yl, 3-methyl-4-pentyn-3-yl, 4-methyl- 1-pentyn-l-yl and 4-methyl-2-pentyn-l-yl

The term "C ₄ -cycloalkane," as used herein, means cyclobutane The term "Cs-cycloalkane," as used herein, means cyclopentane. The teim "C _ύ -cycloalkane," as used herein, means cyclohexane The term "C ₇ -cycloalkane," as used herein, means cycloheptane The term "Cg-cycioalkane," as used herein, means cyclooctane

The term "Cg-cycloalkane," as used herein, means cyclononane The term "Cio-cycloalkane," as used herein, means cyclodecane The teim "Ci i-cycloalkane," as used herein, means cycloundecane The term "Cπ-cycloalkane," as used herein, means cyclododecane The term "Cj ₃ -cydoaϊkane," as used herein, means cyclotridecane

The term "C ₁₄ -cycloalkane," as used herein, means cyclotetτadecane

The term "C ₄ -cycloalkene," as used herein, means cyclobutene and 1,3- cyclobutadiene.

The term "Cs-cycloalkene," as used herein, means cyclopentene and 1,3- cyclopentadiene.

The term "Ce-cycloalkene," as used herein, means cyclohexene, 1,3-cyclohexadiene and 1 ,4-cyclohexadiene,

The term "C ₇ -cycloalkene," as used herein, means cyclolieptene and 1 ,3- cycloheptadiene,

The term "Cs-cycloalkene," as used herein, means cyclooctene, 1,3-cyclooctadiene, 1,4-cyclooctadiene, 1 ,5-cyclooctadiene, 1,3,5-cyclooctatriene and 1,3,6-cyclooctatriene.

The term "Cg-cycloalkene," as used herein, means cyclononene, 1,3-cycloπonadiene, 1 ,4-cyclononadieπe, 1 ,5-cycIononadiene, 1,3,5-cycIononatriene, 1,3,6-cyclonoiiatriene, 1 ,3,7- cyclononatriene and 1,3,5,7-cyclononatetraene.

The term "Cio-cycloalkene," as used herein, means cyclodecene, 1 ,3-cyclodecadiene,

1,4-cyclodecadiene, 1,5-cyclodecadiene, 1 ,6-cyclodecadiene, 1,3,5-cyclodecatriene, 1,3,6- cyclodecatriene, 1,3,5,7-cyclodecatetiaene, 1,3,5,8-cyclodecatetraene and 1 ,3,6,8- cy cl odecatetraene.

The term "C ₁ j-cycloalkene," as used herein, means cycloundecene, 1 ,3- cycloundecadiene, 1,4-cycloundecadiene, 1,5-cycloundecadiene, 1 ,6-cycloundecadiene, 1 ,3,5-cycloundecatriene, 1,3,6-cycloundecatriene, 1,3,7-cycloundecatiiene, 1,4,7- cycloundecatiiene, 1,4,8-cycloundecatiiene, 1,3,5,7-cycloundecatetraene, 1,3,5,8- cycloundecatetraene, 1,3,6,8-cycloundecatetiaene and 1,3,5,7,9-cycloundecapentaene,

The term "C]2-cycloalkene," as used herein, means cyclododecene, 1,3- cyclododecadiene, 1,4-cyclododecadiene, 1,5-cyclododecadiene, 1 ,6-cyclododecadiene, 1,7-

cyclododecadiene, 1,3,5-cyclododecatriene, 1,3,6-cyclododecatiiene, 1,3,7- cyclododecatτiene, 1,3,8-cycIododecatriene, 1 ,4,7-cyclododecatiiene, 1 ,4,8- cyclododecatiiene, 1 ,5,9-cyclododecatiiene, 1 ,3,5,7-cyclododecatetraene, 1 ,3,5,8- cyclododecatetτaene, 1,3,5,9-cyclododecatetraene, 1 ,3,6,8-cyclododecaletiaene, 1,3,6,9- cyclododecatetiaene, 1,3,6,10-cyclododecatetraene, 1,3,7,9-cyclododecatetraene, 1 ,4,7,10- cyclododecateiraene, 1, 3,5,7, 9-cyclododecapentaene, 1,3, 5,7,30-cyclododecapentaene and 1 ,3,5,8, 10-cyclododecapentaene

The term "Ci _j -cycloalkene," as used herein, means 1,3-cyclotiidecadiene, 1,4- cyclotridecadiene, 1 ,5-cyclotiidecadiene, 1 ,6-cyclotridecadiene, 1,7-cyclotiidecadiene, 1,3,5- cyclotridecatiiene, 1 ,3,6-cyclotτidecatiiene, 1,3,7-cyclotridecatriene, 1 ,3,8-cycIotτidecatiiene, 1,4,7-cyclotridecatτiene, 1,4,8-cyclotridecatxiene, 1,4,9-cyclotiidecatiiene, 1,5,9- cyclotridecatriene, 1,3,5,7-cyclotridecatetiaene, 1, 3,5, 8-cyclotridecatetiaene, 1,3,5,9- cyclotiidecatetiaene, 1,3,6,8-cyclotiidecatetraene, 1,3,6,9-cyclotridecatetraene, 1,3,6,10- cyclotxidecatetiaene, 1 ,3,6,11-cyclotridecatetraene, 1,3,7,9-cyclotridecatefraene, 1,3,7,10- cyclottidecatetraene, 1,4,7,10-cyclotridecatetτaene, 1,3,6,1 l-cyclotridecatetraene, 1,3,,5,7,9- cyclotiidecapentaene, 1,3,5,7,10-cyclotτidecapentaene, 1,3,5,8, 10-cyclotiidecapentaene, 3 ,3,5,8,1 1 -cyclotridecapentaene, 1,3,6,8,1 l-cyclotridecapentaene and 1 ,3,5,7,9,1 1- cyclotridecahexaene

The term "Ci4-cycloalkene," as used herein, means cyclotetradecene, 1 ,3- cyclotetradecadiene, 1,4-cyclotetradecadiene, 1,5-cyclotetradecadiene, 1,6- cyclotetτadecadiene, 1,7-cyclotetradecadiene, ijS-cyclotetradecadiene, 1,3,5- cyclotetTadecatfiene, 1,3,6-cyclotetiadecatriene, 1 ,3,7-cyclotetradecatτiene, 1,3,8- cyclotetradecatriene, 1,3,9-cyclotetradecatτiene, 1,4,7-cyclotetradecatriene, 1,4,8- cyclotetradecattiene, 1,4,9-cyclotetτadecatriene, 1,5,9-cyclotetradecatiiene, 1,5,10- cyclotetradecatriene, 1,3,5,7-cyclotetradecatetiaene, 1,3,5,8-cyclotetradecatettaene, 1,3,5,9- cyclotetiadecatetraene, 1,3,5,10-cyclotetiadecatetτaene, 1,3,6,8-cyclotetradecatetiaene, 1 ,3,6,9-cyclotetradecatettaene, 1,3,6,10-cyclotetradecatetraene, 1,3,6,11- cyclotetradecatetraene, 1,3,6,12-cyclotetradecatetraene, 1,3,7,9-cyclotetradecatetraene, 1,3,7,10-cyclotetradecatetraene, 1,3,7,1 l-cyclotetradecatetraene, 1 ,3,8,10- cyclotetradecatetraene, 1,4,7,10-cyclotetradecatetraene, 1,4,7, 11 -cyclotetiadecatetraene, 1,4,8,1 l-cyclotetiadecatetraene, 1,3,5,7,9-cyclotetradecapentaene, 1 ,3,5,7,10-

cyclotetradecapentaene, 1,3,5,7,11-cyclotetiadecapentaene, 1,3,5,8,10- cycloietradecapentaene, 1,3,5,8,11 -cyclotetradecapentaene, 1,3,5,8,12- cyclotettadecapentaene, 1,3,5,9,11 -cyclotetradecapentaene, 1,3,5,8,11- cyclotetradecapentaene, 1,3,6,8,11-cyclotettadecapentaene, 1 ,3,6,9,11- cyclotetradecapentaene, 1,3,6,9,12-cyclotetradecapentaene, 1,3,5,8,11- cyclotetτadecapentaene, 1,3,5,8,12-cyclotetradecapentaene, 1,3,5,7,9,1 ϊ - cyclotetiadecahexaene, 1,3,5, 7,9,12-cyclotetradecahexaene, 1 ,3,5,7,10,12- cyclotetradecahexaene, 1,3,5,8, 10,12-cyclotetradecahexaene and 1 ,3,5,7,9,11 ,13- cyclotetiadecaheptaene.

The term "C ₃ -cycloalkenyl," as used herein, means cycloprop-1 -en-l-yl and cycloprop-2-en- 1 -yl

The term "C^cycloalkenyl," as used herein, means cyclobut-1-en-l-yl and cyclobut- 2-en-l-yl

The term "Cj-cycloalkenyl," as used herein, means cyclopent-1-en-l-yl, cyclopent-2- en-l-yl, cycl op ent- 3 -en-l-yl and cyciopenta-l,3-dien-l-yl

The term "Cg-cycloalkenyl," as used herein, means cyclohex-1 -en-l-yl, cyclohex-2-en-l-yl, cyclohex-3 -en-l-yl, cyclohexa-l,3-dien-l-yl, cyclohexa-l ,4-dien-l-yl, cyclohexa-l,5-dien-l-yl, cyclohexa-2,4-dien-l-yl and cyclohexa-2,5-dien-l-yl

The term "Cγ-cycloalkenyl," as used herein, means bicyclo[2.2 l]hept-2-en-l -yl, bicyclo[2 2.1 ]hept-2-en-2-yl, bicyclo[2 2 1 ]hept-2-en-5-yl, bicyclo[2 2 1 ]hept-2-en-7-yl, bicyclo[2 2 l]hepta-2,5-dien-l-yl, bicyclo[2 2 l]hepta-2,5-dien-2-yl, bicyclo[2.2 l]hepta-2,5- dien-7-yl, cyclohept-1 -en-l-yl, cyclohept-2-en-l-yl, cyclohept-3 -en-l-yl, cyclohept-4-en- 1-yl, cyclohepta-l,3-dien-l-yl, cyclohepta-l,4-dien-l-yl, cyclohepta-l,5-dien-l-yl, cyclohepta-l,6-dien-l-yl, cyclohepta-2,4-dϊen-l-yl, cyclohepta~2,5-dien-l-yl, cyclohepta- 2,6-dien-l-yl, cyclohepta-3,5-dien-l-yl, cyclohepta-l,3,5-tiien-l-yl, cyclohepta-l ,3,6-trien-l-yl, cyclohepta-l ,4,6-trien-l-yl and cyclohepta-2,4,6-trien-l-yl.

The term "Cg-cycloalkenyl," as used herein, means bicyclo[2 2 2]oct-2-en-l-yl, bicyclo[2 2 2]oct-2-en-2-yl, bicyclo[2 2 2]oct-2-en-5-yl _> bicyclo[2 2 2]oct-2-en-7-yl, bicyclo[2 2 2]octa-2,5-dien-l-yl, bicyclo[2 2 2]octa-2,5-dieπ-2-yl, bicyclo[2 2 2]octa-2,5- dien-7-yl, bicyclo[2 2 2]octa-2,5,7-lτien-l-yl, bicyclo[2 2 2]octa-2,5,7-tτien-2-yl cyclooct-1-en-l-yl, cyclooct-2-en-l -yl, cydooct-3-en-l-yl, cyclooct-4-en-l-yl, cycIoocta-1,3- dien-1-yl, cycloocta-M-dien-l-yl, cycloocta-1, 5-dien-l-yl, cycloocta-1, ό-dien-1-yl, cyclooctai, 7-dien-l-yl, cycloocta-2,4-dien-l-yl, cycloocta-2,5-dien-l-y], cycloocta-2,6- dien-1-yl, cycloocta-2,7-dien-l-yl, cycloocta-3,5-dien-l-yl, cycloocta-3,6-dien-l-yl, cycloocta-I 3,5-trien-l-yl, cycloocta-l,3,6-tiien-l-yl, cycloocta-1, 3 ,7-trien-l-yl, cycloocta-1 ,4,6-tiien-l-yl, cycloocta-l,4,7-tiien-l-yl, cycloocta-1 ,5,7-trien-l-yl, cycloocla- 2,4,6-tτien-l-yl, cycloocta-2,4,7-trien-l-yl, cycloocta-2,5,7-tτien-l-yl and cycloocta-1,3,5,7- telτaen-1-yl

The term "Cp-cycloalkenyl," as used herein, means cyclonon-1-en-l-yl, cyclonon-2-en-l-yl, cyclonon-3-en-l-yI, cyclonon-4-en-l-yl, cyclonon-5-en-l-yl, cyclonona-l,3-dien-l-yl, cyclonona-l ,4-dien-l-yl, cyclonona-l,5-dien-l-yl, cyclonona-l.β-dien-l-yl, cyclonona-l,7-dien-l-yl, cyclonona-l,8-dien~l-yl, cyclonona- 2,4-dien-l-yl, cyclonona-2,5-dien-l-yl, cyclonoπa-2,6-dien-l-yl, cyclonona-2,7-dien-l-yl, cyclonona-2,8-dien-l -yl, cyclonona-3,5-dien-l -yl, cyclonona-3 ,6-dien- 1 -yl, cyclonona-3, 7-dien-l-yl, cyclonona-4,6-dien-l-yl, cyclonona-l,3,5-trien-l-yl, cyclonona-3 ,3,6-trien-l-yl, cyclonona-l,3,7-trien-l-yl, cyclonona-l,3,8-trien-l-yl, cyclonona- 1,4,6-tτien-l-yl, cyclonona-l,4,7-trien-l-yl, cyclonona-1 ,4,8-trien-l-yl, cydonona-l _j S^-tiien-l-yl, cyclonona-l,5,8-trien-l-yl, cyclonona-1 ,6, 8-trien-l-yl, cyclonona- 2,4,8-trien-l-yl, cyclonona-2,4,6-hien-l-yl, cyc1onona-2,4,7-trien-l-yl, cyclonona-2,4, 8-trien-l-yl, cyclonona-2,5,7-trien-l-yl, cyclonona-2,5,8-tτien-l-yl, cyclonona- 1,3,5,7-tetiaen-l-yl, cyclonona-1 , 3, 5, 8-tetraen-l-yl, cyclonona-l,3,6,8-tettaen-l-yl, cycIonona-l,4,6,8-tetraen-l-yl and cyclonona-2,4,6,8-tetiaen-l-y]

The term "C _] o- ^c y ^c ' ^oa lkenyl," as used heiein, means cyclodec-1-en-l-yl, cyclodec-2-en-l-yl, cyclodec-3-en-l-y], cyclodec-4-en-l-yl, cyclodec-5-en-l-yI, cyclodeca-l^-dien-l-yl, cyclodeca-l,4-dien-l-yl, cyclodeca-l^-dien-l-yl, cyclodeca-l _j δ-dien-l-yl, cyclodeca-1, 7-dien-l-yl, cyclodeca-l,8-dien-l-yl, cyclodeca- 1,9-dien-l-yl, cyclodeca-2,4-dien-l-yl, cyclodeca-2,5-dien-l-yl, cyclodeca-2,6-dien-l-yl,

cyclodeca-2,7-dien-l-yl, cyclodeca-2,8-dien-l-yl, cyclodeca-2,9-dien-l-yl, cyclodeca- 3,5-dien-l-yl, cyclodeca^ό-dien-l-yl, cyclodeca-SJ-dien-l-yl, cyclodeca-3,8-dien-l-yl, cyclodeca-4,6-dien-l-yl, cyclodeca-4,7-dien-l-yl, cyclodeca-1, 3,6~trien-l-yl, cyclodeca-1 , 3,7-tiien-l-yl, cyclodeca-1, 3,8-trten-l-yl, cyclodeca- 1 ,3,9-trien-l-yl, cyclodeca-1 , 4,6-trien-l-yl, cyclodeca-1 ,4,7-trien-l-yl, cyclodeca-1, 4,8-trien-l-yl, cyclodeca-l,4,9-tτien-l-yl, cyclodeca-1, 5,7-trien-l-yl, cyclodeca- 1,5,8-trien-l-yl, cyclodeca-1, 5,9-tτien-l-yl, cyclodeca-1 , 6,8-tiien-l-yl, cyclodeca-l,6,9-trien-l-yl, cyclodeca-l,7,9-trien-I-yl, cyclodeca-2,4,6-lrien-l-yl, cyclodeca- 2,4,7-tiien-l-yl, cyclodeca-2,4,8-trien-l-yl, cyclodeca-2,4,9-trien-l-yl, cyclodeca-2,5,7-lτien-l-yl, cyclodeca-2,5,8-trien-l-yl, cyclodeca-2,5 _s 9-trien-l-yl, cyclodeca- 2,6,8-trien-l-yl, cyclodeca'3,5,7-trien-l-yl, cyclodeca-3,5,8-tiien-l-yl, cyclodeca-l,3,5,7-tetτaen-l-yl, cyclodeca-l,3,5,8-tetiaen-l-yl, cyclodeca-l,3,5,9-tetiaen-l-yl, cyclodeca-l,3,6,8-tetτaen-l-yl, cyclodeca-l ,3 _> 6,9-tetraen-l-yl, cyclodeca-l,3,7,9-tetraen-l-yl, cyclodeca- 1 ,4,6,8-tetτaen-l -yl, cyclodeca-1 ,4,6,9-tetraen-l-yl, cyclodeca-1 ,4,7,9-tetιaen-l -yl, cyclodeca-1, 5, 7,9-tetraen-l-yI, cyclodeca-2,4,6,8-tetiaen-l-yl, cyclodeca-2,4,6,9-tetiaen-l-yl, cyclodeca-2,4,7,9-tetraen-l-yl and cyclodeca-1, 3,5,7,9-pentaen-l-yl.

The term "Ci j-cycloalkenyl," as used herein, means cycloundec-1-en-l-yl, cycloundec-2-en-l-yl, cycloundec-3-en-l-yl, cycloundec-4-en-l-yl, cycloundec-5-en-l-yl, cycloundec-6-en-l-yl, cycloundeca-l,3-dieπ-l-yl, cycloundeca-l,4-dien-l-yl, cycloundeca-1 ,5-dien-l -yl, cycloundeca-1 ,6-dien-l-yl, cycloundeca- 1 ,7-dien-l -yl, cycloundeca-1 ,8-dien-l-yl, cycloundeca-1, 9-dien-l-yl, cycloundeca-1, 10-dien-l-yl, cycloundeca-2,4-dxen~I-yl, cycloundeca-2,5-dien-l-yl, cycloυndeca-2,6-dien-l-yl, cycloundeca-2,7-dien-l-yl, cycloundeca-2,8-dien-l-yl, cycloundeca-2,9-dien-l-yl, cycloundeca-2,10-dien-l-yl, cycloundeca-3,5-dien-l-yl, cycloundeca-3,6-dien-l-yI, cycloundeca-3,7-dien-l-yl, cycloundeca-3,8-dien-l-yl, cycloundeca-3,9-dien-l-yl, cycloundeca-4,6-dien-l ~yl, cycloundeca-4,7-dien-l-yl, cycIoundeca-4,8-dien-l -yl, cycloundeca-5,7-dien-l -yl, cycloundeca-1 ,3 ,5-trien-l -yl, cycloundeca-1 ,3 ,6-trien-l -yl, cycloundeca-1 ,3,7-trien-l-yl, cycloundeca-1 ,3,8-trien-l-yl, cycloundeca-1, 3, 9-trien-l-yl, cycloundeca-1, 3, 10-tiien-l-yl, cycloundeca-1, 4,6-tiien-l-yl, cycloundeca-1 ,4,7-tri-en-l-yl, cycloundeca- 1 ,4,8-trien-l -yl, cycloundeca-1 ,4,9-trien- 1 -yl, cycloundeca-1 ,4, 10-trien-l -yl, cycloundeca-1, 5,7-trien-l-yl, cycloundeca-1, 5, 8-trien-l-yl, cycloundeca-1, 5, 9-trien-l-yl, cycloundeca- 1,5,10-trien- 1 -yl, cycloundeca- 1 ,6,8-trien- 1 -yl, cycloundeca- 1 ,6,9-trien- 1 -yl,

cycloundeca-l,6,10-tiien-l-y3, cycloundeca-1 , 7, 9-triert-l-yl, cycloundeca-1, 7, 10-tri en- 1-yl, cycloundeca-1 ,8, 10-tτien-1 -yl, cycloundeca-2,4,6-trien-l -yl, cycloundeca-2,4,7-trien-l -yl, cycloundeca-2,4,8-trien-l -yl, cycloundeca-2,4,9-tiien-l -yl, cycloundeca-2,4, 10-trien-1 -yl, cycloundeca-2,5,7-lτien-l-yl, cycloundeca-2,5,8-trien-l-yl, cycloundeca-2,5,9-trien-l-yl, cycloundeca-2,5,10-txi-en-l-yl, cycloundeca-2,6,8-trien-l-yl, cycloιmdeca-2,6,9-trien-l-yl, cycloundeca-2,6,10-tiien-l-yl, cycloundeca-2,7,9-trien-l-yI, cycloundeca-3,5,7-trien-l-yl, cyclouπdeca-3,5,8-trien~l-yl, cycloιmdeca-3,5 ₅ 9-trien-l-yl, cycloundeca-3,6,8-trien-l-yI, cycloundeca-3,6,9-trien-l-yl, cycloundeca-4,6,8-trien-l-yl, cycloundeca-l,3.5,7-letiaen-l-yl _s cycloundeca- 1,3, 5, 8-tetτaen-l-yl, cycloundeca~l ,3,5,9-tetraen-l-yl, cycloundeca-1, 3,5, 10-tetraen-l-yl, cycloundeca-1, 3,6, 8-tetraen-l-yl, cycloundeca-1 , 3,6,9- tetraen- 1 -yl , cycloundeca- 1 ,3 ,6, 10-tetτaen- 1 -yl , cycloundeca- 1 ,3 , 7 ,9-tetraen- 1 -yl , cycloundeca-1, 3, 7, 10-tetraen-l-yl, cycloundeca- 1,3, 8, 10-tetraen-l-yl, cycloundeca- 1,4,6,8- tetiaen-1 -yl, cycloundeca-1 ,4,6,9-tetiaen-l -yl, cycloundeca-1 ,4,6,10-tetraen-1-yl, cycloundeca-1 ,4,8,10-tetraen-I-yl, cycloundeca-1, 5,7,9-tetiaen-l-yl, cycloundeca- 1,5,7,10-tetiaen-l-yl, cycloundeca- 1,5, 8, 10-tetraen-l-yl, cycloundeca-1, 6,8, 10-tetraen-l-yl, cycloundeca-2,4,6,8-tetiaen-l-yl, cycloundeca-2,4,6,9-tetraen-l-yl, cycloundeca-2,4,6,10- telτaen-1 -yl, cycloundeca-2,4,7,9-tetτaen-l -yl, cycloundeca-2,5,7,9-tetiaen-l -yl, cycloundeca- 3, 5,7, 9-tetraen-l-yl, cycloundeca-1, 3,5, 7,9-pentaenyl, cycloundeca-1 , 3.5,7, 10- pentaenyl, cycloundeca- 1 ,3,5,8, 10-pentaenyl, cycloundeca- 1 ,3,6,8, 10-pentaenyl, cycloundeca-l,4,6,8,10-pentaenyl and cycloundeca-2,4,6,8,10-pentaenyl

The term "Cπ-cycloalkenyl," as used herein, means cyclododec-1-en-l-yl, cyclododec-2-en-l-yl, cyclododec-3-en-l-yl, cyclododec-4-en-l-yl, cycIododec-5-en-l-yl, cyclododec-6-en-l-yl, cyclododeca-l^-dien-l-yl, cyclododeca-1 ,4-dien-l-yl, cyclododeca-1, 5-dien-l-yl, cyclododeca-1 ,6-dien-l-yl, cyclododeca-1, 7-dien-l-yl, cyclododeca-1 ,8-dien-l -yl, cyclododeca- 1 ,9-dien-l -yl, cyclododeca- 1 , 10-dien- 1 -yl, cyclododeca-1 ,11-dien-l-yl, cyclododeca-2,4-dien-l -yl, cyclododeca-2,5-dien-l-yl, cyclododeca^.ό-dien-l-yl, cyclododeca-2,7-dien-l -yl, cyclododeca-2,8-dien-l-yl, cyclododeca-2,9-dien-l-yl, cyclododeca-2,10-dien-l-yl, cyclododeca-2,11-dien-l-yl, cyclododeca-3,5-dien-l-yl, cyclododeca-3,6-dien-l-yl, cyclododeca-3,7-dien-l-yl, cyc!ododeca-3,8-dien-l -yl, cyclododeca-3 ,9-dien-l -yl, cyclododeca-3, 10-dien-l -yl, cyclododeca- 3,11-dien-l-yl, cyclododeca-4,6-dien-l-yl, cyelododeca-4,7-dien-l-yl, cyclododeca-4,8-dien-l-yl, cyclododeca-4,9-dien-l-yl, cyclododeca-5, 7-dien-l-yl,

Cyclododeca-l _v B.S-trien-l-yl, cyclododeca-Ui.ό-tiien-l-yl, cyclododeca-1, 3,7-tiien-l-yl, cyclododeca-l,3,8-tiien-l-yl, cyclododeca-l,3,9-trien-l-yl, cyclododeca-ljSJO-txien-l-yl, cyclododeca-1 ,3,11-trien- l-yl, cyclododeca- 1 ,4,6-trien- l-yl, cyclododeca-l,4,7-trien-l-yl, cyclododeca-1 ,4, 8-tiien-l-yl, cyclododeca- 1,4,9-trien- l-yl, cyclododeca- 1,4, 1 1-tiien-l-yl, cyclododeca-1, 5,7-trien-l-yI, cyclododeca-1, 5, 8-tτien-l-yl, cyclododeca-1, 5,9-trien-l -yl, cyclododeca-l,5,10-tiien-l-yl, cyclododeca- 1,5,11-tτien-l-yl, cyclododeca-l,6,8-trien-l-yl, cyclododeca- 1 ,6,9-trien-l-yI, cyclododeca-l,6,10-ttien-l-yl, cyclododeca-1, 6, 11-trien-l-yl, cyclododeca-1, 7,9-trien-l-yl, cyclododeca- 1, 7, 10-tτien- l-yl, cyclododeca-ljjl l-trien-l-yl, cyclododeca-1 , 8, 10-tiien-l-yl, cyclododeca-l,8,l l-tτien-l-yl, cyclododeca- 1, 9, 1 1 -tri en- l -yl, cyclododeca-2,4,6-trien-l-yl, cyclododeca-2,4,7-trien-l-yl, cyclododeca-2,4,8-tiien-l-yl, cyclododeca~2,4,9-tiien-l-yl, cyclododeca-2,4,10-lrien-l-yl, cyclododeca-2,4,11-tiien-l-yl, cyclododeca-2,5,7-trien-l-yl, cyclododeca-2,5,8-tiien-l-yl, cyclododeca-2,5,9-tiien-l-yl, cyclododeca-2,5,10-trien-l~yl, cyclododeca-2,5,11-tiien-l-yl, cyclododeca'2 ₅ 6,8-lτien-l-yl, cyclododeca-2,6,9-trien-l-yl, cyclododeca-2,6,10-tτien-I-yL, cyclododeca-2,6,11-trien-l-yl, cyc!ododeca-2,7,9-tiien-l-yl, cyclododeca-2,7,10-tiien-l-yl _s cyclododeca-2,8,10-trien-l-yl, cyclododeca-3,5,7-tiien-l-yl, cyclododeca-3,5,8-trien-l-yl, cyclododeca-3,5,9-tiien-l-yl, cyclododeca-3,5,10-trien-l-yl, cyclododeca-3,6,8-tτien-l-yl, cyclododeca-3,6,9-trien-l-yI, cyclododeca-3,6,10-tiien-l-yl, cyclododeca'3,7,9-tτien-l-yl, cyclododeca-4,6,8-trien-l-yl, cyclododeca-4,6,9-trien-l-yI, cyclododeca-l ,3,5,7-tetiaen-l-yl, cyclododeca-l,3,5 ₅ 8-tetraen-l-yl, cyclododeca-1, 3,5,9- tetraen-1-yl, cyclododeca-lβ.SJO'tetiaen-l-yl, cyclododeca- 1, 3,5, 11-tettaen- l-yl, cyclododeca-1, 3,6,8-tetraen-l-yl, cyclododeca-l,3,6,9-tetraen-l-yl, cyclododeca-1, 3,6, 10- tetraen-1-yl, cyclododeca-3 ,3,6,11-tetraen-l-yl, cyclododeca-l,3,7,9-tetτaeπ-l-yl, cyclododeca-1 ,3,7, 10-tetraen-l-yl, cyclododeca-1 , 3, 7,11-tettaen- l-yl, cyclododeca-1,3,8,10- tetiaen- 1 -yl , eye lodo deca- 1 ,3 , 8 , 11 -tetraen- 1 -yl , cy cl ododeca- 1 , 3 ,9 , 11 -tetraen- 1 -y I , cyclododeca-1, 4,6, 8-letτaen-l-yl, cyclododeca-1, 4,6,9-letraen-l-yl, cyclododeca-1, 4,6,10- tetraen-1-yl, cyclododeca-1 ,4,6,11 -tetiaen- l-yl, cyclododeca-1, 4,7,9-letτaen-l-yl, cyclododeca-1, 4, 7, 10-tetraen-l-yl, cyclododeca-1, 4,7,11-tetraen-l-yl, cyclododeca- 1,4, 8, 10- tetraen-l-yl, cy clododeca- 1,4, 8, 11 -tetraen- l-yl, cyclododeca- 1,4,9,11-tetraen-l-yl, cyclododeca-1, 5,7,9-tetiaen~l-yl, cyclododeca-1 ,5,7, 10-tetraen-l-yl, cyclododeca-1, 5,7,11-tetraen-l-yl, cyclododeca-1 ,5,8, 10-tetraen-l-yl, cyclododeca- 1,5,8,11-tetraen-l-yl, cyclododeca-1, 5, 9,11-tetraen-l-yl, cyclododeca- 1,6,8, 10-tetraen-l-yl, cyclododeca-1, 6, 8,11-tetraen-l-yl, cyclododeca-1 ,6,9,11-tetraen-l-yl, cyclododeca-1, 7,9,11- tetraen-1-yl, cyclododeca-2,4,6,8-tetraen-l-yl, cyclododeca-2,4,6,9-tetτaen-l-yl,

cyclododeca-2,4,6,10-tet.τaen-l-yl, cyclododeca-2,4,6,1 1-tetraen-l-yl, cyclododeca-2,4,7,9- tetiaen-1-yl, cyclododeca-2,4,7,10-tetraen-l-yl, cyclododeca-2,4,7,11-tetraen-l-yl, cyclododeca-2,4,8,10-tetraen-l-yl, cyclododeca-2,4,8 ₃ l l-tetraen-l-yl, cyclododeca-2,4,9,11- tetraen-1-yl, cyclododeca~2,5,7,9-tetiaen-l-yl, cyclododeca-2,5 _J 7,10-tetτaen-l-yl, cyclododeca-2,5,7,1 1-tetraen-l-yl, cyclododeca-2,5,8,10-tetraen-l-yl, cyclododeca-2,5,8,11- tetτaen-1-yl, cyclododeca-2,6,8,10-tetxaen-l-yl, cyclododeca-3,5,7,9-tetiaen-l-yl, cyclododeca-3 ,5 ,7,10-tetraen- 1 -yl , cyclododeca-3 ,5 , 8 , 10-tetiaen- 1 -yl, cyclododeca- 1,3,5, 7,9-pentaen-l-yl, cyclododeca-1 , 3,5, 7, 10-pentaen-l-yl, cyclododeca-1, 3, 5, 7, 11-pentaen-l-yl, cyclododeca-1 ,3,5,8, 10-pentacn-l-yl, cyclododeca-1 , 3,5,8,11-pentaen-l-yl, cyclododeca-1, 3,5,9,11-pentaen-l-yl, cyclododeca-1 ,3, 6,8, 10-pentaen-l-yl, cyclododeca-1, 3, 6, 8, 11-pentaen-l-yl, cyclododeca-1, 3,6,9,1 1-peπtaen-l-yl, cyclododeca-1,3, 7,9,1 1-pentaen-l-yl, cyclododeca- 1 ,4,6,8,10-pentaen-1-yl, cyclododeca-1, 4,6,8,11 -pentaen-l-yl, cyclododeca- 1,4,6,9, 11- pentaen-l-yl, cyclododeca- 1,4, 7,9,11-pentaen-l-yl, cyclododeca- 1,5, 7,9,1 1-pentaen-l-yl, cyclododeca-2,4,6,8, 10-pentaen- 1 -yl, cyclododeca-2,4,6,8, 1 1 -pentaen- 1 -yl, cyclododeca-2,4,6,9, 11-pentaen-l-yl and cyclododeca-1 , 3,5, 7, 9, 11-hexaen-l-yl

The teim "Cu-cycloalkenyl," as used herein, means cyclotridec-l-en-l-y], cyclotiidec-2-en-l-yl, cyclotiidec-3-en-I-yl, cyclotiidec-4-en-l-yl, cyclotiidec~5-en-l-yl, cyclotτidec-6-en-l-yl, cyclottidec-7-en-l-yl, cyclotrideca-l^-dien-l-yl, cyclotrideca-l^-dien-l-yl, cyclotrideca-Uό-dien-l-yl, cyclotrideca-1 ,7-dien-l -yl, cyclotiideca- 1 ,8-dien-l -yl, cyclotrideca-1 ,9-dien-l -yl, cyclotrideca-ljlO-dien-l-yl, cyclotiideca- 1,1 1-dien-l-yl, cyclotrideca-1, 12-dien-l-yI, cyclotτideca-2,4-dien-l-yl, cyclotiideca-2,6-dien-l-yl, cyclotiideca-2,7-dien-l-yl, cyclottideca-2,8-dien-l-yl, cyclotτideca-2,9-dien-l-yl, cyclotτideca-2,10-dien-l-yl, cyclotτideca-2,11-dien-l-yl, cyclotrideca-2,12-dien-l-yl, cyclotrideca-3,5-dien-l-yl, cyclotrideca-3,6-dien-l-yl, cyclotrideca-3,7-dien-l-yl, cyclotiideca- 3, 8-dien-l-yl, cyclotrideca-3,9-dien-l-yl, cyclotiideca-3,10-dien-l-yl, eye lotrideca-3,11-dien-l-yl, cyclotrideca-4,6-dien-l-yl, cyclotrideca-4,7-dien-l-yl, cyclotrideca-4,8-dien-l-yl, cyclotrideca-4,9-dien-l-yl, cyclotrideca-4,10-dien-l-yl, cyclotii deca-5 , 7-dien- 1 -y 1 , cyclotrideca-5 , 8-dien- 1 -y 1, cyclotrideca-5 ,9-dien- 1 -y 1 , cyclotrideca-6,8-dien-l-yl, cyclotrideca-1, 3,5-trien-l-yl, cyclotrideca-1, 3, 6-tiien-l-yl, cyclotrideca-1, 3,7-tiien-l-yl, cyclottideca-l.Sjδ-tiien-l-yl, cyclotτideca-l,3,9-trien-l-yl,

cyclotrideca-i ,3, 10-trien-1-yl, cyclotτideca-1 ,3, 11-trien-l-yl, cyclotrideca-1 ,3,12-trien-l -yl, cyclotrideca-1 ,4,6-trien-l-yl, cyclotiideca-MJ-trien-l-yl, cyclotrideca-l,4,8-trien-l--y], cyclotτideca-l,4,9-trien-l-yl, cyclotrideca-l,4,10-ttien-l-yl, cyclotiideca- 1,4,11 -trien-l-yl, cyclotτideca-i,4,12-tiien-l-yl, cyclottideca-l _s 5 ₅ 7-tiien-l-yl, cyclotrideca-1, 5,8-trien-l-yl, cyclotiideca-l,5,9-trien-l-yl, cyclotrideca-l.S.lO-trien-l-yl, cyclotrideca-1 , 5, 11 -trien-1-yl, cyclotrideca-l,5,12-trien-l-yl, cyclotiideca- 1 ,6,9-tiien-l-yl, cyclotiideca- 1 ,6,10-tri-en-l-yl, cyclotiideca- 1 ,6,11-trien-I-yl, cyclotrideca-1, 6,12-trien-l -yl, cyclotrideca-1, 7,9-trien-l-yl, cyclotrideca-1 ,7,10-trien-l-yl, cyclotrideca-1 ,7,11-tri-en-l-yl, cyclotrideca-1, 7,12-trien-l-yI, cyclotrideca-l,8,10-ttien~l-yl, cyclotiideca-l,8,π-tτien-l-yl, cyclotiideca-1,9,11-tiien-l-yl, cyclotrideca-1, 9,12-trien-l -yl, cyclotrideca-1, 10,12-trien-l-yl, cyclotiideca-2,4,6-trien-l-yl, cyclotrideca-2,4J-trien~l-yl, cyclotrideca-2,4,8-trien-l -yl, cyclotiideca-2,4,94τien-l-yl, cyclotrideca-2,4,10-tiien-l -yl, cyclotrideca-2,4,11-trien-l-yl, cyclotrideca-2,4,12-ttien-l-yl, cyclotrideca-2,5,7-trien-l-yl, cyclotrideca-2, 5,8-trien-l-yl, cyclotti-deca^.S^-trien-l-yl, cyclotri-deca-2,5,I0~trien-l-yl, cyclotiideca-2,5,11-trien-l-yl, cyclotiideca-2,5,12-trien-l-yl, cyclotrideca-2,ό,8-tτieπ-l-yl, cyclotrideca-2,6 ₅ 9-trien-l-yl, cyclotrideca-2,6,10-trien-l-yl, cyclotrideca-2,6,11-trien-l-yl, cyclotτideca-2,6,12-tτien-l-yl, cyclotrideca-2, 7, 9-trien-l-yl, cyclotrideca-2, 7,10-tiien-l-yl, cyclotrideca-2,7,11-trien-l-yl, cyclotrideca-2,7,12-trien~l-yl, cyclotiideca-2,8,10-trien-l-yl, cyclotrideca-2,8,11-trien-l-yl, cyclotrideca-2, 8, 12-trien-l -yl, cyclotiideca-2,9,11-trien-l-yl, cyclorrideca-2,9,12-trien-l -yl, cyclotri-deca-2,10,12-trien-l-yl, cyclotrideca-3,5,7-trien-l-yl, cyclotrideca-3 ,5 ,8-trien- 1 -yl, cyclotrideca- ϊ ,5 ,9-trien- 1 -yl , cyclotrideca-3 ,5 , 10-trien~ 1 -yl, cyclotrideca-3,5,11-trien-l-yl, cyclotiideca^^^-tiien-l-yl, cyclotrideca-3 ,6,9-trien~l -yl, cyclottideca-3,6,10-tiien-l-yl, cyclotrideca-3,6,11-trien-l-yl, cyclotτideca~3,7,9-trien-l-yl, cyclotrideca-3,7,10-trien-l-yl, cyclotrideca- 3, 7,11-tri-en-l-yl, cyclotrideca-3,8,10-trien-l-yl, cyclotrideca-4,6,8-tiien-l-yl, cyclotrideca-4 _s 6,9-trien-l-yl, cyclotri-deca-4,6,10-tiien-l-yl, cyclotiideca-4,7,9-trien-l-yl, cyclotrideca-4,7,10-trien~l-yl, cyclotrideca-1 ,3,5, 7-tetiaen-l-yl, cyclotrideca-1, 3,5,8-tetraen-l-yl, cyclotτideca-l,3,5,9-tetraen-l-yl, cyclotrideca-1, 3,5, 10- tetraen-1-yl, cyclotiideca-1, 3,5,11-tetiaen-l-yl, cyclotrideca-l,3,5,12-tetraen-l-yl, cyclotrideca- 1 ,3 ,6,8-tetτaen- 1 -yl, cyclotrideca- 1 , 3 ,6,9-tetraen- 1 -yl, cyclotrideca- 1,3,6,10- tetraen-1-yl, cyclotrideca-1, 3,6,11-tetτaen-l-yl, cyclotiideca-l,3,6,12-tetiaen-l-yl, cyclotrideca- 1,3,7,9-tetraen-l-yl, cyclotiideca- 1, 3,7, 10-tetraen-I-yl, cyclotrideca-1,3,7,11- tetraen-1-yl, cyclotrideca-1 ,3,7,12-tetraen-l-yl, cyclotri-deca-l.B.S.lO-tetraen-l-yl, cyclotrideca-1, 3,8,11 -tetraen-1-yl, cyclotrideca-1, 3,8,12-tetiaen-l-yl, cyclotrideca- 1,3,9,11-tetiaen-l-yl, cyclotrideca'l ,3,9,12-tetraen-l-yl, cyclotrideca-1 , 3, 10,12-tetτaen-l-yl,

cyclotrideca-l,4,6,8-tetτaen-l-yl, cyclotiideca~l _t 4,6,9-tetiaen-l-yl, cyclotri-deca- 1 ,4,6,10-tetiaen-1-yl, cyclotrideca-1,4,6,11-tetiaen-l-yl, cyclotrideca-l,4,6,12-telτaen-l-yl, cyclolτideca-l,4,7,9-tetτaen-l-yl, cyclotτideca-l,4,7,10-tetraen-l-yl, cyclotrideca-1, 4,7,1 1- tetraen-1-yl, cyclotrideca-l/ij^-tetraen-l-yl, cyclotri-deca-lAδjlO-tetraen-l-yl, cyclotri- deca-1, 4, 8,11-tetraen-l-yl, cyclotτideca-1, 4,8,12-tetraen-l-yl, cyclotrideca-

1,4,9,1 l-tetoaen~l-yl, cyclotrideca-1, 4,9,124etiaen-l-yl, cyclotrideca-l, 4, 10,12-tetraen-l-yl, cyclotrideca-1, 5,7,9-tetraen-l-yl, cyclotrideca-ljS^lO-tetiaen-l-yl, cyclotri- deca-1,5,7,1 1-tetraen-l -yl, cyclotri-deca-l^Jjπ-tetiaen-l-yl, cyclotrideca-1 ,5,8,10-tetτaen- 1 -yl, cyclotτideca-1 ,5,8, 11 -tetraen-1-yf , cyclotrideca- 1 ,5,8, 12-tetraen-l -yl, cyclotrideca-1, 5,9,1 l-tetraen-1-yl, cyclotrideca-1 , 5,9,12-tetraen-l-yl, cyclotrideca-1 , 5, 10,12- tetiaen-1-yl, cyclotrideca-1, 6,8, 10-tetτaen-l-yl, cyclotri-deca-1, 6,8,11-tetraen-l-yl, cyclotiideca- 1 ,6,8, 12-tetraen-l -yl, cyclotrideca- 1 ,6,9, 11 -tetraeπ-1 -yl, cyclotrideca- l,6,9,12-tetraen-l~yl, cyclotτideca-l,6,10,12-tetraen-l-yl, cyclotrideca-1, 7, 9,1 1-tetiaen-l-yl, cyclotiideca- 1 ,7,9, 12-tetraen-l-yl, cyclotri-deca- 1,7,10,12-tetraen-l-yl, cyclotrideca-1, 8,10, 12-tetraen-l-yl, cyclotτideca-2,4,6,8-tetτaen-l-yl, cyclotrideca-

2,4,6,9-tetraen-l-yl, cyclotri-deca-2,4,6,10-tetraen-l-yl, cyclotrideca-2,4,6,11-tetraen-l-yl, cyclotiideca-2,4,6,12-tetraen-l-yl, cyclotτideca-2,4,7,9-tetraen-l-yl, cyclotτi-deca-2,4,7,10- tetiaen-1-yl, cyclotrideca-2,4,7,1 1-tettaen-l-yl, cyclotτideca-2,4,7,124etτaen-l-yl, cyclotiideca-2,4,8,10-tetraen-l-yl, cyclotii-deca-2,4,8,1 1-tetiaen-l-yl, cyclotxideca-2,4,8,12- tettaen-1-yl, cyclotrideca-2,4,9,11-tetiaen-l-yl, cyclotiideca^^^^l-tetraen-l-yl, cyclotrideca-2,4, 10,12-tetraen- 1 -yl, cyclotrideca-2,5 ,7,9-tetτaen- 1 -yl, cyclotrideca-2 ,5 ,7 , 10- tetiaen-1-yl, cyclotiideca-2, 5,7,11-tetraen-l-yl, cyclotiideca-2,5,7,12-tetraen-l-yl, cyclotiideca^S^lO-tetraen-l-yl, cyclotrideca-2, 5,8,11-tetτaen-l-yl, cyclotrideca- 2,5,8, 12-tetraen-l-yl, cyclotii-deca-2, 5,9,11-tetiaen-l-yl, cyclotrideca-2,5,9,12-tetraen-l-yl, cyclotrideca-2,5,10,12-tetraen-l-yl, cyclotτideca-2,6,8,10-tetraen-l-yl, cyclotii- deca^ _j ό^J l-tetraen-l-yl, cyclotrideca-2,6,8,12-tetιaen-l-yl, cyclotiideca-2, 6,9,11- tetτaen-1 -yl, cyclotτideca-2,6,9,12-tetτaen- 1 -yl, cyclotri-deca-2,6,10, 12-tetraen-l -yl, cyclotrideca-2,7,9,11-tetiaen-l-yl, cyclotτideca-2,7,9,12-tetraeri-l-yl, cyclotrideca-2,7, 10,12- tetraen-1-yl, cyclotri-deca-3,5,7,9-tettaen-l-yl, cyclotiideca-^SJJO-tetraen-l-yl, cyclotiideca-3,5,7,11-tetraen-l-yl, cyclotrideca-S.S^JO-tetraen-l-yl, cyclotri-deca-3,5,8,11- tetraen- 1 -yl , cyclotr idee a-3 ,5 ,9 , 11 -tetraen- l-yl, cyclotrideca-3,6,8,l O-teti aen- 1 -yl , cyclotrideca-3,6,8,11-tetraen-l-yl, cyclotrideca-3,7,9,l l-tetraen-l-yl, cyclotrideca-1, 3, 5,7,9- pentaen-1-yl, cyclotiideca-l^^JJO-pentaen-l-yl, cyclotrideca-1, 3,5,7, 11-pentaen-l-yl, cyclotrideca- 1 ,3 ,5 ,7 , 12-pentaen- 1 -yl , cyclotrideca- 1 ,3 ,5 ,8, 10-pentaen- 1 -yl, cyclotrideca-

1 ,3,5,8,11-pentaen-l-yl, cyclotrideca-l,3,5,8,12~pentaen-l-yl, cyclotiideca-1 ,3,5,9,1 1- pentaen-1 -yl, cyclotrideca-1 ,3,5,9, 12-penlaen- 1 -yl, cyclotrideca- 1 ,3,6,8, 10-pentaen-1 -yl, cyclotrideca- 1,3,6,8,11-pentaen-l-yl, cyclotrideca-1, 3, 6,8,12-pentaen-l-yl, cyclotrideca- 1, 3,6,9,11-pentaen-l-yl, cyclotiideca-1, 3,6,9, 12-penlaen- 1-yl, cyclotrideca- 1,3,7,9,1 1-pentaen-l-yl, cyclotrideca-1, 3, 7,9,12~pentaen-l-yl, cyclotrideca-l,4,6,8,10-pentaen-l-yl, cyclotrideca-1, 4,6, 8,11-pentaen-l-yl, cyclotrideca- 1,4 ,6, 8,12-pentaen-l-yl, cyclotrideca-1, 4,6,9,11-pentaen-l-yl, cyclotrideca- 1 ,4,6,9, 12-pentaen-l-yl, cyclotiideca-1, 4,7,9,11-pentaen-l-yl, cyclotiideca- 1,4,7,9, 12-pentaen-l-yl, cyclotrideca-1, 5,7,9,11-pentaen-l-yl, cyclotiideca-1 ,5,7,9,12- pentaen-1-yl, cyclotiideca-2,4,6,8,10-penlaen-l-yl, cyclotrideca-2,4, 6,8,11 -pentaen-l-yl, cyclotrideca-2,4,6,8,12-pentaen-l-yl, cyclotiideca-2,4,6,9,11-pentaen-l-yl, cyclotrideca-2,5,7,9,11-pentaen-l-yl, cyclotrideca-2,5,7,9,12-pentaen-l-yl, cyclotrideca-1, 3, 5,7,9,1 1-hexaen-l-yl and cyclotiideca~2,4,6,8,10,12-hexaen-l-yl

The teπn "Cπ-cycloalkenyl," as used herein, means cyclotetradec-l-en-l-yl, cycIotetradec-2-en-l-yl, cyclotetiadec-l-en-l-yl, cyclotetiadec-4-en-l-yl, cyclotetiadec-5-en-l-yl, cyclotetradec-6-en-l-yl, cyclotetradec-7-en-l-yl, cycIotetradec-8- en-l-yl, cyclotetradeca-l,3-dien-l-yl, cycloletradeca-l/l-dien-l-yl, cyclotetiadeca-l,5-dien-l-yl, cyclotetiadeca-ljό-dien-l-yl, cyclotetradeca-lj-dien-l-yl, cyclotetradeca-l^-dien-l-yl, cyclotetradeca-l,9-dien-l-yl, cyclotetiadeca-l ,10-dien-l-yl, cyclotetiadeca-l.ll-di-en-l-yl, cyclotetiadeca-l,12-dien-l-yl, cyclotetradeca-l,13-dien-l-yl, cyclotetradeca-2,4-dien-l-yl, cyclotetradeca-2,5-dien-i-yl, cycIotetiadeca-2,6-dien-l -yl, cyclotetiadeca-2,7-dien-l-yl, cyclotetiadeca-2,8-dien-l-yl, cyclotetradeca-2,9-dien-l-yl, cyclotetradeca-2,10-dien-l-yl, cyclotetradeca-2, 1 1-dien-l-yl, cyclotettadeca-2,12-dien-l-yl, cyclotetiadeca-2,13-dien-l-yl, cyclotetradeca-3,5-dien-l-yl, cyclotetτadeca-3,6-dien-l-yl, cycIotetradeca-3,7-dien-l-yI, cyclotetradeca-3,8-dien-l-yl, cyclotetiadeca-3,9-dien-l-yl, cyclotetiadeca-3,10-dien-l-yl, cyclotetiadeca-3,11-dien-l-yl, cyclotetiadeca-3,12-dien-l-yl, cyclotetradeca-4,6-dien-l-yl, cyclotetradeca-4,7-dien-l-yl, cyclotetradeca-4,8-dien-l-yl, cyclotetiadeca-4,9-dien-l-yl, cyclotetiadeca-4,10-dien-l-yl, cyclotetτadeca-4,11-dien-l-yl, cyclotetradeca-SJ-dien-l-yl, cyclotetτadeca-5,8-dien-l-yl, cyclotetiadeca-5,9-dien-l-yl, cyclotetradeca-5,10-dien-l-yl, cyclotetiadeca-6,8-dien-l-yl, cyclotetra-deca-6,9-dien-l-yl, cyclotetiadeca- 1 ,3 ,5-tetraen- 1 -yl, cyclotetradeca- 1 ,3 ,6-tetiaen- 1 -yl, cyclotetiadeca- 1,3,7- tetiaen- 1 -yl , cyclotetradeca- 1 ,3 ,8-tetraen- 1 -yl, cycloteti adeca- 1 , 3 ,9-tettaen- 1 -yl ,

cyclotetradeca- 1 ,3 , 10-tetraen- 1 -yl, cyclotetiadeca- 1,3,11 -tetraen- 1 -yl, cycl otetradeca- 1 ,3,12-tetraen- 1 -yl , cyclotetradeca- 1 ,3 , 13 -tetraen- 1 -y 1 , cyclotetiadeca-l,4,6-tetraen-l-y3, cyclotetiadeca~l,4,7-tettaen-l-yl, cyclotetiadeca-1 ,4,8- tetraen-1-yl, cyclotettadeca-l,4,9-tetτaen-l-yl, cyclotetradeca-l,4,10-tetraen-l-yl, cyclotetradeca- 1,4,1 1 -tetraen- 1 -yl, cyclotetradeca-l,4,12-tetraen-l-yl, cyclotetradeca- 1,4, 13- tetraen-1-yl, cyclotettadeca-l,5,7-tetraen-l-yl, cyclotetiadeca-1 ,5,8-tetraen-l-yl, cyclotetradeca- 1 ,5 ,9-tetτaen- 1 -yl, cyclotetradeca- 1,5,10-tetraen- 1 -yl, cyclotetradeca- 1 ,5,11 -tetraen- 1-yl, cyclotetradeca-l,5,12-tetraen-l-yl, cyclotetradeca- 1,5, 13- tetraen-1 -yl, cyclotetiadeca-1 ,6,8-tetraen-l-yl, cyclotetradeca- 1 ,6,9-tetτaen-l -yl, cyclotetradeca-l,6,10-tetτaen-l-yl, cyclotetradeca-1 ,6,11 -tetraen- 1-yl, cyclotetradeca- 1,6, 12- tetiaen- 1 -yl, cyclotetradeca- 1 ,6, 13 -tetiaen- 1 -yl, cyclotetradeca- 1 ,7 ,9-tetraen- 1 -yl, cyclotetradeca- 1 ,7, 10-tetraen- 1 -yl, cyclotetradeca- 1 ,7 , 11 -tetraen- 1 -yl, cycl otetradeca- 1 ,7,12-tetraen- 1 -y 1 , eye loteti adeca- 1 ,7 , 13 -tetraen- 1 -yl , cyclotetradeca- 1,8,10-tetraen-l-yl, cyclotetradeca- 1 ,8,11 -tetraen- 1-yl, cyclotetradeca-l,8,12-tetraen-l-yl, cyclotetradeca-1 ,8,13-tetraen-l-yl, cyclotetradeca- 1,9,11 -tetraen- 1-yl, cyclotetradeca-

1,9,12-tetraen-l-yl, cyclotetiadeca-l ,9,13-tetτaen-l-yl, cyclotetTadeca-l cyclotettadeca- 1,10,13-tetraen- 1 -yl, cyclotetradeca- 1,1 1,13 -tetraen- 1 -yl , cyclotetradeca-2,4,6-tetraen-l-yl, cyclotetradeca-2,4,7-tetraen-l-yl, cyclotetradeca-2,4,8- tetraen-1-yl, cyclotetr'adeca-2,4,9-tetraen-l-yl, cyclotetiadeca-2,4,10-tetraen-l-yl, cyclotetradeca-2,4,11 -tetraen- 1-yl, cyclotetradeca-2,4,12-tetiaen-l-yl, cyclotetradeca-2,4,13- tetiaen-1-yl, cyclotetτadeca-2,5,7-tetraen-l-yl, cyclotetradeca-2,5,8-tetraen-l -yl, cyclotetτadeca-2,5,9-tetiaen-l-yl, cyclotetradeca-2,5, 10 -tetiaen- 1-yl, cyclotetτadeca-2,5,1 1 -tetraen- 1-yl, cyclotetradeca-2,5,12-tetτaen-l-yl, cyclotetradeca-2,5,13- tetraen-1-yl, cyclotetradeca-2,6,8-tetraen-l -yl, cyclotetiadeca-2,6,9-tetraen- 1 -yl, cyclotetτadeca-2,6,10-tetiaen-l-y], cyclotetradeca-2,6,11 -tetraen- 1-yl, cyclotetradeca- 2,6,12-tetraen- 1-yl, cyclotetradeca-2,6,13-tetiaen-l-yl, cyclotetiadeca-2,7,9-tetiaen-l-yl, cyclotetiadeca-2,7,10-tetraen-l-y], cycIotetradeca-2,7,11 -tetraen- 1-yl, cyclotetradeca- 2 ,7, 12-tetr aen- 1 -yl , cycl otetradeca-2,7 , 13 -teti aen- 1 -yl , cy clotetradeca-2 , 8 , 10-teti aen- 1 -yl , cyclotetradeca-2,8,1 1 -tetraen- 1-yl, cycIotetradeca-2,8,12-tetraen- 1-yl, cyclotetradeca-2,8,13- tetraen-1-yl, cyclotetradeca-2,9,11 -tetiaen- 1-yl, cyclotetiadeca-2,9,12-tetraen-l-yl, cyclotetradeca-2,9,13-tetraen- 1 -yl, cyclotetradeca-2, 10,12-tetraen- 1-yl, cyclotetradeca-2,10,13-tetraen-l-yl, cyclotetradeca-2, 11 ,13-tetτaen-l-yl, cyc3otetradeca-3,5,7-tetτaen-l-yl, cyclotettadeca-SjSjS-tetraen-l-yl, cyclotetiadeca- 3,5,9-tetraen-l-yl, cyclotetradeca-3,5,10-tetiaen-l-yl, cyclotetradeca-3,5,1 1 -tetraen- 1-yl,

cyclotetradeca-3,5,124etraen-l-yl, cyclotetradeca-3,6,8-te(τaen-l-yl, cyclotetradeca-3,6,9-tetτaen-l-yl, cyclotetradeca-3,6,10-tettaen-l-yl, cyclotetiadeca-3,6,11-teliaen-l-yl, cyclotetradeca-3,6,12-tetiaen-l-yl, cyclotetτadeca-3,7,9- tettaen-1-yl, cyclotetradeca-3,7,10-tetraen-I-yl, cyclotetiadeca-3,7,1 1-tetraen-l-yl, cyclotettadeca-3,7,12-tetraen-l-yl, cyclotetiadeca-3,8,10-tetτaen-l-yl, cyclotetτadeca-3, 8,1 1-tetraen-l-yl, cyclotetτadeca-3,9,11-tetraen-l-yl, cyclotetτadeca-4,6,8-tetraen- 1 -yl, cyclotetradeca-4,6,9-tetτaen- 1 -yl, cyclotetradeca- 4,6, 10-tetraen-l-yl, cyclotetradeca-4,6,π-tetτaen-l-yl, cycloletradeca-4,7,9-tetiaen-l-yl, cyclotetiadeca-4,7, 10-tetiaen- 1 ~yl, cyclotetiadeca-4,7, 11 -tetiaen- 1 -yl, cyclotelτadeca-4,8,10-tetraen-l-yl, cyclotetradeca-l,3 _J 5,7-tetτaen-l-yl, cyclotetradeca-l,3,5,8-tetraen-l-yl, cyclotetradeca-1, 3,5, 9-tetraen-l-yl, cyclotetradeca- 1 ,3,5, 10-tetraen-l-yl, cyclotetradeca-1,3,5,11-tetraen-l-yl, cyclotetradeca-1, 3, 5, 12-tetτaen-l -yl, cyclotetradeca- 1,3,5,13-tetraen-l-yl, cyclotetiadeca-1 ,3,6,8-tetτaen-l-yl, cycloletradeca-l^ό^-tetiaen-l-yl, cyclotetradeca- 1,3,6,10-tetiaen-l-yl, cyclotetradeca-1, 3,6,11-tetraen-l-yl, cyclotetiadeca-l,3,6,12-tetraen-l-yl, cyclotetradeca-1 , 3,6, 13-tetiaen-l-yl, cyclotetradeca-1 ,3,7,9-tetraen-l-yl, cyclotetradeca-1, 3,7,10-tetraen-1-yl, cyclotetradeca- 1,3,7,1 1-tetraen-l-yl, cyclotetradeca-l^.T.lZ-letraen-l-yl, cyclotetiadeca-1 ,3,7,13-tetraen-l-yl, cyclotetradeca-1 ,3,8,10-tetτaen-1-yl, cyclotetiadeca-1,3.8,11-letraen-l-yl, cyclotetradeca-1, 3, 8,12-tetraen-l-yl, cyclotetiadeca- 1, 3 , 8, 13-tetraen-l-yl, cyclotetradeca- 1, 3,9,1 1-tetiaen-l-yl, cyclotetradeca-1 , 3,9,12-tetraen-l-yl, cyclotetradeca-1, 3,9,13-tetraen-l-yl, cyclotettadeca-1,3,10,12-tetraen- 1 -yl, cycl otetradeca- 1 , 3 , 10, 13 -tetraen- 1 -yl , cyclotetradeca- 1,3, 1 1,13-tetraen-l-yl, cyclotetradeca-l,4,6,8-tetiaen-l-yl, cyclotetradeca-1, 4,6,9-tetraen-l-yl, cyclotetradeca-l^ _j βjlO-tetraen-l-yl, cy cl otetradeca - 1, 4 ,6, 11-tetraen-l-yl, cyclotetradeca-1, 4,6, 12-tetτaen-l-yl, cyclotetradeca-1,4,6,13- tetτaen-1-yl, cyclotetradeca-1 ,4,7,9-tetraen-l-yl, cyclotetradeca-1, 4,7, 10-tetraen-l-yl, cyclotetradeca- 1 ,4,7, 1 1 -tetraen- 1 -yl, cyclotetradeca-1 ,4,7,12-tetraen-l -yl, cyclotetradeca-1 , 4,7,13-tetraen-l-yl, cyclotetradeca- 1, 4,8, 10-tetraen-l-yl, cyclotetradeca- 1,4,8,11-tetiaen-l-yl, cyclotetradeca-1, 4,8, 12-tetiaen-l-yl, cyclotetradeca-1 ,4,8,13- tetiaen-1-yl, cyclotetradeca- 1,4,9,11-tetraen-l-yl, cycl otetradeca- 1,4, 9, 12 -tetraen- 1 -yl, cyclotetradeca- 1 ,4,9, 13-tetraen-l-yl, cyclotetiadeca- 1 ,4, 10, 12-tetraen- 1 -yl, cyclotetradeca-1 ,4,10, 13 -tetraen- 1 -yl, cyclotetradeca-1 ,4, 11,13-tetτaen- 1 -yl, cyclotetτadeca-l ,5,7,9-tetraen-l-yl, cyclotetradeca-1, 5,7, 10-tetτaen-l-yl,

cyclotetradeca-1 ,5,7,11-tetiaen-l-yl, cyclotelτadeca-l,5,7,12-tetraen-l-yl, cyclotettadeca- 1 ,5,7,13-tetraen-l -yl, cycloteiτadeca-1 ,5,8, 10-tetraen-l -yl, cyclotetradeca-1 ,5,8, 11-tetraen-l-yl, cyclotetradeca-1,5, 8, 12-tetraen-l-yl, cyclotetiadeca-l,5,8,13-tetraen-l-yl, cyclotetradeca-1, 5,9,11-tetiaen-l-yl, cyclotetradeca- 1 ,5,9,12-tetraen-l-yl, cycloterradeca-US^π-tetiaen-l-yl, cyclotetradeca-1 , 5,10,12-tetiaen-l-yl, cyclotetradeca-1,5, 10,13-tetraen-l-yl, cyclotetradeca-1 ,5, 11,13-tetraen-l -yl, cyclotetradeca-1, 6,8, 10-tetraen-l -yl, cyclotetτadeca-1 ,6,8,11 -tetraen-1-yl, cyclotetradeca-1 ,6,8,12-tetraen-l-yl, cyclotetradeca-1, 6, 8,13-tetraen-l -yl, cyclotetradeca-1, 6, 9, 11-tetiaen-l-yl, cyclotetradeca- 1,6,9,12-tetraen-l-yl, cyclotetradeca-1, 6,9,13-tetraen-l -yl, cyclotetradeca-1 ,6, 10, 12-tetraen-l-yl, cyclotetradeca-1, 6,10,13-tetraen-l -yl, cyclotetradeca-1, 6,1 1,13-tetraen-l-yl, cyclotetradeca-1, 7,9,11-tetraen-l-yl, cyclotetradeca-1 ,7,9, 12-tetraen-l-yl, cyclotetradeca-1, 7 ,9,13-tetraen-l-yl, cyclotetradeca- 1, 7, 10, 12-tetraen-l-yl, cyclotetradeca-1, 7, 10,13-tetraen-l -yl, cyclotetradeca-1 ,7, 11 ,13-tetraen-l -yl, cyclotetradeca-1 ,8,10,12-tetraen- 1 -yl, cyclotetτadeca-1 ,8,10,13-tetraen-l-yl, cyclotetradeca-1, 8,11,13-tetraen-l-yl, cyclotetradeca-2 _J 4,6,8~tetraen-l -yl, cyclotetradeca-2,4,6,9-tetτaen-l -yl, cyclotetτadeca-2,4,6,10-tetraen-l-yl, cyclotetiadeca-2,4,6,11-tetraen-l-yl, cyclotetradeca- 2,4,6, 12-tetraen-l-yl, cyclotetradeca-2,4,6,13-tetraen-l-yl, cyclotetradeca-2,4,7,9-tetraen-l-yl, cyclotetradeca-2,4,7,10-tetraen-l-yl, cyclotetradeca-2,4,7,1 1-tetraen-l-yl, cyclotetradeca-2,4,7, 12-tetraen-l-yl, cyclotetradeca- 2,4, 7,13-tetraen-l-yl, cyclotetradeca-2,4,8,10-tetraen-l-yl, cyclotetradeca-2,4,8, 11-tetraen-l-yl, cyclotetradeca-2,4,8, 12-tetraen-l-yl, cyclotetradeca-2,4,8,13-tetraen-l-yl, cyclotetradeca-2,4,9,11-tetraen-l-yl, cyclotettadeca- 2,4,9,12-tetraen-l-yl, cyclotetτadeca-2,4,9,13-tetraen-l -yl, cyclotetradeca-2,4,10,12-tetraen-l-yl, cyclotetτadeca-2,4 ₁ 10,13-tetraen-l-yl _! cyclotetradeca- 2,4,11,13 -tetraen- 1 -yl, cyclotetradeca-2,5,7,9-tetraen-l-yl, cyclotetradeca-2,5,7,10- tetτaen-1-yl, cyclotetradeca-2,5, 7,11-tetraen-l-yl, cyclotetradeca-2,5,7, 12-tetraen-l-yl, cyclotetradeca-2,5,7,13-tetiaen-l-yl, cyclotetradeca-2 ₅ 5,8,10-tetraen-l-y3, cyclotetradeca-2,5, 8, 11-tetraen-l-yl, cyclotetradeca-2,5,8, 12-tetraen-l-yl, cyclotetradeca- 2,5, 8,13-tetraen-l-yl, cyclotetτadeca-2,5,9,11-tetraen-l-yl, cyclotetτadeca-2,5,9,12- tetraen- 1 -yl, cyclotetτadeca-2,5,9, 13 -tetraen- 1 -yl, cyclotetradeca-2,5 , 10,12-tetiaen- 1 -yl, cyclotetiadeca-2,5,10,13-tetiaen-l-yl, cyclotetradeca-2,6,8,10-tetτaen-l-yl, cyclotetradeca- 2,6,8,11-tetraen-l-yl, cyclotetradeca-2,6,8, 12-tetraen-l-yl,

cyclotetradeca-2,6,8,13-tetiaen~l-yl, cyclotetiadeca-2,6,9,l l-tetraen-l-y], cyclotetradeca~2,6 ₁ 9,12-tetraen-l -yl, cyclotetradeca-2,6,9,13-tetraen-l -yl, cyclotetradeca- 2,6,10,12-tetraen-l-yl, cyclotetradeca-2,6, 10,13-tetraen-l -yl, cyclotetradeca-2, 6,1 1,13-tetraen-l -yl, cyclotetτadeca-2,7,9,11-tetraen-l-yl, cyclotetradeca- 2,7,9,12-tetraen-l-yl, cyclotetradeca-2,7,10,12-tetτaen-l-yl, cyclotetradeca- 3,5,7, 9-tetraen-l -yl, cyclotetradeca-3,5,7,10-tetτaen-1 -yl, cyclotetradeca- 3,5,7,1 l-letraen~l-yl, cycloletiadeca-3,5 _s 7,12-tetiaen-l -yl, cycloletiadeca-3,5,8,10- tetraen-1-yl, cyclotelτadeca-3,5,8,11-tetiaen-l-yl, cyclotetradeca-3 _s 5,8,12-tetτaen-l-yl, cyclotetradeca-3,5,9,l l-tettaen-l-yl, cyclotetxadeca-3, 5,9,12-tetraen-l-yl, cyclotetradeca-3,5,10,I2-tetraen-l-yl, cyclotetradeca-3,6,8,10-tetiaen-l-yl, cyclotetiadeca-3,6,8,l l-tetiaen-l~yl, cyclotetτadeca-3,6, 8,12-tetraen-l-yl, cyclotetradeca-3, 7,9,11-tetraen-l-yl, cyclotetradeca-l,3,5,7,9-pentaen-l-yl, cyclotetradeca- 1,3,5,7,10-pentaen-l-yl, cyclotetiadeca-1 ,3,5,7,11-pentaen-l-yl, cyclotetradeca- 1 ,3,5,7,12-pentaen-l-yl, cyclotetradeca-1 , 3.5,7, 13-penlaen-l-yl, cyclotetia- deca-l,3,5,8,10-pentaen~l-y], cyclotetradeca-1 ,3,5,8,11-pentaen-l-yl, cyclotetradeca-1, 3, 5,8, 12-pentaen-l-yl, cyclotetradeca-1, 3,5,8,13-pentaen-l-yl, cycloletiadeca-1, 3,5,9,11-pentaen-l-yl, cyclotetradeca-1, 3,5,9, 12-pentaen-l-yl, cycloletradeca-1, 3,5,9,13-pentaen-l-yl, cyclotetradeca-1, 3,5, 10,12-penlaen-l-yl, cyclotetradeca-1, 3,5, 10,13-pentaen-l-yl, cyclotetradeca-1, 3, 5, 11,13-pentaen-l-yl, cyclotetradeca-1, 3,6,8, 10-pentaen-l-yl, cyclotetradeca-1, 3,6, 8,11-pentaen-l-yl, cyclotetradeca-1 , 3,6, 8, 12-pentaen-l-yl, cyclotetradeca-1 ,3,6,8,13-pentaen-l-yl, cyclotetradeca-1 ,3,6,9,11-pentaeπ-l-yl, cyclotetradeca-1 ,3,6,9,12-pentaen-l-yl, cyclotetiadeca-1 ,3,6,9,13-pentaen-l-yl, cyclotetiadeca-1 ,3,7,9,1 1-pentaen-l-yl, cyclotetiadeca-l,3,7,9,12-pentaen-l-yl, cyclotetiadeca-1 ,3,7,9,13-pentaen-l-yl, cyclotetradeca-1 ,4,6,8,10-pentaen-l-yl, cyclotetradeca-1, 4,6, 8,11-pentaen-l-yl, cyclotetradeca-1 ,4,6,8,12-pentaen-l -yl, cyclotetiadeca-1 ,4,6,8,13-pentaen- 1 -yl, cyclotetiadeca-1 ,4,6,9,11 -pentaen-1-yl, cyclotetradeca-1 ,4,6,9,12-pentaen-l -yl, cyclotetradeca-l,4,6,9,13-pentaen-l-yl, cyclotetradeca-1 ,4,7,9,11-pentaen-l-yl, cyclotetradeca-1 ,4,7,9, 12-pentaen-l-yl, cyclotetradeca-1 ,4,7,9,13-pentaen- 1 -yl, cyclotetradeca-1 ,5,7,9,11-pentaen-l-yl, cyclotetradeca-1, 5,7,9, 12-pentaen-l-yl, cyclotetradeca-1, 5,7,9,13-pentaen-l-yl, cyclotetradeca-2,4,6,8,10-pentaen-l-yl, cycloletradeca-2,4,6,8,11-pentaen-l-yl, cyclotetradeca-2,4,6,8, 12-pentaen-l-yl, cyclotetradeca-2,4,6,8,13-pentaen- 1 -yl, cyclotetradeca-2,4,6,9,11 -pentaen-1-yl, cyclotetradeca-2,4,6,9, 12-pentaen-l-yl, cyclotetradeca-2,4,6,9,13-pentaen-l-yl,

cyclotetradeca-2 ,4,6, 10, 12-pentaen-l -yl, cyclotetradeca-2,4,6, 10, 13-pentaen-l -yl, cyclotetradeca-2,4,6,11,13-pentaen-l-yl, cyclotelτadeca-2,4,7,9,11-pentaen-l-yl, cyclotetradeca-2,4,7,9,12-pentaen-l-yl ₅ cyclotelτadeca-2,4,7,9,13~pentaen-l-yl, cyclotetradeca^^JJOJl-pentaen-l -yl, cyclotetτadeca-2,4,7, 10,13-pentaen-l -yl, cyclotetiadeca-2,4,7,11 ,13-pentaen-l-yl, cyclotetradeca^AlO.π-pentaen-l-yl, cyclotetτadeca-2,4, 8, 10, 13-pentaen-l-yl, cyclotetradeca-2, 5,7,9,11-pentaen-l-yl, cyclotetradeca-2,5,7,9,12-pentaen-l-yl ₅ cyclotetiadeca-2,5,7,9,13-pentaen-l-yl, cyclotetradeca-2, 5,7, 10,12-pentaen-l -yl, cycloteiτadeca-2,5,7, 10,13-penlaen-l-yI, cyclotetiadeca-1, 3,5,7,9,11-hexaen-l-yl, cyclotetradeca-1 , 3,5, 7,9,12-hexaen-l-yl, cyclotetiadeca-1, 3,5,7,9,13-hexaen-l-yl, cyclotetradeca-2,4 ,6,8, 10,12-hexaen-l-yl, cyclotetradeca-2,4,6,8,10,13-hexaen-l-yl, cyclotetradeca-2,4,6,8,11,13-hexaen-l-yl and cycloletiadeca-1 , 3,5, 7,9,11 ,13-heptaen-l-yI.

The teim "Cj-cycloalkyl," as used herein, means cycloprop-1-yl

The teim "C ₄ -Cy cloallcyl," as used herein, means cyclobut-1-yt

The term "Cs-cycloalkyl," as used herein, means cyclopent-1-yl.

The teim "Cβ-cycloallcyl," as used herein, means cyclohex-1-yl

The term "C ₇ -cycloalkyl," as used herein, means bicyclo[2 2.1]hept-l-yl, bicyclo[2.2,l]hept-2-yl, cyclohept-1-yl, bicyclo[2.2.1]hept-7-yl and cyclohept-1-yl.

The term "Cg-cycloalkyl," as used herein, means bicyclo[2 2,2]oct-l-yl, bicyclo[2,2.2]oct-2-yl, bicyclo[2.2.2]oct-7-yl, cyclooct-1-yl

The term "Cg-cycloallcyl," as used herein, means cyclonon-1-yl

The term "Cio-cycloalkyl," as used herein, means adamant- 1-yl, adamant-2-yl and cyclodec-1-yl.

US2007/077579

The term "Cπ-cycloalkyl," as used herein, means cycloundec-1-yl, tricyclo[4.3.1 1 ' ]undec-l-yl (homoadarnant-1-yl), tricyclo[4 3.1.1 ' ]undec-2-yl (homoadamant-2-yl), tricyclo[4.3.1 1 ' ]undec-3-yl (homoadamant-3-yl),

3 8 ^T O tiicyclo[4 3.1 1 ' ]undec-4-yl (homoadamant-4-yl), and tricyclo[4.3.1 1 ' ]undec-9-yl (homoadamant-9-yl)

The term "Cs ₂ - ^C ycloalkyl," as used herein, means cyclododec-1-yL

The terni "Cπ-cycloalkyl," as used herein, means cyclotiidec-l-yi.

The term "C^-cycloalkyl," as used herein, means cycloletradec-1-yl

The term "C ₂ -Sp" oalkenyl," as used herein, means ethen-l,2-ylene, both ends of which replace hydrogen atoms of the same CH2 moiety,

The term "C3-spiroalkenyl," as used herein, means prop~l-en-l,3-ylene, both ends of which replace hydrogen atoms of the same CH2 moiety.

The term "C ₄ -spiτoalkenyl," as used herein, means but-l-en-l,4-ylene, but-2-en-l ,4-ylene and buta- 1 ,3-dien- 1 ,4-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "Cg-spiroalkenyl," as used herein, means pent-l-en-l,5-yl-ene, penl-2-en-l,5-ylene, penta-l,3-dien-l,5-ylene and penla-l,4-dien-l,5-ylene, both ends of which xeplace hydrogen atoms of the same CH ₂ moiety

The term "C^-spiroalkenyl," as used herein, means hex-l-en-l,6-ylene, hex-2-en-l,6-ylene, hexa-l,3-dien-l,6-ylene, liexa-l,4-di-en-l,6-ylene and hexa- 1,3,5 -tiien- 1 ,6-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "C ₇ -spiroalkenyl," as used herein, means hept-l-en-l,7-yl-ene, hept-2-en-l ,7-ylene, hept-3-en-l ,7-ylene, hepta-1 ,3-dien-l ,7-ylene, hepla-1 ,4-dien-l ,7-ylene, hepta-1, 5-dien-l ,7-ylene, hepta-2,4-dien-l,7- ylene, hepta-2,5-dien-l,7-ylene, hepta-1, 3, 5-lτien-l ,7-ylene and hepta-1 ,3,6-trien-l,7-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "Cg-spiroalkenyl," as used herein, means oct-l-en-l,8-ylene, oct-2-en-l,8-ylene, oct-3-en-l,8-ylene, octa-l,3-dien-l,8-ylene, octa-l,4-dien-l,8-ylene, octa-l,5-dien-l,8-ylene, octa-l,6-dien-l,8-ylene, octa-2,4-dien-l,8-ylene, octa-2,5- dien-l,8-ylene, octa-3, 5-dien-l, 8-ylene, octa-1 ,3,5-trien-l,8-ylene, octa-l,3,6-trien-l ,8-ylene and octa-2,4,6-tri-en-l ,8-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "Cij-spiroalkenyl," as used herein, means nona-l-en-l,9~yl-ene, nona-2-en-l,9-ylene, nona-3 -en- 1, 9-ylene, nona-4-en-l, 9-ylene, nona-1, 3-dien-l, 9-ylene, nona-1, 4-dien-l ,9-ylene, nona-1, 5-dien-l ,9-ylene, nona-1 ,6-dien-l, 9-ylene, nona-1, 7- dien-l,9-ylene, nona-1, 8-dien-l,9-ylene, nona-2,4-dien-l,9-ylene, nona-2, 5-dien-l ,9-ylene, nona-2,6-dien-l,9-ylene, nona-2,7-dien-l,9-ylene, nona-3, 5-dien-l, 9-ylene, nona-3,6- dien~l,9-ylene, nona-4,6-dien-l ,9-ylene, nona-1, 3, 5-trien-l, 9-ylene, nona-l,3,6-trien- 1 ,9-ylene, nona-l,3,7-trien-l,9-ylene, nona-1, 3 ,8-trien-l, 9-ylene, nona-1, 4,6-trien-l,9-yl-ene, nona-1, 4,7 -trien-1 ,9-ylene, nona-1, 4, 8-trien-l, 9-ylene, nona-1, 5, 7-tiien-l, 9-ylene, nona- 2,4,6-trien-l ,9-ylene, nona-2,4,7-tτien-l ,9-ylene, nona-1, 3,5,7-tetraen-l, 9-ylene, nona-1 ,3,5,8-tetraen-l, 9-ylene and nona-1, 3, 6,9-tetraen-l, 9-ylene, both ends of which replace hydrogen atoms of the same CH2 moiety.

The term "C ₂ -spiroalkyl," as used heiein, means eth- 1,2 -ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "C ₃ -spiroalkyl," as used herein, means prop- 1,3 -ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety .

7 077579

The term "C ₄ -spiτoalkyl," as used herein, means but~l,4-ylene, both ends of which replace hydiogen atoms of the same CH2 moiety.

The term "Cs-spiroalkyl," as used herein, means pent-l,5-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "Ce-spiroalkyl," as used herein, means hex-1 ,6-ylene, both ends of which replace hydiogen atoms of the same CH ₂ moiety

The term "C ₇ -spiroalkyI," as used herein, means hept-1 ,7-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety.

The term "Cg-spiroallcyl," as used herein, means oct-1 ,8-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety,

The term "Gj-spiroalkyl," as used herein, means non-l,9-ylene, both ends of which replace hydrogen atoms of the same CH ₂ moiety

Compounds useful in the invention may contain asymmetrically substituted carbon atoms in the R or S configuration, in which the terms "R" and "S" are as defined by the IUPAC 1974 Recommendations for Section E, Fundamental Stereochemistry, Pure AppL Chem (1976) 45, 13-10 Compounds having asymmetrically substituted carbon atoms with equal amounts of R and S configurations are racemic at those carbon atoms. Atoms with an excess of one configuration over the other are assigned the configuration present in the higher amount, preferably an excess of about 85%-90%, more preferably an excess of about 95%-99%, and still more preferably an excess greater than about 99%, Accordingly, this invention includes racemic mixtures, relative and absolute stereoisomers, and mixtures of relative and absolute stereoisomers.

Compounds useful in the invention may also contain carbon-carbon double bonds or carbon-nitrogen double bonds in the Z or E configuration, in which the term "Z" represents the larger two substituents on the same side of a carbon-carbon or carbon-nitrogen double

bond and the term "E" iepresents the larger two substituents on opposite sides of a carbon- carbon or carbon-nitrogen double bond. The compounds may also exist as an equilibrium mixture of Z or E configurations

Compounds useful in the invention containing NH, C(O)OH, OH or SH moieties may have attached thereto prodrug-forming moieties. The prodiug-forming moieties are removed by metabolic processes and release the compounds having the freed hydroxyl, amino or carboxylic acid in vivo Prodrugs are useful for adjusting such pharmacokinetic properties of the compounds as solubility and/or hydiophobicity, absorption in the gastrointestinal tract, bioavailability, tissue penetration, and iate of clearance For example, examples of piodrug-forming moieties for compounds having C(O)OH moieties are pivalate (CH ₂ OC(O)C(CH ₃ ) ₃ ) or phosphonooxy (CH ₂ OP(O)(OH) ₂ ) esters.

Metabolites of compounds useful in the invention, produced by in vitro or in vivo metabolic processes, may also have utility for treating diseases associated with expression of an anti-apoptotic protein family member such as of BCI-XL, Bcl-2 and Bcl-w

Certain precursor compounds which may be metabolized in vitro or in vivo to form compounds useful in the invention may also have utility for treating diseases associated with expression of an anti-apoptotic protein family member such as Bcl-X^, and Bcl-2 and Bcl-w

Compounds useful in the invention may exist as an acid addition salts, basic addition salts or zwitterions. Salts of the compounds are prepared during their isolation or following their purification Acid addition salts of the compounds are those derived from the reaction of the compounds with an acid. For example, the acetate, adipate, alginate, bicarbonate, citrate, aspartate, benzoate, benzenesulfonate, bisulfate, butyrate, camphoiate, camphorsufonate, digluconate, formate, fumarate, glycerophosphate, glutamate, hemisulfate, heptanoate, hexanoate, hydrochloride, hydrobromide, hydroiodide, lactobionate, lactate, maleate, mesitylenesulfonate, methanesulfonate, naphthylenesulfonate, nicotinate, oxalate, pamoate, pectinate, persulfate, phosphate, piciate, propionate, succinate, tartrate, thiocyanate, trichloroacetic, trifluoroacetic, para-toluenesulfonate, and undecanoate salts of the compounds and prodrugs thereof are contemplated as being embraced by this invention Basic addition salts of the compounds are those derived from the reaction of the compounds

with the hydroxide, carbonate oi bicarbonate of cations such as lithium, sodium, potassium, calcium, and magnesium.

Compounds useful in the invention may be administered, for example, bucally, ophthalmically, orally, osmotically, paienterally (intramuscularly, intraperintoneally intt asternal Iy, intravenously, subcutaneously), rectally, topically, transdermally, or vaginally.

The compounds of this invention can also be incorporated into medical devices for introduction of compounds into selected tissues or organs in the body such as, but not limited to, coronary stents, peripheral stents, catheters, biliary stents, ureteural stents, CNS shunts and catheters, arterio-venous grafts, by-pass grafts and drug delivery balloons which are used in the vasculature; and one measure of the effectiveness of this invention is reduction in such as device-associated thrombi and complications associated therewith

Accordingly, another embodiment of this invention comprises medical devices comprising a supporting structure having a coating in the surface thereof, said coating comprising a compound which prevents or treats a disease caused or exacerbated by an excess of, or undesired activation of, platelets in a mammal

Therapeutically effective amounts of compounds useful in the invention depend on recipient of treatment, disorder being treated and severity thereof, composition containing it, time of administration, route of administration, duration of treatment, its potency, its rate of clearance and whether or not another drug is co-administered. The amount of a compound useful for the practice of this invention used to make a composition to be administered to a patient varies in doses from about 0 001 mg/kg to about 200 rag/kg body weight

Compounds useful in the invention may be administered with or without an excipient Excipients include, for example, encapsulating materials or additives such as absorption accelerators, antioxidants, binders, buffers, coating agents, coloring agents, diluents, disintegrating agents, emulsifiers, extenders, fillers, flavoring agents, humectants, lubricants, perfumes, preservatives, propellants, releasing agents, sterilizing agents, sweeteners, solubilizers, wetting agents and mixtures thereof

US2007/077579

Excipients foi pieparation of compositions comprising an anti-apoptotic Bcl~2 family protein member useful for the practice of this invention to be administered orally in solid dosage form include, for example, agar, alginic acid, aluminum hydroxide, benzyl alcohol, benzyl benzoate, 1,3-butylene glycol, carbomeis, castor oil, cellulose, cellulose acetate, cocoa buttei, com starch, corn oil, cottonseed oil, cross-povidone, diglycerides, ethanol, ethyl cellulose, ethyl laureate, ethyl oleate, fatty acid esters, gelatin, germ oil, glucose, glycerol, groundnut oil, hydroxypropylmethyl cellulose, isopropanol, isotonic saline, lactose, magnesium hydroxide, magnesium stearate, malt, mannitol, monoglycerides, olive oil, peanut oil, potassium phosphate salts, potato starch, povidone, propylene glycol, Ringer's solution, safflower oil, sesame oil, sodium carboxymethyl cellulose, sodium phosphate salts, sodium lauryl sulfate, sodium sorbitol, soybean oil, stearic acids, stearyl fumarate, sucrose, surfactants, talc, tragacanth, tetrahydrofuifuryl alcohol, triglycerides, water, and mixtures thereof Excipients For pieparation of compositions comprising an anti-apoptotic Bcl-2 family protein member useful for the practice of this invention to be administered ophthalmically or orally in liquid dosage forms include, for example, 1 ,3-butylene glycol, castor oil, corn oil, cottonseed oil, ethanol, fatty acid esters of sorbitan, germ oil, groundnut oil, glycerol, isopropanol, olive oil, polyethylene glycols, propylene glycol, sesame oil, water and mixtures thereof Excipients for pieparation of compositions comprising an anti- apoptotic Bcl-2 family protein member useful for the practice of this invention to be administered osmotically include, for example, chlorofjuoiohydiocaibons, ethanol, water and mixtures thereof Excipients for preparing compositions comprising an anti-apoptotic Bcl-2 family protein member useful foi the practice of this invention to be administered parenterally include, for example, 1,3-butanediol, castor oil, com oil, cottonseed oil, dextrose, germ oil, groundnut oil, liposomes, oleic acid, olive oil, peanut oil, Ringer's solution, safflower oil, sesame oil, soybean oil, U S P or isotonic sodium chloride solution, water and mixtures thereof. Excipients for preparation of compositions comprising an anti-apoptotic Bcl-2 family protein member useful for the practice of this invention to be administered rectally or vaginally include, for example, cocoa butter, polyethylene glycol, wax and mixtures thereof

Representative compounds that non-selectively or selectively inhibit the activity of an anti-apoptotic Bcl-2 family protein member were tested for their ability to lower the number of circulating platelets in mammals

2007/077579

Potency is measured by IC5 ₀ value, wherein ϊC5 ₀ means concentration of compound needed for 50% inhibition

BAX and BAD peptides are reported in Zhang, H C , Nimmer, P , Rosenberg, S H , Ng, S C , and Joseph, M (2002) Development of a High-Throughput Fluorescence Polarization Assay for Bcl-x(L) Analytical Biochemistry 307, 70-75

Binding affinity of compounds to BC]-XL protein is indicia of their inhibition of the activity of this protein To determine the binding affinity of compounds to BCI-XL protein, representative examples weie diluted in DMSO to concentrations between 100 μM and 1 pM and added to each well of a 96-welϊ microliter plate A mixture comprising 125 μL per well of assay buffer (20 mM phosphate buffer (pH 7 4), 1 niM EDTA, 50 mM NaCl, 0 05% PF-68), 6 nM of BCI-XL piotein (prepared as described in Science 1997, 275, 983-986), 1 nM fluorescein-labeled BAD peptide (prepared in-house) and the DMSO solution of the compound was shaken for 2 minutes and placed in a LJL Analyst (LIL Bio Systems, CA) A negative control (DMSO, 15 nM BAD peptide, assay buffer) and a positive control (DMSO, 1 nM BAD peptide, 6 nM BCI-XL, assay buffer) were used to determine the range of the assay Polarization was measured at room temperature using a continuous Fluorescein lamp (excitation 485 nm, emission 530 nm) Percentage of inhibition was determined by (l-((mP value of well-negative contioi)/range)) x 100%

Binding affinity of compounds to Bcl-2 protein is indicia of their inhibition of the activity of this protein To determine the binding affinity of compounds to Bcl-2, representative examples were diluted in DMSO to concentiations between 10 μM and 10 pM and added to each well of a 96-well microliter plate A mixture comprising 125 L per well of assay buffer (20 mM phosphate buffer (pH 7 4), 1 mM EDTA, 50 mM NaCl, 0 05% PF-68), 10 nM of Bcl-2 protein (prepared according to the procedure described in PNAS 2001, 98, 3012 - 3017), 1 nM fluorescein-labeled BAX peptide (prepared in-house) and the DMSO solution of the representative example was shaken for 2 minutes and placed in a LJL Analyst (LlL Bio Systems, CA Polarization was measured at room temperatuie using a continuous Fluorescein lamp (excitation 485 nm, emission 530 nm). Percentage of inhibition was determined by (l-((mP value of well -negative control)/range)) x 100%

2007/077579

The effect of the Bcl-2 family piotein inhibitors on circulating platelets has been demonstrated in multiple species including, but not limited to, mouse, rat, dog and monkey The effect of Bcl-2 protein inhibitors on circulating platelets can be determined by administration of test compounds, preferably orally oi intravenously, to an animal and analyzing a blood sample and determining the number of platelets by tecliniques well-known in the ait. Preferably, blood samples are obtained from about 2 hours to about 48 hours after compound administration.

Male beagle dogs (n=3/gτoup; 8-12 kg) were treated with a single dose of 5 mg/kg N- (4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-l-en-l-yl)me thyl)pipeiazin-l-yl)benzoyl)- 4-(({lR)-3-(morpholin-4-yl)-l-((phenylsulfanyl)methyl)propyl )amino)-3' ((tτif!uoromethyl)sulfonyl)benzenesulfonamide in 10:30:60 ethanoϊ/phosal 50 PG/PEG 400 (by weight) by oral gavage. Blood samples were collected at baseline and at the indicated time points from the jugular vein, treated with EDTA and the whole blood analyzed foi platelet counts on a Cell-Dyn 3700 (Abbott Laboratories). The results are shown in Figure 1 , wherein a rapid reduction in circulating platelet count in dogs after one 5 mg/kg oral dose of drug was observed,

Male beagle dogs (n=3/group; 8-12 kg) were treated with a single dose of 5 mg/kg 3- ((chloro(difluoro)methyI)sulfonyl)-N-(4-(4-((2-(4-chlorophen yl)-4 _! 4-dimethylcyclohex-l-en- l-yl)methyl)piperazin-l-yl)ben2oyl)-4-(((lR)-3-(moφholin-4- yl)-I- {(phenylsulfanyl)methyl)propyl)amino)benzenesulfonamide in 10:90 DMSO / PEG 400 (by volume) by oral gavage. Blood samples were collected at baseline and at the indicated time points from the jugular vein, treated with EDTA and the whole blood analyzed for platelet counts on a Cell-Dyn 3700 (Abbott Laboratories). The results are shown in Figure 2, wherein a similar reduction in circulating platelet count in dogs after one 5 mg/kg oral dose of drug was observed

Two male and two female beagle dogs (n = 4/group, 8-12 kg) received single dosages of 15 mg/kg of Example N-(4-(4-((4'-chloro(l,r-biphenyI)-2-yl)methyl)pipeiazin-l- yl)benzoyl)-4-((( 1 R)-3 -(dimethylarn ino) - 1 -((phenylsul fanyl)methyl)propyl)amino)-3 - nitrobenzenesulfonamide in Captisol (modified cyclodextrin) or vehicle control via an intravenous catheter (jugular vein) over a four-hour infusion period. Blood samples were

collected at baseline and at 2, 6, 24, 48 and 72 hours post dosing from the jugular vein, heated with EDTA and the whole blood analyzed foi platelet counts on a Cell-Dyn 3700 (Abbott Laboratories). The results are shown in Figure 3, wherein the effect on circulating platelet count of a single 15 mg/kg intravenous dose of versus control (the vehicle in which it was administered) in dogs over a thiee day (72 hour period) including time intervals of 0, 2 and 6 hour periods on day 0 was observed,

Male beagle dogs (n=3/group; 8-12 kg) were treated with a single dose of 2.5 mg/kg Examples 1-6 in 10:90 DMSO / PEG 400 (by volume) by oral gavage. Blood samples were collected at baseline and 6 hours post compound administration from the jugular vein, treated with EDTA and the whole blood analyzed for platelet counts on a Cell-Dyn 3700 (Abbott Laboratories). Percent starting platelet counts (PC) were calculated using the following equation. [1 - (PC _t =o~~ PC _t =6)/PC _t =o] ^x 100%, The results are shown in Figure 4, wherein the effect on circulating platelet count of a single 2.5 mg/kg oral dose of each of EXAMPLES 1 -6 in dogs at 6 hours aftei dosing was observed.

Male beagle dogs (n=3/group; 8-12 kg) were treated once daily with N-(4-(4-((2-(4- chloropheny^-S^-dimethyl-l-cyclohex-l-en-l-y^methylJpiperazi n-l-y^benzoylJ^-fttlR)- 3-(morpholin-4-yl)-l-((phenylsulfanyl)methyl)propyl)amino)-3 - ((trifluoromethyl)sulfonyl)benzenesulfonamide in 10:90 DMSO / PEG 400 (by volume) by oral gavage at a dose of 2 mg/kg on days 2 - 7 and at a dose of 6 mg/kg on days 8 - 15 of the study. Blood samples were collected at baseline and 6 hours post dosing on days 2 - 5, 8 - 12 and day 15 from the jugular vein, treated with EDTA and the whole blood analyzed for platelet counts on a Cell-Dyn 3700 (Abbott Laboratories). Percent starting platelet counts (PC) were calculated using the following equation [1 - (PC _t = ₀ - PC _l=6 )/PQ=o] * 100%. The results are shown in Figure 5, wherein the proportionate effect of multiple oral dosing of drug on circulating platelet count in dogs was observed.

Additionally, exemplary anti-apoptotic Bcl-2 family protein member inhibitor EXAMPLE 2 induced a unique thrombocytopenia in multiple species that is characterized by a rapid clearance of circulating platelets with recovery to normal platelet counts within several days after treatment.

Furlheimoie, anti-apoptotic Bcl-2 family protein raembei inhibitoi EXAMPL E 2 reduced the viability of dog and human platelets and activated apoptotic processes such as cytochrome c release, caspase 3 activation and PS (phosphotidyl serine) external ization EXAMPLE 2 did not induce aggregation of isolated platelets

Criteria for diagnosis of essential thrombocythemia (ET) and exclusion are known Exemplary criteria can be those used in published anagrelide or hydroxyurea studies, such as those by C Harrison, et al , Hydroxyw ea Compared with Anagi elide in High Risk Essential Tht ombocythemia, N. Engl. J. Med. 2005, 353 (1), 33-45

ET patients can be stratified according to whether they met any of the criteria foi vascular events, such as age, existing or pievious platelet count of 1 million/ml ³ , history of ischemia, thrombosis or embolism, hemorrhage caused by ET, hypertension requiring therapy and diabetes requiring medication

Patients are then dosed For chronic ET patients, dosing of compounds according to the invention may be sustained for a period of time until a desirable reduction in platelet count and/oi steady state is accomplished Perioperative administration of compounds according to the invention to patients with undesirable platelet levels (though not necessarily at levels high enough to constitute ET) may be more limited, such as before or during or postoperatively or at two or moie of these time periods depending on the level of platelet reduction desired and the patient

It is also contemplated that biomaτker level may be an important endpoint

For certain disease states, the physician may desire to lower even normal platelet counts Thus, it is contemplated that a compound according to the present invention cart be administered from a coated stent, for example, that has been implanted in a patient.

As a proxy for platelet count, bleeding events or thrombosis may be used as endpoints

EXAMPLE 1

3-((chloro(difluoro)methyl)suIfonyl)-N-(4-(4-{(2-(4-chlor ophenyl)-4,4-dimethylcyclohex-l- en- 1 -yl)methyl)piperazin- 1 -yl)benzoyl)-4-((( 1 R)-3 -(dimethylamino)- 1 - ((phenylsulfanyl)methyl)propyl)amino)benzenesulfonarnide

EXAMPLE 2

N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-l-cyclohex-l-en -l-yl)methyl)piperazin-l- yl)benzoyl)-4-((( 1 R)-3-(morpholin-4-yl)- 1 -((phenylsulfanyl)methyl)propyl)amino)-3- ((lτifluoromethyl)sulfonyl)benzenesιilfonamide

EXAMPLE 3

N-(4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-l-en-l- yl)methyl)pipeiazin-l- yl)benzoyl)-4-{((lR)-3-(dimethylamino)-l-((phenylsulfanyl)me thyl)propyl)amino)-3- ({iτifluoromethyl)sulfonyl)benzenesulfonamide

EXAMPLE 4

N-(4-(4-((2-(4-chlorophenyl)cyc3oheX"l -en-1 -yl)methyl)pipei azin-1 -yl)benzoyl)-4- (((lR)-3-(2-oxa-5-azabicyclo[2 2,l]hept-5-yl)~l-((phenylsulfanyl)methyI)propyl)amino)"3~ ((tiifluoiomethyl)sulfonyl)benzenesulfonamide

EXAMPLE 5

3-((chloro(difluoio)methyl)sulfonyl)-N-(4-(4-((2-(4-chlor ophenyl)-4,4-dimethylcyclohex-l- en-l-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3-(mθφholi n-4-yl)-l- ((phenylsulfanyl)rnethyl)piopyl)amino)benzenesulfonamide

EXAMPLE 6

N-(4-{4-((2-(4-chloroplienyl)-4,4-dimethylcyclohex-l -en-1 -yl)methyl)piperazin- 1 - yl)benzoyl)-4-(((lR)-3-(moφholin-4-yl)-l-((phenylsulfanyl)m ethyl)propyl)amino)-3- ((trifluoiomethyl)sulfonyl)benzenesulfonamide

EXAMPLE 7

N-(4-(4-((4'-chloro(l,l ^! -biphenyl)-2-yl)methyl)piperazin-l-yl)benzoyl)-4-(((lR)-3- (dimethylamino)-l-((phenylsulfanyl)methyl)propyl)arnino)-3-n itiobenzenesulfonamide

The foregoing is meant to illustrate the invention and not limit it to the disclosed embodiments. Variations and changes obvious to one skilled in the art aie intended to be within the scope and nature of the invention as defined in the claims.